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SUMMARY
Mycotoxins have assumed worldwide importance due to the ubiquitous occurrence of
toxigenic fungi, their infestation of plant-based foods and feeds and the subsequent
economical and health impact it because of their contamination of commercial
products. Ochratoxin A (OA) is a nephrotoxic mycotoxin produced by isolates of
Aspergillus ochraceus and Penicillium verrucosum and occurs frequently in nature.
The major target for toxicity of OA in mammalian species is the kidneys and it has
been the major cause of Danish Porcine Nephropathy. OA has also been extensively
implicated in the aetiology of Balkan Endemic Nephropathy and Chronic Interstitial
Nephropathy in Northern-Africa. Furthermore, OA has been identified as a
carcinogen, an immunosuppressant and a teratogen with respect to the foetal central
nervous system.
Although a large amount of research has been conducted into the chemical nature of
the toxicity of OA, the exact molecular mechanism of action of OA is not yet
conclusive. Numerous structure activity relationship studies have suggested that the
toxicity of OA may be assigned to three major processes: (i) inhibition of ATP
production; (ii) inhibition of protein synthesis; and (iii) the disruption of hepatic
microsomal calcium homeostasis through the promotion of membrane lipid
peroxidation. It is the aim of this thesis to gain a better understanding, through the
synthesis ofOA analogues, of the chemical structure responsible for the toxic function
of the ochratoxins.
The halogen-group has extensively been implicated in the toxicity of the ochratoxins.
This is evident in ochratoxin B (OB), the dechloro analogue of OA, which is
approximately ten times less toxic than OA. Preliminary tests have indicated that
bromo-ochratoxin B(BrOB), the bromo analogue of OA, is more toxic than ochratoxin
A to renal cells. Fluoro-ochratoxin B and other analogues of OA, where other amino
acids are incorporated, should provide invaluable information on the structure-activity
relationships and the mode of action of the ochratoxins. Our research effort addresses
both these aspects (i) fluorination of the dihydroisocoumarin moiety and (ii) the
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coupling of different amino acids and dipeptides to the non-toxic hydrolysed product
of OA, ochratoxin a.
Chapter one includes a review of the important biological aspects of OA that has
served as a guideline to the synthesis of effective OA analogues. An overview of the
relevant chemistry involved in the modification of OA will conclude the chapter.
Chapter two entails a discussion of fluorine in bio-organic chemistry. This includes an
overview of the impact that fluorine substitution has on the biological reactivity of
molecules. A review on the synthesis of organofluorine compounds, which forms the
emphasis of this study, concludes the chapter.
Chapter three elaborates on the different methodologies used in our attempts to
synthesise fluoro-ochratoxin B and other analogues. These included the direct
electrophilic fluorination of OB and different analogous aromatic model compounds
by xenon difluoride, N-fluorobenzenesulfonimides and Selectfluor™ as fluorinating
agents. Also involved is an investigation into an alternative route for the synthesis of
fluoro aromatic compounds from bromo and chloro analogues by means of palladium
catalysed trimethyl- and tributylstannyl and trimethylsilylation which in tum may be
substituted with fluorine by means of xenon difluoride. Efforts towards the direct
catalytic fluorosubstitution of aryl halides are also investigated. The synthesis of a key
intermediate, fluoroacetoacetaldehyde, in a de nova synthetic route to fluoro-
ochratoxin B is also discussed.
Furthermore, the synthesis of novel OA analogues with respect to the replacement of
the L-phenylalanine moiety is addressed. This includes the conversion of OA to Oa,
by acid hydrolysis, followed by the coupling of ortho-, meta- and para- substituted
DL-fluorophenylalanine to the lactone acid. This is followed by the synthesis of
histidylhistidine methyl ester and attempted coupling to Oa. The coupling of
halosalicylic acids and salicylic acid to L-phenylalanine, for use as model aromatic
substrates for fluorination, IS discussed. Peptide coupling by
dicyclohexylcarbodiimide carboxyl activation, with reference to the protection of the
phenolic hydroxyl group in 5-chlorosalicylic acid for application to Oa, concludes
this work.
----------------------------------------------------------------ii
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Mikotoksiene is van wêreld-wye belang as gevolg van die alomteenwoordige
voorkoms van toksigeniese fungi, hul besmetting van plantaardige kossoorte en
voerstowwe en die gevolglike ekonomiese en gesondheidsimpak deur die
besoedeling van kommersiële produkte. Ochratoksien A (OA) is 'n nefrotoksiese
mikotoksien wat geproduseer word deur isolate van Aspergillus ochraceus en
Penicillium verrucosum en kom algemeen in die natuur voor. Die niere is die hoof
teiken vir vergifiting deur OA in soogdierspesies en is as die vername oorsaak van
"Danish Porcine Nephropathy" aangewys. OA word verder aangedui as die oorsaak
vir "Balkan Endemic Nephropathy" en "Chronic Interstitial Nephropathy" in Noord-
Afrika. OA is verder geïdentifiseer as 'n karsinogeen, immuno-onderdrukker en is
teratogenies ten opsigte van die sentrale senuweestelsel van fetusse.
Alhoewel aansienlike navorsing alreeds gewei is aan die chemiese natuur van die
toksisiteit van OA, is die presiese molekulêre meganisme van OA reaktiwiteit
onbeslis. Verskeie struktuur-aktiwitweit verwantskaps studies dui daarop dat die
toksisiteit van OA hoofsaaklik toegeskryf kan word aan drie hoof prosesse: (i)
inhibisie van ATP produksie; (ii) inhibisie van proteïen sintese; en (iii) die
ontwrigting van hepatiese mikrosomale kalsiumhomeostase deur die bevordering van
membraanlipiedperoksidasie. Hierdie tesis het ten doel, deur die sintese van OA
analoë, om 'n beter insig oor die chemiese struktuur wat verantwoordelik is vir die
toksiese funksionaliteit van ochratoksiene te verkry.
Die halogeen substituent is grootliks geïmpliseer in die toksisiteit van OA. 'n Bewys
hiervan is ochratoksien B (OB), die dechlooranaloog van OA, wat ongeveer tien maal
minder toksies is as OA. Voorlopige ondersoeke het aangetoon dat bromo-
ochratoksien B (BrOB), die broomanaloog van OA, meer toksies is vir nierselle as
OA. Fluoorochratoksien B en ander analoë van OA, waar ander aminosure
geïnkorporeer word, behoort waardevolle inligting te voorsien met betrekking tot die
struktuur-aktiwiteitsverwantskappe en die wyse waarop ochratoksiene funksioneer.
Hierdie navorsingspoging spreek beide aspekte aan; (i) die fluorering van die
-------------------------------iii
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dihidroïsokumarien gedeelte en, (ii) die koppeling van verskillende armnosure en
dipeptiede aan die nie-toksiese hidrolieseproduk van OA, nl. ochratoksien a.
Hoofstuk een vervat 'n oorsig van die belangrike biologiese aspekte van OA wat dien
as riglyn vir die sintese van doeltreffende OA analoë. Die hoofstuk word afgesluit met
'n oorsig van die relevante chemie betrokke by die modifisering van die struktuur van
OA.
Hoofstuk twee bevat 'n bespreking van die aanwending van fluoor in bio-organiese
chemie. Dit bevat 'n oorsig van die impak wat fluoorsubstitusie het op die biologiese
reaktiwiteit van molekules. 'n Opsomming oor die sintese van
organofluoorverbindings, wat die essensie van hierdie studie is, beëindig die hoofstuk.
Hoofstuk drie handeloor die veskillende metodes wat toegepas is in pogings om
fluoorochratoksien B en ander analoë te sintetiseer. Dit sluit in die direkte
elektrofiliese fluorering van OB en ander verwante aromatiese modelverbindings deur
gebruik te maak van xenondifluoried, N-fluoorbenseensulfonimied en Selectfluor™ as
fluoreringsreagense. Dit behels verder ook 'n ondersoek na 'n alternatiewe roete tot
die sintese van fluooraromatiese verbindings vanaf broom- en chlooranaloë. Vir die
doel word palladiumgekataliseerde trimetiel- en tributielstannilering, en
trimetielsililering wat vervolgens deur middel van xenondifluoried met fluoor
gesubstitueer kan word, aangewend. Pogings tot die direkte katalitiese
fluoorsubstitusie van arielhaliede word ook bespreek. Die sintese van 'n sleutel-
intermediêr, fluoroasetoasetaldehied, in 'n de nova sintese roete tot fluoorochratoksien
B word bespreek.
Die sintese van nuwe OA analoë, met betrekking to die vervangmg van die L-
fenielalanien (L-Phe) groep word ondersoek. Dit bevat die omsetting van OA na Oa,
deur suurhidrolise, gevolg deur die koppeling van orto-, meta- en para-
gesubstitueerde DL-fluoorfenielalanien aan die laktoonsuur, Oa. Daarna word die
sintese van histidielhistidienmetielester en die verdere pogings aangaande koppeling
met Oa bespreek. Die koppeling van halosalisielsure en salisielsuur aan L-Phe wat
dien as model aromatiese verbindings vir fluorering, word behandel. Peptiedkoppeling
met behulp van disikloheksielkarbodiimied-karboksielaktivering, met inbegrip van die
--------------------------------------------------------------lV
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beskerming van die fenoliese hidroksiel groep m 5-chloorsalisielsuur Vir die
toepassing op Oa, beëindig hierdie werk.
---------------------------------------------------------------V
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CHAPTER!
SECTION A: BIOLOGICAL ASPECTS OF OCHRATOXIN A
AND OTHER MYCOTOXINS.
1.1 Introduction
All forms of life, including fungi, require exogenous material to incorporate into their
biomass. Certain heterotrophs* such as molds require simple organic compounds for
both the synthesis of cell constituents and to produce energy for these synthetic
processes. These facets, which encompass a complex network of enzyme-catalysed
reactions, are known as primary metabolism. In addition to the reactions of primary
metabolism, reactions frequently occur which are non-essential to life, often
characteristic to genera, species or strain and which may be considered as an
expression of the uniqueness of the organism. These reactions are grouped under the
term secondary metabolism and the products associated with it as secondary
metabolites.
Secondary metabolites are distinguished from pnmary metabolites by their
constrained distribution in plants and other organisms, there specificity to its
producing organism and to the biochemical pathways it is derived of. An important
characteristic of secondary metabolites is that they may be derived from primary
metabolism and may be regarded as excretions, which have no vital importance as an
energy source or as a mechanism of storage. The significance of secondary
metabolites to their producers has been the source of much debate and numerous
theories have been proposed.
Weinberg, 1971, rationalized the broad spectrum of pharmacological activity
exhibited by secondary metabolites in lower to highly specialized organisms as factors
participating in an ecological relationship between the producer and interacting
organisms. Bu'Lock, 1965,proposed a maintenance hypothesis that gave emphasis to
the regulatory role of secondary metabolites in metabolism, thus accentuating the
greater importance of secondary metabolism than its products.
• Organisms that require an organic source of carbon.
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Bu'Lock, 1980, reported on the possible relationship between the production of
secondary metabolites and differentiation of the producing organism. This was
illustrated in cultivated strains of Aspergillus fumigatus producing the antibiotic
trypacidin in surface cultures. It was found that the production of metabolites in the
individual cultivation vessel was directly proportional to the sporulation of the
cultures. It was demonstrated by Parker and Jenner, 1968, that trypacidin was only
isolated from spores and could not be found in the vegetative mycelium or growth
medium.
One such class of secondary metabolites is the Mycotoxins. These naturally occurring
toxicants are produced by a variety of fungal species and originate from different
biosynthetic pathways. This results in a heterogeneous group of chemically diverse
compounds (see Figure l.1), manifested in living cells by a broad spectrum of
biochemical effects.
Polyketides
..
Patulin
(Tetraketide)
H02CWOH 0- ~02HwO OH g
o ~ /; CH2~NH -/" '0
o CH} ~ I .... "CH3
H
CH} CH3 Cl
Citrinin
(Pentaketide)
Ochratoxin A
(Pentaketide)
o CO?H
R= ~C02H
o
OR OH OH
Fumonism B.
(Nonaketide)
Aflatoxin BI
(Decaketide)
Tetramie acidsDiketopiperazines
OH OH
Cl
Sporidesmin A Cyclopiazonic acid
Figure 1.1 Mycotoxins as representatives of the main biosynthetic categories of
secondary metabolites.
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Peptides
Phomopsin A
Ergotamine
Terpenes
Penitrem A
(Diterpene )
T2-toxin Phaseolinone
(Sesquiterpenes)
Pyranyl/pyridone
OH
Sambutoxin
Figure 1.1 Continued
TMC-69
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Mycotoxins have attained worldwide importance due to the ubiquitous occurrence of
toxigenic fungi and their subsequent infestation of plant -based foods and feeds. More
importantly though is the health concerns of affected consumers, such as mammals,
fish and poultry. The diseases caused by the consumption of mycotoxins by humans
and animals are called mycotoxicoses and is not only derived from contaminated
plant-based foods, but also from their metabolites in animal-derived foods such as,
milk, cheese and meat.
The magnitude of this problem is evident from the numerous diseases associated with
mycotoxins (see Table 1.1). The chemical diversity and complexity of the mycotoxins
and the associated pathological manifestations in living tissue pose a difficult task in
the diagnosis of affected species. Kuiper-Goodman, 1989; Kuiper-Goodman and
Scott, 1989, and Kuiper-Goodman et al., 1996, contributed greatly to the risk
assessment of mycotoxins. The human health concerns depend on the amount and
toxicity of the mycotoxin consumed, the body weight and physical status of the
affected individual, the simultaneous presence of other mycotoxins and other dietary
factors. The occurrence of animal mycotoxicoses is mainly governed by climatic
conditions in a region and the agricultural practices employed in growing and
harvesting crops and feeds.
Hsieh, 1990, correlated the role of a mycotoxin in the aetiology of a form of human
disease along the following criteria:
a) Occurrence of the mycotoxin(s) in food supplies;
b) Human exposure to the mycotoxins;
c) Correlation between exposure and incidence;
d) Reproducibility of characteristic symptoms in experimental animals;
e) Similar mode of action in human and animal models.
Of these criteria, the most important evidence in the assignment of a mycotoxin as the
causative substance would be the incidence of the disease in response to the exposure
to the mycotoxin.
4
Stellenbosch University http://scholar.sun.ac.za
LITERATURE REVIEW: BIOLOGICAL ASPECTS OF OCHRATOXIN A
Table 1.1 Diverse biological activity displayed by some representative mycotoxins (Source: modified
from Steyn and Stander, 2000).
Mycotoxin Biological Associated Diseases Producing References
activity Genus
Patulin Mutagenicity, Tremorgenie toxin Penicillium Engel and Teuber (1984)
neurotoxin, ("staggers syndrome")
antibacterial
Citrinin Nephrotoxicity Yellow rice toxicoses Aspergillus, Betina (1984)
Penicillium
Ochratoxin A Carcinogenicity Balkan endemic Aspergillus, Van der Merwe et al. (1965)
nephrotoxicity nephropathy, Penicillium Petkova-Bocharova et al.
Cronic interstitial (1988)
nephropathy in North Pohland et al. (1992)
Africa. Nephropathy in Creppy et al. (1999a)
pigs (Danish porcine
nephropathy) and poultry
Fumonisin BI Carcinogenicity, Equine leuko- Fusarium Bezuidenhout et al. (1988)
neurotoxicity encephalomalacia, Gelderblom et al. (1988)
Porcine pulmonary Jackson et al. (1996)
oedema, oesophageal
cancer
Aflatoxin BI Carcinogenicity , Human primary liver Aspergillus Buchi et al. (1966)
teratogenicity cancer, turkey X disease Van Rensburg (1986)
Bressac et al. (1991)
Groopman et al. (1992)
SporidesminA Hepatotoxicity, Facial eczema in New Pithomyces Mortimer et al. (1978)
photosensitivity Zealand sheep
u-Cyclopiazonic Neurotoxicity, Acute toxicity, liver Aspergillus, Holzapfel (1968)
acid carcinogenicity necrosis in rats Penicillium Purchase (1971 )
Phomopsin A Hepatotoxicity Lupinosis in sheep Phomopsis Culvenor et al. (1989)
Ergotamine Vasoconstriction, Ergotism, St Anthony's Claviceps Stoll (1952)
neurotoxicity Fire in humans Scott et al. (1992)
Penitrem A Neurotoxicity Tremorgenie toxins Penicillium De Jesus et al. (1983)
Steyn and Vleggaar (1985)
Trichothecenes Dermatoxicity , Alimentary toxic aleukia Fusarium Plattner et al. (1989)
(T-2 toxin) haematopoietic Wannemacher et al. (1991)
effects Grove (1996)
Phaseolin one Mutagenic, anti- Antifertility in rats Aspergillus, Bhattacharya (1990)
leishmanial and Macrophomina Isaka et al. (2000)
antiplasmodial
Sambutoxin Hemorrhagic Fusarium Kim et al. (1995)
Williams and Turske (2000)
TMC-69 Antitumor Chrysosporium Kohno et al. (2001)
antibiotic
4'
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Kuiper-Goodman, 1991, emphasized that based on the aforementioned approach of
risk assessment, especially with respect to carcinogenicity data, the extrapolation of
toxicological data from animal models to humans is subject to numerous variables.
The differences in the pharmacokinetics between the species, which include
absorption, distribution and metabolism, affect the assessment of the toxicity of the
compound.
Kuiper-Goodman, 1991, concluded that the overall risk extrapolation from animal
data to humans involves:
a) Extrapolation from high doses within the experimental range of animal
experiments to low doses, usually outside the experimental range, to which
humans might be exposed
b) Extrapolation from test species to humans; and
c) Extrapolation to the most sensitive subgroup of humans.
A study of a specific mycotoxicosis, specifically ochratoxicosis, would require the
isolation and identification of the producing fungus. Followed by the chemical
characterization of the mycotoxin, which will allow the monitoring of the toxin in
nature and regulation of the toxin in biological systems.
In our research effort, the study into the structure activity relationship of different
ochratoxin analogues becomes of fundamental importance in elucidating the role of
ochratoxins as causative agents in diseases.
In the following sections attention will be directed to the different aspects of
ochratoxin metabolism, which will include production, natural occurrence, chemical
characteristics, molecular mechanisms, pharmacokinetics, toxicology, prevention and
treatment. The knowledge gained will be employed in the synthesis of relevant
ochratoxin A (OA) 3, analogues.
5
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1.2 Production of Ochratoxin A.
The most frequent fungal contaminants of cereal grains and other plant-based foods in
storage are the genera Penicillium and Aspergillus, several of which produce OA
(Frisvad and Samson, 1991). These fungi have been termed as storage fungi.
OA was first reported as a naturally occurring mycotoxin, produced as toxic
secondary metabolites of Aspergillus ochraceus Wilh. by Van der Merwe et al., 1965.
In recent years a wide range of other Aspergillus and Penicillium species has been
identified as producers of OA (Frisvad and Samson, 1991; Marquardt and Frohlich,
1992; Abarca et al., 1994 and Varga et al., 1996) (see Table 1.2).
Table 1.2 OA-producing fungal species.
Aspergillus Penicillium
Main producing species
A. ochraceus (A. alutaceus) P. viridicatum (P. verrucosum)
Other producing species
A. melleus (A. quercins)
A. alliaceus
A. ostianus
A. sclerotiorum
A. albertensis
A. wentii
A. auricomus
A. niger var.niger
A. sulphureus (A. fresenii)
P. commune
P. cyclopium
P. palitans
P. purpurescens
P. variabile
The ochratoxins are contaminants of a wide range of plant and animal products, the
extent of which are governed by various factors. These include water activity (a,»),
temperature, type of substrate, presence of competitive microflora, fungal species, and
the integrity of the seed (Marquardt and Frohlich, 1992).
6
Stellenbosch University http://scholar.sun.ac.za
LITERATURE REVIEW: BIOLOGICAL ASPECTS OF OCHRATOXIN A
The nummum aw values for OA production by A. alutaceus and P. verrucosum
observed for stored grains varied between 0.83 and 0.90. At optimum aw levels the
temperature range for OA production by A. alutaceus and P. verrucosum, was 12 to
37°C and 4 to 31°C, respectively. This is evident in countries with colder climates
such as Scandinavia and Canada, where P. verrucosum is the key producer of OA in
cereals. In contrast, in the warmer climatic zones such as Australia and Yugoslavia,
A. alutaceus is the foremost producer ofOA in stored crops (Krogh, 1987a).
Madhyastha et al. 1990, in an in vitro study, followed the production in time of OA,
ochratoxin B (OB) and citrinin by A. alutaceus and P. verrucosum, when inoculated
in grain (wheat and com) and oilseeds (soybean, peanuts and rapeseed). The results
indicated that the A. alutaceus inoculated oil seeds (peanuts and soybean) achieved
higher OA and OB production than the grain substrate (wheat and com). The opposite
applied for the P. verrucosum inoculated grain crops (wheat and com), supporting OA
and citrinin production more effectively than the oilseed substrates.
Chelack et al., 1991a, found that the production of OA by A. alutaceus on sterilized
barley was comparatively higher than the production of OA on unsterilized barley. It
would thus be possible to regulate the production of OA by varying the amount of
non-OA producing microflora in inoculated storage grains.
Roschenthaler et al., 1984, found that subdivided and subcultures of A. alutaceus
produced variable amounts of OA. Chelack et al., 1991b, reported on the inconsistent
OA production by variants of A. alutaceus (isolated from the fungus after gamma
irradiation) from inoculated barley.
1.3 Natural Occurrence of OA
OA contamination of commodities worldwide has become a serious problem, not only
from a health perspective but also from an economical point of view. High-energy
plant-based products such as cereal grains, oil seeds, nuts, dried fruit and other
feedstuffs are all susceptible to contamination by OA due to the widespread
distribution of toxigenic fungi. The consumption of contaminated feeds by non-
ruminant animals such as poultry and pigs poses the risk of contamination of meat and
7
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meat products, which inevitably affects humans (Van Egmond and Speijers, 1994).
This is manifested further by the detection of OA in milk of lactating women, posing
the threat of possible spread to infants.
OA occurrence is most prevalent in European and North American countries. Apart
from climatic conditions the agricultural techniques employed during harvesting and
pre-harvesting play an equally important role in the prevention of contamination. Van
Egmond and Speijers, 1994, reported the highest levels of OA contamination to be in
cereals (maize between 10 and 500 ug kg', wheat between 5 and 135 !-lg kg' and
barley between 10 and 500 ug kg"),
In meat products the highest incidence is found in kidneys from pigs (which range
between 2 and 100 ug kil) and poultry (average of 19 ug kg"). Lower levels of OA
are also found in other tissue such as liver, muscle, adipose and blood of these
animals.
The natural occurrence of OA in commercial feedstuffs, such as coffee beans has been
reported by several authors (Joosten et aI., 2001; Mantle and Chow, 2000).
Concentrations of OA in green coffee beans ranges between 0.2 and 360 ug kg".
Blanc et aI., 1998, found that more than 80% of OA found in contaminated beans are
destroyed during the roasting and brewing processes.
Reports on the occurrence of OA in wine have shown a considerable level of
contamination (Visconti et al., 1999; Abrunhosa et al., 2001). The degree of
contamination shows prevalence for both the type of wine and the geographical origin
of the grapes. The highest concentrations of OA (up to 7.0 ng/ml) and incidence
(92%) were found in red wine samples originating from southern and warmer regions
of Europe (Ottender and Majerus, 2000). Stander and Steyn, 2001, in a
comprehensive survey of OA in South African wines, reported that no regional
influence could be observed and found that both red and white wines contained
similar levels of OA.
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1.4 Chemical Structure.
The structure of OA was derived from its physical characteristics, several degradation
experiments (Van der Merwe, 1965), the total synthesis (Steyn and Holzapfel, 1967),
and by biosynthetic studies employing both radioactive isotopes (Steyn et al., 1970)
and stable isotopes (de Jesus et al., 1980). Bredenkamp et al., 1989, determined the
crystal structure for both OA and OB in an attempt to rationalize the relationship
between structure and function (see Figure 1.2).
OA is comprised of a pentaketide derived, 7-carboxy-5-chloro-8-hydroxy-3R-methyl-
3, 4-dihydroisocoumarin (the hydrolysed product ochratoxin a, Oa) which is linked
through its 12-carboxyl group via an amide bond to L-phenylalanine (L-Phe) (Van der
Merwe et al., 1965).
OA is a colourless, crystalline compound, obtained readily by crystallisation from
benzene. The crystals have a melting point (m.p.) of ca 90°C (containing
approximately 1 mol of benzene). Recrystallisation from xylene yields crystals with a
m.p. 171°C (Van der Merwe et al., 1965). The compound is soluble in polar organic
solvents, slightly soluble in water, and soluble in a dilute alkaline solution of sodium
hydrogen carbonate (Steyn, 1967).
Cl
Figure 1.2 Ochratoxin A, [3-form (Bredenkamp et al., 1989)
1.4.1 Naturally occurring analogues of OAe
The dechloro analogue OB, is a colourless crystaline compound spectroscopically
closely related to OA but differing vastly in biological activity. OB is approximately
10 times less toxic than OA and displays no immunosuppressive activity (Luster et
9
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al., 1987). OB can be obtained by quantitative catalytic dechlorination of OA (10%
palladium-charcoal and ammonium formate in methanol) (Bredenkamp et al., 1989).
0 OH 0 0 OH 0
II II II II
/C C'- /C
C-O-
Rl 0 Rl CH3
" .."CH2Rs
H OH
~ R2
Tabel1.3 Naturally occurring ochratoxins.
OA analogues RI R2 R3 n, Rs References
Ochratoxin B (OB) Phe H H H H Van der Merwe (1965)
Ochratoxin C (OC) Phe- Cl H H H Steyn and Holzapfel( 1967)
ethyl ester Chu (1974)
Ochratoxin A Phe- Cl H H H Steyn and Holzapfel(1967)
methyl ester (OE) methyl ester Chu (1974)
Ochratoxin B Phe- H H H H Steyn and Holzapfel( 1967)
methyl ester (OF) methyl ester Chu (1974)
Ochratoxin B Phe- H H H H Steyn and Holzapfel(1967)
ethyl ester (OD) ethyl ester Chu (1974)
Ochratoxin a (Oa) OH Cl H H H Suzuki et al. (1977)
Hansen et al. (1982)
Ochratoxin ~ (O~) OH H H H H Hutchison et al. (1971)
4R-OH-Ochratoxin A Phe Cl H OH H Hutchison et al. (1971)
(4-0H-OA) Stormer et al. (1983)
Xiao et al. (1996a)
4S-0H-Ochratoxin A Phe Cl OH H H Scott et al. (1971)
(4-0H-OA) Stormer et al. (1983)
4R-OH-Ochratoxin B Phe H H OH H Xiao et al. (1996a)
(4-0H-OB)
10-0H-Ochratoxin A Phe Cl H H OH Stormer et al. (1983)
(10-0H-OA) Xiao et al. (1996a)
Lactone opened ring Phe Cl Xiao et al. (1996b)
OA (OP-OA)
Ochratoxin A, OH-Pro Cl H H H Hadidane et al. (1991)
hydroxyproline
Ochratoxin A, Lys,Ser,Tyr Cl H H H Hadidane et al. (1991)
lysine, serine, tyrosine Creppy et al. (1990)
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Both the ethyl and methyl esters of OA and OB have been isolated from A. ochraceus
cultures (Steyn and Holzapfel, 1967). Stander et al., 2001a, reported that OA methyl
ester was not hydrolysed by carboxipeptidase A (CPA). This was ascribed to the
obstruction, brought about by the methyl group, of the ionic interaction between the
carboxyl group and the active site of carboxypeptidase A. The observed similarity in
in vivo toxicity of OA and OE can be attributed to the facile ester hydrolysis of OE by
intestinal esterases. In a similar manner the respective esters of OB was found to be
resistant to hydrolysis and as expected, non-toxic.
The non-toxic cleavage product, Oo, a residue from the protozoan and bacterial
enzyme hydrolysis of OA, is found in various organs in rats. This includes mostly the
caecum, duodenum, ileum and the pancreas, whereas in the kidneys and liver low to
no activity has been found, respectively (Suzuki et al., 1977; Hansen et al., 1982 and
Stermer et al., 1983). Oe can be obtained synthetically by acid hydrolysis (6M HCI),
treatment with carboxypeptidase A or a-trypsin, rendering the dihydroisocoumarin
(Oa) and corresponding amino acid (L-Phe).
In a similar manner the hydrolysis product of OB, 013, occurs in nature. Patterson et
al., 1976, studied the comparative rates of hydrolysis ofOA and OB in pregnant sows.
OA was found to be partially hydrolysed in the intestines, whereas the presence of
higher levels of 013 in the faeces of sows fed only OB indicated a higher rate of
hydrolysis. It was further found that OB relative to OA has a lower absorption from
the intestines. This suggested a more rapid enzyme hydrolysis of OB in the liver.
Extracts of rat hepatocytes and intestinal tissue confirmed a higher hydrolysis of the
non-toxic analogue (Hult et al., 1977). Doster and Sinnhuber, 1972, in an in vitro
kinetic study of bovine carboxypeptidase A, showed that OB hydrolyses up to two
hundred times faster than OA. Stander et al., 2001 b; found that although CPA had a
lower relative affinity for OB than OA, the turnover for OB was ten times higher than
for OA (see also section 1.5).
Naturally occurring analogues with modification to the isocoumarin moiety have been
isolated by Hutchison et al., 1971, from P. viridicatum grown from YES medium. The
intraperitoneal injection of male Wistar rats with OA caused the excretion of OA, Oo;
Il
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and 4-hydroxyochratoxin in the urine. With the OA proving fatal in all of the test
cases, the hydroxyochratoxin was non-toxic. Stermer and Pederson (1980) implicated
cytochrome P-4S0 in the hydroxylation, and subsequent detoxification, by rat liver
rrncrosomes.
Stormer et al., 1981, concluded that under the influence of cytochrome P-4S0 the
(4R)-OH-OA epimer is formed as the major product in human and rat liver
rmcrosornes, while the (4S)-OH-OA epimer is more readily formed in pig liver
mierosomes. Oster et al., 1991, contributed by purification and indentification of
porcine hepatic cytochrome P-4S0 fractions and suggested this enzyme to have an
important role in OA oxidation.
The lO-OH analogue to OA was isolated from rabbit liver mierosomes (Stermer et al.,
1983) and shown to be less toxic than OA. Xiao et al., 1996b, reported the isolation of
an opened lactone ring analogue of OA in the bile of rats after administering OA. OP-
OA was shown to be highly toxic when injected intravenously but not intraperitonealy
in rats, with the toxicity of intravenously administered OP-OA being even greater than
that for OA.
1.4.2 Synthetic analogues of OA.
Several derivatives of OA have been prepared by the substitution of the L-Phe side
chain with various amino acids (see Table 1.4). Creppy et al., 1983a, found that for
tyrosine, valine, serine and alanine analogues the toxicity is the greatest, the
methionine, tryptophan, and glutamic acid analogues have on intermediate toxic
effect, and the glutamate and proline substituted OA has the lowest toxicity. The
relative toxicity of these analogues may be correlated to some extent to the presence
of an aromatic ring substituent on the respective amino acids. Creppy et al., 1990 also
showed that OA could be hydroxylated by phenylalanine hydroxylase to form the
tyrosine analogue of OA.
12
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Table 1.4 Synthetic analogues of OA.
Analogue RI Rz R3 R4 Rs References
OA-O-methyl COOH CH) Cl Xiao et al.
ether (OM-OA) (1995)
OA-O-methyl- COOCH3 CH) Cl Van der Merwe
methyl ester et al. (1965)
OA-ethylamide CONHC2Hs H Cl Xiao et al.
(OE-OA) (1995)
Decarboxylated H H Cl Xiao et al.
(d-OA) (1995)
Bromo-OB COOH H Br Steyn and Payne
(BrOB) (1999)
Iodo-OB COOH H Steyn and Payne
(lOB) (1999)
Ou-methyl ester OCH3 Xiao et al.
(M-Oa) (1995)
OA-D-Phe o-Phe Xiao et al.
(D-OA) ( 1995)
OA-L-Tryp, Ala, L-Trp, Ala, Steyn et al.
Tyr, Cys, Gill, OH- Tyr, Cys, (1975)
Pro, Leu, Met, Val, Gill OH-Pro, Creppy et al.
Ser, Asp, Thr Leu, Met, (1983)
Val,Ser, Asp,
Thr
Salicyl-Phe H Stander et al.
(SAPhe) (200Ia)
Fluorosalicyl-Phe F Stander et al.
(5FSAPhe) (2001a)
Chlorosalicyl-Phe Cl Stander et al.
(5CISAPhe) (2001a)
Bromosalicyl- Phe Br Stander et al.
(5BrSAPhe) (2001a)
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In a study to ascertain the role of the halogen group in the toxicity of OA, Steyn and
Payne, 1999, synthesised the bromo and iodo analogues of OA. This was followed by
the first biological production of bromo ochratoxin B by A. ochraceus Wilh. (Stander
et al., 2000). In a comparitive study Stander et al., 2001a, found that OA and BrOB
exhibited similar enzyme affinity (kcat) and turnover values (Km) upon treatment with
CPA (Tabel l.5). For the specific case of the chi oro and bromo compounds the
halogen group has no apparent influence on substrate binding or catalytic function.
The fact that preliminary results have revealed an increase in toxicity of BrOB to
renal cells compared to OA, shows that the rate of hydrolysis is not solely responsible
for the degree of toxicity of the ochratoxins (Creppy, 1999b).
Table 1.5 Hydrolysis of Ochratoxins and analogues by Carboxypeptidase A. (Source:
Stander et al., 2001a).
Toxin Km kcat kcat/Km
(I-LM) (min -I) (min-I ).lM-1)
OA 5.6 266 47
OB 36.8 2717 74
BrOB 6.6 283 43
SAPhe 0.8 2372 3163
5FSAPhe 16.0 4276 267
5CISAPhe 5.5 2869 521
5BrSAPhe 12.9 3724 289
Stander et al., 2001a, further studied the hydrolysis of various halo salicylic acid and
salicylic acid coupled L-Phe analogues by CPA. It was found that for 5BrSAPhe and
5FSAPhe, higher catalytic efficiencies (kcat/Km) were obtained compared to the
corresponding chIoro substrate. In agreement with the ochratoxins, the non-
halogenated salicylic acid coupled L-Phe showed both increased substrate binding and
hydrolysis by CPA compared to the halogenated analogues. The comparison of OA
and L-Phe coupled analogues hydrolysis data further reveals an increased catalytic
efficiency of CPA for the L-Phe coupled substrates. This finding implies the presence
of the lactone moiety directly in the toxicity of the ochratoxins. In the following
section these and other functionalities implicated in the toxicity of OA will be
discussed in more detail.
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1.5 Molecular mechanisms of toxicity.
Although extensive research has been conducted into the chemical nature of the
toxicity of OA, the exact molecular mechanism of action of OA is not yet conclusive.
The toxicity of OA may be the result of three major effects: (i) inhibition of ATP
production; (ii) inhibition of protein synthesis; and (iii) the disruption of hepatic
microsomal calcium homeostasis, through the promotion of membrane lipid
peroxidation (Creppy et al., 1990). Recent studies have suggested that apart from the
direct role in toxicity several indirect roles do exist in living systems (Xiao et al.,
1996b ).
The isolation of covalent DNA adducts in OA-treated mice and from urine of patients
suffering from urinary tract tumors has suggested a possible relationship between OA
toxicity and macromolecule formation (Pfohl-Leszkowicz et al., 1993a, 1993b).
Malaveille et al., 1994, have implicated the formation of a genotoxic OA phenoxide
radical and a cytotoxic thiol conjugate of OA as reactive metabolites in E. coli strains
and causative agent of toxicity.
Meisner and Chan, 1974; and Wei et al., 1985, reported in an in vitro study of rat liver
mitochondria, that OA inhibited mitochondrial respiration (see section 1.8.3) by the
competitive inhibition of carrier proteins located in the inner mitochondrial
membrane. Meisner, 1976, further elaborated on the effect of OA uptake, an energy
consuming process with the depletion of intramitochondrial ATP and the subsequent
inhibition of phosphate transport across the mitochondrial membrane.
Chu, 1971, first implicated the role of the phenolic hydroxyl group in the toxicity of
OA, other natural analogues OB, Oa and OC and synthetic analogue OM-OA. Chu,
1974, showed that the dissociation constants (pKa) of the phenolic hydroxyl group for
the different analogues was related to the toxicity of the analogue, and that
dissociation of the hydroxyl group was required for its toxicity. This is further
substantiated by the reports of higher toxicity of BrOB to kidney cells compared to
OA (Steyn and Payne, 1999).
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In physiological systems a significant proportion of OA, oe and possibly BrOB is in
the dissociated form, and the resultant phenoxide ion could be may to react with
biological constituents. A correlation between the pKa values and the observed
toxicities of the ochratoxins is shown in Table 1.6.
In support of this approach, Doster et al., 1974, suggested that increasing the
molecular mass while still maintaining the dissociative properties of the phenolic
hydroxyl group could enhance the toxicity of the ochratoxins. Doster et al., 1974,
found that oe is almost twice as toxic to trout than OA, while both compounds share
the same pKa value.
Table 1.6 A correlation between the comparitive cytotoxicity and antimicrobial
activity of OA and its dissociation- and iron chelation-potential (Source: Xiao et al.,
1996b).
OAand pKa3
analogues
OA 7.0
OB 7.8
oe 7.2
D-OA 7.2
Oa 11.6
OM-OA NN
d-OA 7.9
OE-OA 6.7
M-Oa 8.2
OP-OA NOt'
Fe2+
chelationb
B.brevis MTDd
(nmol/disc)
HeLa cell LCso C
(mM)
++
+
+++
++
0.005
0.054
0.009
0.163
0.56
0.83
7.6
10.1
NOf
NOf
8.7
54
2.0
5.5
390
NIg
Nlg
1.1
90
Nlg
+++
+++
aThe pKa values are for the dissociation of phenolic hydroxyl group and not for the carboxyl groups.
bIron-chelation ofOA and its analogues at pH 4.5 as determined visually by colour change, strong
(+++), moderate (++), weak (+) and none (-). cLCso, the concentration of toxin required to reduce
number of cells by 50% as determined by linear regression. dMTD, minimum toxic dose for measurable
inhibition of B. brevis growth in a medium at pH 6.5. eNA, not applicable as the phenolic group is
methylated. fND, not determined gNl, no inhibition attained at 350 nmol/disc.
As mentioned before (section 1.4.2) the relative rates of hydrolysis of the ochratoxins,
and subsequent detoxification, in living tissue could be a parameter in establishing its
toxicity. Bredenkamp et al., 1989, speculated that apart from the direct role that the
aromatic halogen group has to play in the dissociation of the phenolic hydroxyl group,
the steric nature of the halogen substituent may play an important role in the ability of
the ochratoxin to react with enzymes. In vitro studies with the enzyme, bovine
carboxypeptidase A showed OB to be hydrolysed almost hundred times faster than
16
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OA (Doster and Sinnhuber, 1972). In vivo studies in rat tissue extracts (liver and
intestines) agreed with these findings. The in vitro hydrolysis by HCI revealed a
reversal in the relative rates of hydrolysis for OA and OB. It was postulated that the
bulkiness of the chloro-group of OA might hinder the approach of the toxin to active
sites of carboxypeptidase A.
Stander et al., 2001a, reported that the toxicity of BrOB could not be attributed solely
to its rate of hydrolysis. When compared to OA, CPA had relatively similar catalytic
efficiency values for the bromo analogue (kcal/Km = 43) and OA (kcal/Km = 47). The
fact that BrOB showed a much elevated toxicity to renal cells as compared to OA
suggests that other factors may be involved in the toxicity of OA. In agreement to the
ochratoxins, the halosalicylic acid coupled phenylalanine analogues showed little
disparity to the affinity of CPA. Efficiency levels for CSAPhe (kcal/Km = 521) were
comparable to that of BrSAPhe (kcal/Km = 289) and FSAPhe (kcal/Km = 267).
Rahimtula et al., 1988 and Omar et al., 1990, proposed that the iron-chelating ability
of OA in lipid peroxidation (see section 1.8.1) might play an important role in
rendering the molecule toxic. The presence of the phenolic hydroxyl group in the
formation of the OA-Fe3+ chelate is essential (see Table 1.6). The complexation of
OA with iron (an essential cofactor in lipid peroxidation) facilitates the subsequent
reduction of iron in both NADPH-dependant microsomal and ascorbate-dependant
lipid peroxidation. This was demonstrated by the increase in lipid peroxidation in liver
and kidney mierosomes treated with OA, and in the in vivo lipid peroxidation
assessment in OA inoculated rats. Hasinoff et al., 1990, postulated that the OA-iron
complex, in the presence of the NADPH-cytochrome P-450 reductase system
produces an extremely toxic hydroxyl radical, which may be responsible for the
toxicity of OA.
Xiao et al., 1996b, in a study assayed the toxicity of different analogues in prokaryotic
(Bacillus brevis), eukaryotic (HeLa) systems (see Table 1.6) and animals (mice, see
Table 1.7). They found no direct correlation between the dissociation of the phenolic
hydroxyl group and the iron-chelating ability of the analogues and their observed
toxicity. The methylated-OA analogue (OM-OA) does not contain a free phenolic
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hydroxyl group, and thus cannot participate in the chelation of Fe2+, yet still exerts a
marked toxicity to HeLa cells.
Creppy et al., 1983a, 1984 and 1990, suggested that OA toxicity is derived from its
phenylalanine moiety. This was established by the ability of OA, as a phenylalanine
analogue, to competitively inhibit phenylalanine tRNA synthase and thus inhibit
protein synthesis (see section 1.8.2). This was also observed for other phenylalanine
metabolizing enzymes (Pitout and Nel, 1969; Parker et al., 1982). The findings of
Xiao et al., 1996b, (Table 1.6, 1.7) supports this proposal as the toxicity of D-OA is
approximately 30-fold less toxic to HeLa cells than OA, while it is essentially non-
toxic to mice. In contrast OA shows a high toxicity to mice. The differences in
metabolic constituents, e.g. the composition of the cell wall, may explain the observed
differences in the relative toxicity of OE-OA to B. brevis and HeLa cells compared to
that ofOA.
Table 1.7 Toxicity ofOA and its analogues to mice (Source: Xiao et al., 1996b).
Analogues Dosage Death Analogues Dosage Death
(mg/kgBWt Rateb (mg/kg BWt Rateb
Control 0 0110 OP-OA 500 0110
OA 20 3110 OM-OA 200 0110
50 9110 500 10/10
D-OA 50 0110 OB 200 0110
200 0/10 500 10110
OE-OA 200 0110 Oa 200 0110
500 10110 500 10110
d-OA 200 0/10 M-Oa 200 0110
500 10/10 500 10/10
a Dosage, the amount of toxin (mg) injected (ip) into mice per kg body weight (BW)
bDeath rate, numbers of dead micellO mice dosed 72 h after injection.
Xiao et al., 1996b, postulated that the toxicity of the analogues IS more closely
associated with the isocoumarin moiety, and with the lactone carbonyl specifically.
This was substantiated in the isolation of the OP-OA in the bile of rats injected with
OA, and by the subsequent high toxicity observed for the intravenous administration
of OP-OA in the same rats. In contrast, intraperitoneally administered OP-OA in mice
showed much lower toxicity compared to OA. Itwas postulated that the difference in
toxicity might be due to the lower rate of delivery of OP-OA to target organs (kidney
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and liver) relative to OA. The latter is in agreement with the findings of Kumagai,
1988, in that the rate of absorption across the intestinal epithelium for OA is much
slower when it exists in its more polar form. OP-OA was found to be stable at
physiological pH, but converted back to OA at low pH.
Xiao et al., 1996b, concluded that OA could react in accordance with naturally
occurring lactones, by covalently modifying vital biomacromolecules such as
enzymes (Borgstrom, 1988; Saltz et al., 1993). In an example of the inhibition of
serine proteases by certain isocoumarin compounds, the hydroxyl group of serine in
the active site of the enzyme and the lactone carbonyl group of the isocoumarin is
involved in the formation of an acyl enzyme complex which leads to the inhibition of
the enzyme (Kam et al., 1992; Hernandez et al., 1992). This concept is supported by
the isolation of ochratoxin A metabolites and adducts to DNA extracted from monkey
kidney cells. In a similar fashion the toxicity of OA may be the result of the covalent
modification of hydrolytic enzymes by a reaction involving the lactone carbonyl
group (Grosse et al., 1995).
In conclusion the toxicity of OA and its analogues can be ascribed to the presence of
an array of functional groups, which may act in a direct or indirect manner and in
either an exclusive or in collaborative capacity with other functional groups.
1.6 Pharmacokinetics of OA.
Several toxicokinetic studies have been performed with OA in a number of different
species of animals. A broad spectrum of results and toxigenic profiles obtained have
shown that several factors influence absorption, distribution, metabolism
(biotranformation), and excretion that ultimately affect the toxicity of OA (Kuiper-
Goodman and Scott, 1989; Marquardt and Frolich, 1992).
The distribution of OA was found to be in two kinetically distinct compartments with
variations among different animals (Chang and Chu, 1977; Galtier et al., 1979 and
1981). The first is a central metabolic and excretion compartment, which includes the
plasma, and the other the peripheral compartment, which includes the large intestines,
skin, muscle and other organs able to retain the toxin (Galtier et al. 1981).
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OA is mainly absorbed in a passive manner from the upper gastrointestinal tract i.e.
oesophagus, stomach, and the small intestines (jejunum) (Lee, 1984; Galtier, 1978;
Kumagai and Aibara, 1982; Roth et al., 1988), although a large amount of OA is
absorbed across the mucosal membrane in the nonionized or partially ionized form
rather than the ionized form. As mentioned previously, the phenolic hydroxyl group
(pKa 7.1) at physiological pH (7.1) will only be partially ionized. The role of the
carboxyl group in absorption is secondary to the phenolic hydroxyl group, since it
exists mostly in the ionized form at digestive pH (::::2.6) (Metzler, 1977). Xiao, 1991,
found that the diet (hay or grain) of sheep plays an important role in the
bioavailability of OA. The pH of the digestive substance affects the rate and amount
of OA absorption in these animals. In ruminants, the low pH of the rumen facilitates
the absorption of OA into the systemic circulation.
The presence of microorganisms in the rumen, caecum and large intestine alleviates
the toxic effects of OA by its enzymatic hydrolysis to 00.. Madhyastha et al., 1992,
found that micro-organisms in the digesta from the caecum and large intestines of the
rat were capable of hydrolysing OA in vitro. Madhyastha et al., 1992, further reported
that the excretion in urine and faeces of 00. and OA decreased and increased
respectively, in rats treated with a broad spectrum antibiotic, e.g. neomycin. These
findings illustrate that the intestinal microorganisms in non-ruminants affect the
disposition of OA in its biotransformation of OA to the hydrolysed metabolite, 00..
The affinity of OA to bind certain plasma proteins in the blood plays an important role
in its distribution and ultimate toxicity. The OA-protein complex not only allows for
the passive adsorption of ionized forms of OA but also an extended half-life in the
systemic circulation (Hagelberg et al., 1989). This essentially delays the elimination
of OA from the systemic circulation to the renal and hepatic cells. This was illustrated
by Kumagai, 1985, in the increased clearing of OA from system circulation by
albumin deficient rats.
Stojkoic et al., 1984, reported that apart from albumin, as plasma binding protein, a
smaller plasma constituent is present with a superior binding affinity to OA. It was
proposed by the authors that the ability of such aggregates to be transported across
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glomelular membrane in the kidneys could be the causative agent of the accumulation
of OA and ultimate nephrotoxic effects observed. This concept was given substance
by the study of Ychiyama and Saito, 1987, who found that OA had lower affinity for
the soluble tissue proteins of kidneys and liver than for plasma albumin. Hagelberg et
al, 1989, established a correlation between the binding affinity and the half-life of OA
in the circulatory system, by toxicokinetic studies in a variety of animals (See Table
1.8).
Table 1.8 Toxicokinetic parameters and binding
Constants of OA. (Source: Hagelberg et al., 1989)
S(!ecies KD{M-I13 tll2{hlli fu{%t
Fish 0.07 8.3 22
Quail 5 12 0.2
Mouse 48 0.1
Rat 40 170 0.02
Monkey 0.7 840 0.08
Pig 2 150 0.1
Man 1 0.02
"KD, affinity constants Biological half-life ofOA after intra
venous administration.T.Inbound or free fraction of the toxin
Hagelberg et al., 1989, concluded that the exact relationship between the strong-
protein binding of OA, the low rate of systemic circulatory clearance and resultant
toxicity has not been established. Screemannarayana et al., 1988, in a toxicokinetic
study of orally administered OA in calves, found that absorption occurred in two
distinct phases. The distribution followed two first-order processes, which varied in
rate. It was proposed that OA was rapidly absorbed from the rumen and then followed
by enterohepatic recycling.
Stander et al., 2001 b, reported that the markedly high elimination half-lives observed
for non-human primates (rhesus and vervet monkeys) compared to other species
(mammals, fish and birds) could be ascribed to the differences in the degree of
binding to serum proteins, including albumin. Furthermore, the long retention of OA
in the blood can be ascribed not only to the high affinities for plasma proteins but also
the recirculation of the toxin in the liver.
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Roth et al., 1989, in the elucidation of secondary distribution peaks further
substantiated this approach by reports that large amounts of OA were secreted in the
bile as conjugated OA (glucoronides and sulfates). The billary recycling and secretion
will be followed by the reabsorption of the OA from the intestines into the blood. This
will further facilitate the redistribution of OA into the peripheral compartments,
ultimately leading to an overexposure of OA to organs, such as the kidneys and the
liver.
Apart from the liver, the kidneys also play an important role in the recycling of OA.
Stein et al., 1985, reported that the reabsorption of OA from the renal proximal
tubules back into the blood promotes the residual persistence of OA in the peripheral
tissues and may be implicated in the degeneration of renal tubules found in rats
(Albassam et al., 1987) pigs (Szczech et al., 1973) and poultry (Elling et al., 1979).
The pharmacokinetic data for OA and its metabolites in different animal species are
given in Table 1.9.
Table 1.9 Distribution and elimination half-lives of different animal species (Source:
modified from Steyn and Stander, 2000).
Test animal (, . ~" b Test t1l2a(min) t1/2fJ(h)tJ/2a mm t1l2fJ(h)
animal
OA OB
Rats(iv) 160±17c 103±16c Rats(iv) 14±4c 4.2±1.2c
126d 120e
Rats(p) 170e oe
Rats(o/iv) 55d Rats(iv) 6±1.2c 0.6±0.2c
Rabbits 114f s.z' Oa
Chickens 30f 4.1 f Rats(iv) 31±5c 9.6±2.3c
Cattle 108g
Pig 72_150e,f OA-OH
Pre-ruminant calf 77h Rats(iv) 19±4.7c 6±0.9c
Mouse 24-48e
Rhesus monkey (iv) 840e OP-OA
Vervet monkey (iv) 58-7i 462-484i Rats(iv) 163±5c 50.5±2.8c
at1l2a = Distribution half-life; bt1/2P = Elimination half-life; p = peripherally; iv = intravenous;
0= orally. "Marquardt and Frohlich, 1992; dGaltier et al., 1979; "Hagelberg et al., 1989; fGaltier et al.,
1981; gSreemannarayana et al., 1988; hFukui et al., 1987; iStander et al., 2001 b.
The biotransformation of OA extends further than the enzymatic hydrolysis rendering
On. Stormer and Pederson, 1980, reported that liver mierosomes from humans, pigs
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and rats are able to hydroxylate OA in the presence of NADPH to (4R)- and (4S)-
hydroxyochratoxin A. They further observed that hydroxylation occurs in the
cytochrome PASO system. In addition to the 4-hydroxyochratoxin, Stermer et al.,
1983, reported on the isolation of lO-hydroxyochratoxin from rabbit liver
microsomes. Creppy et al., 1983b, reported that the (4R)-hydroxy epimer was as toxic
to yeast cells as OA, in that they both inhibit phenylalanine-tRNA synthase. These
results together with the findings by Hutchison et al., 1971, that the 4-hydroxy
epimers are non-toxic to rats, suggest that the lower toxicity of the hydroxy analogues
in mammals is due to their more rapid clearance in the faeces and urine.
1.7 Toxicology
1.7.1 OA linked to nephrotoxicity
The nephrotoxicity, together with the carcinogenicity of OA, are the most threatening
effects of ochratoxicoses. This is evident in all animal species studied so far (Krogh,
1974; Krogh et al., 1977; Bernt and Hayes 1979; Krogh, 1987). Histopathological
profiles include the degeneration and atrophy of proximal tubules, the interstitial
fibrosis of the renal cortex and the hyalination of the glomeruli.
First discovered in Denmark in 1928, Danish Porcine Nephropathy (DPN) is
characterized by "mottled or pale enlarged kidneys" of pigs fed mouldy cereal feeds.
The prevalence of the disease in European countries is especially high after a wet
harvesting period. The unmarked clinical changes including polyurea, polydispia and
a depression of growth, provides for difficult diagnosis. Haematological and
biochemical studies have to be conducted on blood and urine samples of suspected
pigs in order to determine infection.
Balkan endemic nephropathy (BEN), a human chronic interstitial nephropathy, is a
strictly endemic disease in the rural population of Bulgaria, Romania and Yugoslavia.
Although the disease is of unknown aetiology, OA has been extensively implicated.
Based on the similarities in structural and physiological kidney impairment between
Danish porcine nephropathy and BEN, OA has been implicated as the causative agent
of the disease (Stoev, 1993). Hult, 1982; Petkova-Boharova and Castegnaro, 1985;
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Petkova-Bocharova et al., 1988, reported on the simultaneous occurrence of OA in
human blood, human food and animal feed in a high endemic area of the disease and
compared this with the lower levels of OA found in non-endemic areas.
Mantle, 1998, reported that the renal atrophy in BEN might involve the loss of tubular
epithelium by apoptosis. This observation implicates Penicillium aurantiogriseum, a
nephrotoxic fungal species, which exerts a more potent and target specific effect than
OA. Mantle et ai, 1991, reported that the nephrotoxin causes severe histopathological
changes in the proximal tubules of rats, which better correlates with the experimental
model for the human disease (BEN) than ochratoxicosis.
OA is also implicated in Chronic Interstitial Nephritis (CIN) in North Africa (Bacha,
1993; Maaroufi, 1995) which is invariably associated with urinary system tumours
(UST). Petkova-Bocharova et al., 1988, reported that 95% of Tunisians suffering from
urinary tract tumours were found to contain high levels of OA in their blood.
1.7.2 Carcinogenicity
Kanisawa and Suzuki, 1978, reported that the exposure ofDDY mice to 40 mg/kg OA
in their feed over a 50-week period caused renal and hepatic tumours. The renal
tumours diagnosed were a benign cystic papillary adenoma and a malignant solid type
renal cell tumour.
Bendele et al., 1985, reported that renal adenomas and carcinoma were prevalent in
mice fed a diet, which included high dosages of OA (34 mg/kg of feed). Boorman,
1989, showed in a similar two-year study of male Fisher 344/N rats that there was a
high incidence of renal tubular cell adenomas and carcinomas.
It was further found that at increased levels of OA exposure the renal tumours were
multiple and bilateral. Of importance was the high prevalence of metastasis found in
the pulmonary and lymphoid cells. An increase in the multiplicity of fibroadenomas in
the mammary glands of female rats was also of significance.
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OA exposure also caused non-neoplastic renal changes including tubular cell
hyperplasia, tubular cell proliferation, cytoplasmic alterations, karyomegali and
degeneration of the tubular epithelium (Boorman, 1989).
1.7.3 Immunotoxicity
OA is immunotoxic to both humoural and cellular immune systems. A decrease in
lymphoid cell production, proceeding from low amounts of OA ingestion, in mainly
the thymus, bursa of Fabricius, spleen, and the Peers patches, has been reported for
different animal species (Szczech et al., 1973; Dwivedi and Bums, 1984 and 1985).
The depression of thymus proliferation occurs in conjunction with a cell-mediated
delayed hypersensitivity, implicating OA in both immune responses.
Luster et al., 1987, reported that OA decreases natural killer cell activity by the
inhibition of endogenous interferon levels. Polyinosinic:polycytidylic acid-induced
interferon was markedly reduced in OA inoculated mice. The subsequent injection of
polyinosinic:polycytidylic acid enhanced the natural killer cell activity in the presence
of OA. The fact that the level of enhancement was slightly lower than the level
induced by the acid in the absence of OA, suggests that the presence of the toxin
inhibited the production of basal interferon. The ability of OA to regulate the activity
of these cel1s contributes to the impact that OA can have on the proliferation of renal
and hepatic carcinomas.
Lea et al., 1989; conducted an in vitro study on the effect of OA on highly purified
subpopulations of T lymphocytes expressing the CD4 (helperlinducer) and CD8
(suppressor/cytotoxic) phenotypic markers. OA revealed no selectivity in the
inhibition of the phytohaemaglutinin-induced proliferative ability of the varied T-cell
populations. The proliferation of T-cell is regulated by the binding of interleukin-2
(IL-2) to its receptors, which delivers the mitogenic signal that initiates cell division
of the specific T-cell population. The absence of IL-2 induced cell proliferation
observed for OA treated cel1 cultures could be due to the decrease of IL-2 receptor
expression or production. It was suggested that the inhibitory role that OA has on
protein synthesis, could provide the basis of this effect. This was supported by the
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findings of Stermer and Lea, 1995 that OA had a pronounced effect on the protein
synthesis of dormant T-cells.
The subchronic exposure of Balb/c mice to OA decreased the anti-body production of
plaque-forming cells and suppressed the total thymocyte cell count, which included
the proportion of mature thymic lymphocyte (CD4+ or CD8+) cells. A decrease in the
mitogenic responsiveness of thymocytes and splenocytes to concanavalin A (Con A)
in the presence of OA is also significant. In contrast, the IL-2 production of Con A
induced lymphocytes, the natural killer cell activity and the concentrations of humoral
antibodies to viral antigens are not affected by the OA poisoning (Thuvander et al.,
1995).
Thuvander et al., 1997, reported on the immunosuppression of Balb/c mice and
Sprague-Dawley rats after the prenatal exposure of OA. The subchronic exposure
from dietary OA resulted in the suppression of proliferation in lymphoid organs but
did not affect the immune response in the offspring.
Numerous discrepancies have been reported in immunotoxicity studies of OA where
the dietary intake of phenylalanine, as well as the route of administration had not been
taken into consideration. Haubeck et al., 1981, reported on the inhibition by OA to the
immune response of Balb/c mice to sheep red blood cells in the absence and presence
of phenylalanine. It was found that when the concentration of phenylalanine was
approximately twice that of OA (w/w) immunosuppression was either not observed or
extensively attenuated.
Creppy et al., 1979a, showed that the addition of phenylalanine to OA inoculated
hepatoma tissue culture cells could alleviate the inhibition of growth and protein
synthesis. Creppy et al., 1980, illustrated that acute poisoning by OA of mice could be
prevented by the simultaneous intraperitoneal injection of phenylalanine.
Furthermore, aspartame, a structural analogue to OA and phenylalanine, could be
used as a preventive agent of the chronic toxic effects of OA in rats (Creppy et al.,
1996).
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1.7.4 Teratogenicity
OA administered orally or intraperitoneally during the period of gestation had severe
embryotoxic effects in rats, mice, hamsters and pigs (Brown et al., 1976; Hayes et al.,
1974; Hood et al., 1975 and Schreeve et al., 1977). The degree of effects depends,
among other factors, on the route of exposure and the time of the gestation period
when the toxin is administered.
These effects included an increase in the number of dead and resorbed foetuses, a
decrease in the foetal body weight as well as the hemorrhages and oedema in certain
foetuses of rats. In conjunction with these effects, numerous anomalies were observed
in the foetuses of animals treated with OA. This includes multiple gross, visceral and
skeletal malformations in rats (Brown et al., 1976) and hamsters (Hood et al., 1975).
Skeletal anomalies, specifically in the ribs, vertebrae and the skull, were accompanied
by necrotic eye and brain cells of foetal mice exposed early or later in the gestation
period.
1.7.5 Genotoxicity and Mutagenicity
OA is a non-mutagenic carcinogen, evident from the numerous negative gene
mutation assays conducted on both micro-organisms and mammalian cells (Boorman,
1989; Wurglet et al., 1991; Bendele et al., 1995 and Sakai et al., 1992).
Manalova et al., 1990, reported that OA was found to induce various numerical and
structural aberrations on X-chromosomes of similar types to those detected in
lymphocytes from patients suffering from endemic nephropathy. Dirheimer, 1996,
reported that OA induced mutations in the modified Ames assay, sister chromatid
exchange in human peripheral lymphocytes in vitro, and the SOS DNA repair in E.
coli (Hennig et al., 1991). De Groene et al., 1996, emphasized that OA required the
additional metabolic processing, by cytochrome P450 enzymes, to its metabolites (4-
OH-OA) in order to exert a mutagenic effect on living tissue.
Pfohl-Leszkowics et al., 1993a, identified DNA adducts in vivo in the liver, kidney
and spleen of rodents and humans suffering from urinary tract tumours. Grosse et al.,
1995, reported that monkey cells were able to produce DNA-adducts when incubated
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with OA. The adducts observed were similar to those found in human kidney and
bladder tumours from people suffering from BEN. Furthermore, the presence of DNA
adducts in cytochrome P450-expressing cells, implied their formation via an oxidative
process involving cytochrome P450 synthase. Grosse et al., 1995, further found that at
elevated dosages of OA (100 IJ.M) some adducts were completely absent. An
explanation for this may be due to the inhibition of protein synthesis by OA which
would lead to the impairment of certain cytochromes P450-synthase and the decrease
of reactive metabolites responsible for DNA adduct formation.
1.8 Mechanisms of action.
1.8.1 Lipid peroxidation
Membrane lipid peroxidation is an important part of oxidative tissue damage and can
be an effect as well as a cause of the reactions culminating in cytotoxicity (Omar et
al., 1990). Omar et al., 1991, reported that OA disrupts hepatic microsomal calcium
homeostasis by impairment of the endoplasmic reticulum membrane, via the induction
of lipid peroxidation. It was found that OA greatly enhanced the rate of NADPH- or
ascorbate-dependant lipid peroxidation both in vivo (rats) and in vitro (liver or kidney
microsomes) as measured by the formation of malondialdehyde. Rahimtula et al.,
1988 and 1989, implicated the reactivity of the phenolic hydroxyl group of the
different ochratoxins in the efficiency of lipid peroxidation induction.
OA facilitates the reduction of ferric ions (Fe3+) to ferrous ions (Fe2+) via chelation.
The subsequent reoxidation is accompanied by 02 consumption (Omar et al., 1990).
Hasinoff et al., 1990, reported that the Fe3+-OA chelation complex produces
extremely toxic hydroxyl radicals in the presence of the NADPH-cytochrome P450
reductase system and NADPH. In the presence of oxygen, the resultant OA-Fe2+-Fe2+-
OA complex provides the active species, which induces lipid peroxidation. This
provides for the offset in cellular constituents, containing polyunsaturated fatty acids
and oxygen, of an array of degenerative radical reactions producing chemically
reactive metabolites (Baudrimont et al., 1997).
The presence of iron in the tubular lumen, due to the glomerular leak of iron bound
transferrin, provides for the formation of hydroxyl radicals. The dissociation of iron
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from transferrin in the acidic tubular fluid, allows for the catalysis of hydroxyl radical
formation, which leads to the lipid peroxidation of the tubular membranes (Stermer et
al., 1996).
Baudrimont et al., 1997, found that the lipid peroxidation caused by the free oxygen
species induced by OA can be limited in monkey kidney cells by the addition of
superoxide disrnutase (SOD) and catalase, piroxicam or aspartame to the culture
medium prior to OA inoculation (Figure 1.3). SOD and catalase were found to prevent
lipid peroxidation more efficiently than piroxicam (at a ten-fold higher concentration
than OA) and aspartame (at equimolar concentration).
Aspartame Piroxicam
Figure 1.3 Chemical structures of aspartame and piroxicam.
1.8.2 Inhibition of phenylalanine-tRNA formation.
Creppy et al., 1984, reported that OA, as a phenylalanine analogue, suppresses protein
synthesis by the competitive inhibition of phenylalanine in the Phe-tRNA
aminoacylation reaction catalysed by phenylalanyl-tRNA synthase (PheRS). This was
illustrated by in vitro studies conducted on both bacterial and eukaryotic systems
(Konrad and Roschenthaler. 1977; Bunge et al., 1978 and Creppy et al., 1979b). Apart
from the effect on protein synthesis, OA also inhibits the synthesis of DNA and RNA.
Creppy et al., 1979a and 1984, reported that the inhibitory effect of OA could be
alleviated by the addition of phenylalanine substrate to hepatoma cells and in mice in
vivo. Mayura et al., 1984, illustrated that the administration of phenylalanine
alleviated the teratogenic effects induced by the prenatal exposure of rats to OA.
Creppy et al., 1983, conducted a study on the effects of OA metabolites on yeast
phenylalanyl-tRNA synthetase and on the growth and in vivo protein synthesis of
hepatoma cells. It was found that both OA and the metabolite (4R)-OH-OA was toxic
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to the cell cultures. It was postulated that the phenylalanine moiety, acting not in
isolation, could be linked to the toxicity of OA and (4R)-OH-OA due to the fact that
O« had no effect on the growth of cell cultures and by the reversal of the inhibition of
cell growth by the addition of phenylalanine.
Creppy et al., 1983a, further illustrated the direct effect of OA and (4R)-OH-OA on
the catalytic action of PheRS. It was established that both compounds inhibited the
reaction catalysed in vitro by this enzyme and that their toxicity could be partly
ascribed to this ability. Creppy et al, 1983a, extended the study to include OA
analogues with respect to modification to the L-Phe. The OA-phenylalanine-tRNA
synthetase system exhibited the highest affinity to OA compared to other amino acid
analogues (K, ~ 1.3 mM). This was followed by Tyr-Oc, Ala-Ou, Trp-Oc and Ser-
o« expressing Kl values of 1.5, 1.6, 2.3 and 6.0 mM respectively. Val-Oa, Met-Oa,
Glu-O« and Pro-Oe had markedly lower affinity with K, values of 11.0, 13.0, 14.5,
and 19.0; respectively. All of the amino acid OA analogues inhibited the growth of
hepatoma cells at a concentration of 90 ).lM. Tyr-O«, Ala-Oe proved the most
cytotoxic with the first 24 hours, followed by Ser-Oe and Val-Ou after 48 hours. The
remaining analogues seem to be less pronounced and exerted cytotoxicity within 72
hours.
Creppy et al., 1983a, concluded by reporting on the inhibition of protein synthesis in
hepatoma cells by OA analogues. Ala-On was shown to have a similar inhibition to
OA, with Val-Oe and Ser-Ou exerting a slightly lower inhibition. Met-Ou and Trp-
Oo; had a slower offset but were more pronounced after 90 minutes. Glu-Oo; had a
momentary inhibitory effect after an hour, with protein synthesis returning to normal
after 4 hours. Pro-Ou had little effect. It was emphasised that no apparent correlation
existed between the inhibition constants of aminocyl-tRNA synthetase for the various
amino acid analogues and the effect observed on the cell growth or protein synthesis.
1.8.3 Inhibition of mitochondrial ATP synthesis
Moore and Truelove, 1970; reported that OA inhibits mitochondrial state 3 and 4
respiration, by the competitive inhibition of mitochondrial transport carrier proteins
located in the inner mitochondrial membrane. In addition OA also alters the
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mitochondrial morphology after in vivo administration to rats (Suzuki et al., 1975;
Brown et al., 1986).
Meisner, 1976, implicated OA in the disruption of the intramitochondrial phosphate
transport systems, as the major cause of mitochondrial deterioration. The maintenance
of structural integrity of the mitochondria is essential for the optimum production of
ATP. The disruption of inner mitochondrial membrane leads to the inability to
transport H+ ions from and to the matrix via the Fo channel in the FoFl synthase
complex and to subsequently generate ATP from ADP by catalytic phosphorylation.
This effect is further amplified by the fact that the uptake of OA is an energy
consuming process. The depletion of intramitochondrial ATP was most pronounced in
the middle and terminal segments of the proximal tubule (Jung and Endou, 1989). The
direct correlation between the inhibition of mitochondrial ATP synthesis and the
toxicity of OA is not known, as can be seen by the ability of Oo, predominantly non-
toxic, to inhibit mitochondrial respiration in rat liver (Moore and Truelove, 1970).
1.9 Prevention and Treatment
Several different approaches can be followed in order to minimize the exposure of
humans to OA and to alleviate the toxic effect in animals. Some of the factors that are
involved in the growth of storage fungi are moisture, temperature, time of storage, the
integrity of the seed, 02 and C02 concentrations, composition of the substrate, fungal
abundance and the proportion toxigenic strains present, inter microbial interaction and
routes of transmittance (Marquardt and Frohlich, 1992; Abramson and Mills, 1985).
The regulation of moisture content together with the storage temperature of feeds and
foodstuffs is essential in the prevention of OA production (see section 1.2). Post
harvest treatment of crops by gamma and electron beam irradiation has shown to be
effective against mycotoxin producing fungi such as A. aluteus (Chelack et al.,
1991b). Tong and Draughan, 1985, reported that addition of antimicrobial food
additives such as methyl paraben and potassium sorbate was effective in regulating
the growth of Aspergillus and Penicilium toxigenic fungal species.
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Several dietary additives have been employed to reduce OA absorption and
bioavailability. Madhyastha et al., 1992, reported that cholestyramine, a commercial
anion exchange resin, has been shown to be an effective absorbent of OA in the
gastrointestinal tract of non-ruminant animals. Itwas shown that 0.5% cholestyramine
in the diet of a rat containing 1 mg/kg of OA, reduced the concentration of OA in the
blood by 50%, and further reduced the urinary excretion and enhanced the total faecal
excretion of OA.
The impact of phenylalanine administration III alleviating teratogenic and
immunosuppressive effects of OA poisoning in animals has been discussed
(section. I.7.3 and 1.7.4.). The action of superoxide dismutase and catalase together
with aspartame and piroxicam in the prevention of the nephrotoxic effects of OA has
been discussed (section 1.8.1).
Haazele, 1992, reported that the ascorbic acid (Vitamin C) addition to the diets of
laying hens markedly reduced the toxic affects, including a decrease reduction of egg
mass, of OA as compared to OA poisoned laying hens not treated with ascorbic acid.
It has been suggested that the anti-oxidant could suppress the offset of lipid
peroxidation. Gastrointestinal microorganisms in ruminants play an important role in
the disposition of OA because they promote the hydrolysis of the toxin to non-toxic
Oa. This is also of consequence to non-ruminant animals as found by the role that
microbial populations play in the caecum and large intestines (Madayastha et al.,
1992) (Section 1.6).
1.10 Conclusions
From the discussion on the metabolism of OA in bacterial and animal cells, it is
evident that an array of structural functionalities is implicated in the toxicity of the
ochratoxins. The implicated OA functionalities include:
The halogen group: The chlorine group is evidently important in the toxicity of OA
since the dechloro analogue OB is ten times less toxic. The chloro group functions in
a direct role in allowing for the interaction of OA and phenyl alanyl RNA-synthetase.
This leads to the inhibition of protein synthesis as well as the synthesis of RNA and
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DNA. OB has no interaction with phenylalanine tRNA-synthetase. The presence of
the halogen group could further be implicated indirectly in the relative rates of
hydrolysis of OA and OB.
In addition the chloro group may function in an indirect role, i.e. by affecting the
dissociation of the phenolic hydroxyl group. In coherence to this notion, the bromo-
analogue reveals an increased toxicity to renal cells (Creppy, 1999b). Recent reports
showed that the methyl ester of iodo-ochratoxin is approximately twice as toxic as the
bromo-analogue.
It is assumed that the dissociation of the phenolic hydroxyl group will decrease as the
electronegativity of the aromatic halogen group decreases which could be a plausible
explanation for the toxicities observed.
The phenolic hydroxyl group: The hydroxyl group, in its dissociative form has
clearly been implicated in lipid peroxidation. This is evident in that the toxicities of
the different analogues correlate with the dissociation constants of the phenolic group.
This is evident in the high toxicity of OA and OC compared to the much lower
toxicity of the O-methylated analogue. The hydroxyl group has also been implicated
in the formation of DNA adducts and the bioavailability of OA by binding to serum
albumin.
Amide bond: The peptide bond is readily cleaved by proteolytic enzymes
carboxypeptidase A, trypsin and a-trypsin. It was found that OA had a much greater
affinity for CPA than for trypsin or a-trypsin. The stability of the amide bond was
first implicated in the toxicity of OA by the isolation of natural occurring, non-toxic
Oa.
It was proposed that the rate of hydrolysis, a detoxification process rendering non-
toxic metabolites Ou and Phe, of OA was to play an important role in the half-life of
the toxin and ultimately its toxic effect in vivo. In vitro kinetic studies with the
enzyme bovine carboxypeptidase A revealed that OB was hydrolysed up to two
hundred times times faster than OA. It was suggested that the lesser toxicity of OB
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was due to the more rapid detoxification by hydrolysis. This was challenged by
reports that OB is inherently non-toxic as was shown by the inability to inhibit protein
synthesis.
The lactone moiety: The lactone functionality has been the centre of
biotransformation of OA to lesser toxic hydroxylated analogues (4S,4R)-OH-OA and
IO-OH-OA in fungal and animal systems. The lesser toxicity may be ascribed to the
increased rate of excretion into the bile and urine.
The isolation of the opened lactone form (OP-OA) analogue has implicated the
lactone carbonyl group in the possible covalent modification of certain
biomacromolecules. In the case of the animal models, a lower rate of delivery to
target organs (kidney and liver) may explain the lower toxicity of OP-OA relative to
OA.
Amino acid substituent: The natural occurrence of ammo acid modified OA
analogues, lysine, serine and hydroxyproline emphasized the role of the amino acid
moiety in the toxicity of OA. An attempt to correlate the binding affinity of the
analogues to aminoacyl-tRNA-synthetase to the inhibition of hepatoma cell growth
and the inhibition of protein synthesis was inconclusive.
Ala-Oe; and Tyr-Oo; proved to be the most toxic with regard to the inhibition of
protein synthesis and hepatoma cell growth.
No apparent correlation could be established between the chirality of the amino acid
and the toxicity of OA in bacterial cells. This was shown in the similar toxicities of D-
OA and OA in B. brevis. The study was inconclusive owing to the inability of
bacterial cells, unlike eucaryotic cells, to distinguish between the Land D isomers.
However, a decrease in toxicity of D-OA to eukaryotic (HeLa cells) systems (30 fold
less toxic) revealed that the chirality of amino acid substituent may play an important
role in the toxicity of OA.
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The carboxylic acid group: The ethyl esters of both OA and OB showed greater
toxicity than the corresponding parent molecules. It was proposed that the increase in
toxicity was due to an increase in the molecular weight of the toxin. Holding true to
this approach, the N-ethylamide analogue OE-OA, was found to be four times more
toxic to B. brevis than OA. It was further suggested that the increase in lipophilicity,
and subsequent cell permeation, of the ethyl ester analogue relative to OA might play
a more important role than the increase in molecular weight. The carboxylic acid
moiety has also been implicated in the bonding of protein.
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SECTION B: THE SYNTHESIS OF THE OCHRATOXINS AND
ANALOGUES.
1.11 Introduction
In this chapter the chemistry that serves as the necessary background to our research
effort is highlighted. A sound understanding of this chemistry is essential for the
preparation of ochratoxin analogues. The synthesis of these compounds can be
accomplished by the modification of either OA or On, which if viable, would be a more
elegant route than the alternative of a de nova synthesis. Aspects of both these distinct
synthetic routes will be discussed starting with the total synthesis of OA, which in part
encompasses the synthesis of dihydroisocoumarins. A proposed method for the de nova
synthesis of fluoro-ochratoxin will be derived from these.
An overview of the synthesis of ochratoxin analogues by direct modification of OA or
Ou will include, a) the substitution of the phenylalanine side chain, b) modification of the
phenolic hydroxyl group, and c) the substitution of the chloro group. A discussion on the
methods available for the synthesis of fluoroaromatic compounds will conclude the
chapter.
1.12 The synthesis of OA and OB
The acid hydrolysis of OA furnishes a chlorolactone acid (O«), formulated as 7-carboxy-
5-chloro-3,4-dihydro-8-hydroxy-3-methylisocoumarin, and L-phenylalanine. From a
synthesis design point of view the first step towards the synthesis of OA must be the
preparation of the dihydroisocoumarin, which could then be coupled via an amide bond at
its 7-carboxyl group to L-phenylalanine.
1.12.1 The synthesis of dihydroisocoumarins
The importance of the isocoumarins as discrete natural products was confirmed in early
biosynthetic studies. It was established, through a range of labeling experiments, that the
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isocoumarin moiety of OA is formed via the acetate-polymalonate pathway (Fereira and
Pitout, 1969; Steyn et al., 1970). The incorporation of the carbonyl carbon atom (derived
from the Cl pool) allowed for coupling to phenylalanine (derived from the shikimic acid
pathway). The different approaches to the synthesis of OA have varied little from the
established biosynthetic route.
1.12.1.1 Steyn and Holzapfel, 1967.
The synthetic approach to the lactone acid VII, was based on the fact that the 3,4-
dihydro-3-methylisocoumarins can be prepared by the oxidation of the corresponding
isochroman, 5-chloro-7-hydroxymethyl-8-methoxy-3-methylisochromans VI (Figure
1.4).
OH
OJ) of)
OH
Qn, c Il Cu: III Cu:
I Jl ITI IV
OH OCH3 OH 0
IV OH V
R VI HOOC
Cl
Vla: R=CH2CI
VIb: R=CH20H
Cl
V
Cl
VII
Figure 1.4 Synthesis of Oa by Steyn and Holzapfel, 1967.
Reagents: i) Dihydropyran, H+, ii) (a) Mg, cat. EtBr, in THF (b) propylene oxide, iii) HCI, iv)
ei, v) ZnCI2, CICH20CH3, vi) Cr03.
The intermediate isochroman, VIb, was prepared from the protected 3-bromophenol, II,
which was converted to the deprotected 1-(3-hydroxyphenyl)propan-2-01, IV, by means
of a Grignard reaction. This was followed by the non-specific chlorination of IV that
produced the chlora analogue, V, in low yield. V was subsequently chloromethylated to
VIa, which in tum was hydrolysed to afford the intermediate isocroman, VIb. Finally, the
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oxidation of Vlb yielded the desired Oa, VII. The low overall yield of 10% was ascribed
mainly to the non-selective chlorination step.
1.12.1.2 Roberts and Woollven, 1970.
Roberts and Woollven proposed the following method for the synthesis of Oa starting
from 4-chloro-7 -hydroxyindanone, in which the phenolic hydroxyl group and the chlorine
function were already present and correctly orientated. The dihydroisocoumarin
carboxylic acid X was synthesized from I in nine steps with an overall yield of 0.65%
(Figure 1.5).
~ Cl
OH 0 NOH <nOH 0
~ :?' I NH
:::::-...0
Cl Cl
III
iii )lo MOH
~C02H
Cl
I II M9
~CH3
Cl
v )lo
JV
iv )lo ¢¢OAC0 HC02H
Cl Ac
VI
V
OH 0 VI OH 0OH 0
~9 CIH2C
~c~
Cl
VII
OH 0
OHC
~
H02C
ix )lo
Cl Cl Cl
VIII IX x
Figure 1.5 Synthesis of Oa by Roberts and Woollven, 1970.
Reagents: i) Isopentyl nitrite, HCI, ii) Toluene-p-sulphonyl chloride, iii) (a) NaOH (b) HCI, iv)
AcONa-Ac20, v) (a) NaOH (b) HCI, vi) (a) NaBH4 (b) HCI, vii) TiCI4, CICH20CH3, viii) (a)
(CH2)6N4(b) aq. AcOH, ix) Ag20.
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1.12.1.3 Sibi et al., 1985.
Sibi and coworkers reported on the combined use of carbamate- and amide-directed
ortho-metalation reactions to achieve rapid access to multifunctional aromatic systems,
which was extended to the synthesis ofisocoumarins, O« and OB.
In the synthetic design, involving comprehensive use of aromatic metalation, the first
electrophile E introduced into the ortho-lithiated carbamate I is chosen to be compatible
with subsequent metalation strategies and as a weaker ortho-director than the carbamate.
This forces the second metalation into the alternative ortho site, allowing the 1,3-
carbamoyl rearrangement (step ii). Following phenol protection, the third metalation is
directed by the migrated amide, leading to the regioselective introduction of the second
electrophilic substituent (step iv)(Figure 1.6).
la: R=H
lb: R=Cl
Ha: R=H, E=C02H (95%)
JIb: R=Cl, E=C02H (69%)
He: R=H, E=CONEt2 (89%)
lId: R=Cl, E=CONEt2 (77%)
E*OMe Z:t2
-::?' <,0
I
~
R
E
IV
R
IVa: R=H, E=C02H (37%)
rvi» R=CI, E=C02H (60%)
IVe: R=H, E=CONEt2 (59%)
IVd: R=CI, E=CONEt2 (42%)
iii.
III
OH 0
V
R
Va: R=H, E=C02H (14%)
Ve: R=H, E=CONEt2 (55%)
Vd: R=CI, E=CONEt2 (38%)
IVa: R=H (50%)
IVb: R=Cl (49%)
Figure 1.6 Synthesis of Oa and OB by Sibi et al, 1985.
Reagents: i) (a) sec-BuLi, TMEDA in THF, -78°C (b) CO2(s) (IIa,b), ClCONEt2 (IIc,d), ii) sec-
BuLi, TMEDA, iii) MeI, iv) (a) sec-BuLi, TMEDA (b) MgBr2.Et20 (c) Allyl bromide, v) HCl
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Apart from the relative modest overall yields obtained for Oe and O~, 14% and 6%
respectively, a few drawbacks exist on the synthetic approach. In spite of considerable
experimentation, improvement in the yield of the transformation IVa-Va was not
achieved. Furthermore, the chioro benzamide IVb precursor for Oe, obtained in good
yield by the analogous sequence IIb-+IIIb-+IVb, failed to undergo the transmetallation-
allylation reaction corresponding to the conversion IVb-+ Vb.
1.12.1.4 Kraus, 1981.
From an efficiency point of view the synthetic route applied by Kraus is the most
successful up to date, generating a total overall yield of 20% for Oe (Figure 1.7).
I
000
H3CO)lJUOCH3 +
OH 0 OH 0
Il
69% 58%
IV Cl
V
Figure 1.7 Synthesis of Oo, Kraus, 1981.
Reagents: i) (a) 2 i-Pr2NLi, THF-HMPA, -78°C (b) CH3CHO, ii) (a) S02Cb, CH2Cb (b) LiOH,
H20, CH30H
The diester III was prepared in one step from dimethyl 3-oxopentanedicarboxylate I and
the sodium salt of hydroxymethyleneacetone II. III was subsequently deprotonated with
2 equivalents of lithium diisopropylamide in THF-hexamethylphosphortriamide at -78°C.
The addition of acetaldehyde and aqueous acid workup produced lactone IV in good
yield. Chlorination of IV with sulfuryl chloride in methylene chloride afforded a
chlorolactone that was immediately suspended in methanol and saponified with aqueous
lithium hydroxide. Apart from the relative low yield of III, this route is by far the most
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efficient preparation of ochratoxin intermediates and should be amenable to considerable
variation.
1.12.1.5 A proposed method for the synthesis of 5-fluorodihydroisocoumarin.
In terms of electrophilic aromatic substitution the efficient incorporation of a fluoro
substituent into a multifunctional aromatic ring will most likely be encountered with
difficulty. The fluorination of the aromatic nucleus will thus be confined to the first steps
of a multi-step synthesis of the substituted fluoro benzene. Furthermore the lability or
reactivity of the fluoro substituent to further strategies needs to be taken into
consideration.
The successful bromination of sodium acetoacetaldehyde to produce 2-bromoaceto
acetaldehyde has prompted the question whether this method could be extended to
fluorination (Lip insky et al., 1984). Selective fluorination of dicarbonyl compounds has
been reported by Banks et al., 1996, using Selectfluor™ and Chambers et al., 1999, using
F2. The synthesis of the fluorinated analogue to the intermediate used by Kraus,
1981(Figure 2.4) will allow for the incorporation of the fluorine substituent at an early
stage. The sodium salt of 2-fluoroacetoacetaldehyde, when reacted with dimethyl 3-
oxopentanedicarboxylate I, can furnish the fluorinated aromatic diester (Figure 1.8).
OH
__ )1000 CH302C~C02CHl
yCH3
F
OH 0 III
000
H3CO~OCH3 +
OH 0
F
IV
F
V
Figure 1.8 A proposed route to 5-fluorodihydroisocoumarin via a fluorinated diester
analogous to the synthesis by Kraus, 1981, of the chIoro equivalent.
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In the synthetic routes taken by both Sibi et al., 1985, and Roberts and Woollven, 1970,
the chlorine substituent was incorporated into the aromatic ring at the start of the
sequence. This approach evades the non-specific chlorination step. Sibi and coworkers
showed, in the synthesis of O« and O~, that the chlorine substituent has an inferior role
to play in the artha-directed metallation of the aromatic nucleus.
Of greater importance will be the choice of starting compounds. Sibi et al., 1985, could
not achieve the transmetallation-allylation of the chlorobenzamide (IVb, Figure 1.6), and
the corresponding dechloro benzamide IVa, Figure 1.6) could only be afforded in the
lowest yield for the allylic species Va (14%)(Figure 1.6). If it is assumed that the fluoro
substituent will act analogously to the chloro group in activating the artha-position
(secondary to the amide activation) the use of Ib and lIb will be the desired starting
compound and intermediate of choice (Figure 1.9).
OHE'¢
F
E~NEt2 E*~:t2s-: '0
I
~
F F
la:E=C02H
Ib:E=CONEt2
OMe NEt2 OH 0
I
E C, H02C
'0
~
F F
IIa:E=C02H
IIb:E=CONEt2
E*OMe Z:t2
~ '0
I
~
F
Figure 1.9 A proposed synthesis of 5-fluorodihydroisocoumarin from 5-fluorosalicylic
acid via a artha-directed metallation approach.
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1.13 Synthesis of ochratoxin A analogues.
Most of the functional groups that constitute OA have been implicated in its toxicity. In
order to probe the activity of a substituent, modified analogues of OA are synthesized and
their toxicity measured relative to OA. High efficiency, single step conversion reactions
form the ideal to this study from a cost and time point of view. Functional groups that
have been probed for reactivity include a) the phenylalanine side chain b) phenolic
hydroxyl group and c) the halogen group.
1.13.1 Substitution of L-phenylalanine.
Probing this reactivity, by substitution of the L-phenylalanine by other amino acids,
requires a thorough understanding of peptide synthesis methodologies. A first aspect to
consider is the acid hydrolysis of OA for preparation of the starting material, Oa. This
will be followed by an overview of the most suitable coupling techniques available for
the synthesis of analogous peptide side chains.
1.13.1.1 Acid hydrolysis of OA.
The availability of O«, directly from the acid hydrolysis of OA, forms an easy access
route to the coupling of novel amino acids to the lactone acid. N-Substituted amides
(RCONHR'), such as OA, can by hydrolysed by either acidic or basic catalysis, with the
products being the free acid and the primary amine. The mechanism entails cleavage of
the peptide bond brought about by the protonation of the acyl oxygen in acid catalysis
and the nucleophilic substitution of the amino group by water or a hydroxyl group in base
catalysis. In acidic medium, a water molecule reacts with the resultant oxonium ion at the
carbonyl carbon, allowing for the formation of the free acid. Prolonged heating is often
required for complete hydrolysis of the amide.
Steyn, 1967, employed acid hydrolysis for the formation of Ou from OA. The method
described required the treatment of OA with 6M HCI for 30 h under reflux. The
chloroform extract furnished the lactone acid in excellent yield. Xiao et al., 1995,
employed a modification of this procedure in prolonging the reaction period (72 h) at
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room temperature. The hydrolysed Oe crystallised from the 6M Hel solution over a 12 h
period and was isolated by filtration. The relative harsh conditions necessary for the
hydrolysis of the amide bond of OA compared to aliphatic amides can be ascribed to
several factors. Firstly, the electron rich aromatic ring will lower the electrophilicity of
the carbonyl carbon and thus retard the hydrolysis reaction. Furthermore, the electron
donating a-hydroxyl group will increase the electron density at the ipso position,
rendering the carbonyl carbon less electrophilic. Thirdly, and to a lesser extent, from the
structure determined by Bredenkamp et al., 1989 (Figure 1.2), it could be envisioned that
the relatively stable six-membered ring will demand more drastic hydrolysis conditions
for the cleavage of the amide bond as is used for other amides.
1.13.1.2 Peptide Synthesis
The creation of a peptide bond usually entails the coupling of two amino acid derivatives.
More specifically, it requires the nucleophilic attack of a free amine I of one amino acid
on the carboxyl carbonyl carbon II of the other. The subsequent elimination of the
carboxylic heteroatomic group renders the amide bond III (Figure 1.10).
I Il
x = Protective group
Y = Activating group
ï~YNHX
~N R
R I +
C02X (~
Deprotection ..
III
Figure 1.10 The mechanism of peptide bond formation.
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However, in order to achieve effective coupling of the reactive groups, the functional
groups that are not directly involved in the amide bond-forming reaction must be
protected or blocked. The reactivity of the N' -amino group of one of the amino acids and
the C-terminal carboxyl group of the other are both blocked with suitable protecting
groups. This is followed by the activation of the free carboxylic acid towards nucleophilic
attack by the free amine group.
The amme ]If--protecting groups normally used are urethanes (alkoxycarbonyl
derivatives). These groups can be easily introduced, as well as removed by simple acyl
cleavage. The resultant carbamic acids decarboxylate spontaneously generating the free
amine with minimal racemisation of the stereogenie centre. Examples of urethane-based
]If--amino-protecting groups include benzyloxycarbonyl groups, tert-butoxycarbonyl
group (Boe), the 9-fluorenylmethoxycarbonyl group (Fmoc) (Lloyd-Williams et al.,
1997). The benzyloxy- and butoxycarbonyl groups are acid labile, whereas the Fmoc
group can be removed by treatment with a solution of secondary amine. Carboxylic acids
are usually protected by conversion to the corresponding methyl or ethyl esters.
Activation of a carboxyl group of an amino acid (in the case of Oa, a benzoic acid) can
be achieved by the derivatisation of the acyl carbon with an electron-withdrawing leaving
group. The increase in the electrophilic nature of the carboxyl carbonyl carbon as well as
the decrease in bond strength to the activating group, allows for the nucleophilic
substitution by the amine group. The activated states that have been employed in the
coupling of O« to L-Phe and other novel amino acids include acyl chlorides (Xiao et al.,
1995), acyl azides (Steyn et al., 1967), and coupling agents such as
dicyclohexylcarbodiimide (DCC) (Steyn, 1965), N-hydroxysuccinimide (NRS)
(Rousseau et al., 1984) and N,N-carbonyldiimidazole (CDI) (Xiao et al., 1995). The
reactivity of these groups towards nucleophilic substitution corresponds to their electron
withdrawing capability (hydroxyl < secondary amine < azide < activated ester <
anhydride < chloride).
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The reactions described can be carried out in two phases including reactions in liquid
phase or solid phase synthesis (Merrifield, 1959). The latter approach allows for a
sustained control over the protection, deprotection and isolation steps in the sequence.
For the creation of a single peptide bond, as in the coupling of amino acids to Oa, these
reactions are normally conducted with great success by solution phase synthesis.
1.13.1.2.1 Activation as acyl chloride.
The acyl chloride functionality provides the most reactive acyl species for amide bond
formation. However, the drastic conditions necessary to generate them, such as the
treatment with thionyl chloride or phosphorous pentachloride, has prevented its
application in the presence of sensitive amino acid derivatives. Although several milder
methods for its preparation have been proposed, these methods have not been shown to
tolerate sensitive tert-butyl or trityl protective groups (Schmidt et al., 1988).
The formation of the acid chloride of Oa (Oa-CI) and the subsequent coupling with the
methyl ester of L-phenylalanine could readily be achieved, however the product isolated
(in 90% yield) was predominantly the racemic product (Steyn and Holzapfel, 1967). The
process entails the treatment of the lactone acid with thionyl chloride to produce the acyl
chloride which is then treated with the methyl ester of L-phenylalanine in dry pyridine.
Xioa et aI., 1995, employed an alternative procedure to produce the acyl chloride
intermediate, and reported that no racemization took place in the coupling of D-
phenylalanine methyl ester to Oa. This was accompanied by excellent yields (85%) of D-
OA. The procedure entails the treatment of Oa with thionyl chloride in anhydrous
chloroform at reduced pressure. The hydrochloride salt of the methyl ester of
phenylalanine was deprotonated by fine dry sodium metal powder in anhydrous
chloroform and reacted with freshly prepared Oe-Cl. The efficiency of the reaction is
greatly enhanced by the use of the sodium metal, which deprotonates the amino group
which, if protonated retards the reaction. The subsequent hydrolysis of the methyl ester
of OA could lead to the opening of the lactone ring. Thus the reaction mixture should be
acidified to pH 1.0 and left for 12 hours to ensure the restoration of the lactone ring.
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1.13.1.2.2 Activation as acyl azide
In contrast to the acyl chloride method, the use of acyl azides as an activated intermediate
provides minimal racemisation but is prone to low yields. This was illustrated by Steyn
and Holzapfel, 1967, in the coupling of both 5-chlorosalicylic acid and Ou to L-phe
(Figure 1.11). The advantage of this method lies in the stability of the corresponding
azide. Payne, 1998, in an attempt to improve the yield of the coupled product,
investigated the stability of 5-chlorosalicyl azide and the coupling of 5-chlorosalicylazide
to L-phe in solution and in the presence of bases: Na2C03, triethylamine (TEA) and 1,8-
diazobicyclo[5.4.0]undec-7-ene (DBU). Although no method could be established for
increasing yields above 50%, which will make the application to Oa viable, it was found
that in the use of 2 eq TEA in the coupling process the reaction time could be accelerated
from 1-4 days to 2 hours.
~OH soct,
OH 0
((lel N,N;
- +
CO2 NHEt}
H'N~-
Figure 1.11 The coupling of salicylic acid to L-Phe by acyl azide activation (Payne,
1998).
1.13.1.2.3 Activation by coupling reagents
The use of coupling reagents as carboxyl activating agents IS the most prevalent
technique in modem peptide synthesis, of these the carbodiimides are used most often.
The process entails the reaction of the coupling reagent with the free carboxylic acid
group of the amino acid. The reactive intermediate, an O-acylisourea, will allow for
amide bond formation to occur at room temperature, upon treatment with the amino
component.
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Dicyclohexylcarbodiimide (DCC) has been used with great success on a broad selection
of substrates (Sheenan and Hess, 1955). The major advantage of this method lies in the
fact that peptide coupling can be achieved at room temperature and in a short period of
time.
Steyn and Holzapfel, 1967, used DCC in the coupling of L-phenylalanine methyl ester to
Oa. This approach rendered very poor yields «5%) of the desired coupled product. It
was established that the majority of the lactone acid reacted rapidly with DCC to furnish
a crystalline adduct I (Figure 1.12). Similar reactions with 5-chlorosalicylic acid showed
that a similar adduct formed and that the free phenolic hydroxyl group was involved in
the formation of the adduct.
o
II
C
HO""'"
Cl
+
Q-N=C=N-Q Cl
Figure 1.12 Reaction ofOa with DCC to form adduct I.
In order to overcome this problem the hydroxyl group was acetylated, to form 2-acetoxy
5-chlorobenzoic acid, and reacted under similar conditions. Altough the desired product
could only be obtained in 50% yield, it was shown that by the addition of p-nitrophenol to
the acid and coupling reagent, prior to the addition of the t-phenylalanine methyl ester,
the amide could be obtained in quantitative yield.
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1.13.1.2.4 Other coupling techniques
Xiao et al., 1995, reported that the use of CDr I as activating agent of Ou, resulted in
slow reaction rates and low yield of the coupled product (Figure 1.13). The activated
intermediate in this process is the acyl imidazolide II. Rousseau et al., 1984; employed
NBS III as coupling reagent in the synthesis of 14C-Iabeled OA from Oe and [14C]_
phenylalanine (Figure 1.13). The reactive intermediate is the N-hydroxysuccinimide ester
of the acid moiety IV. The product using this method of activation was isolated with
difficulty, but in higher yield compared to the CDr-method and with maintenance of
chirality.
o
II
C
HO/"
OH o
IIC,o
+ -
o
IIo /cN N
W
Cl Cl
lJ
o
II
C
HO/" +
o
HO-N~
o
OH 0
IIc.,o
Cl
TIl
Cl
rv
Figure 1.13 The carboxyl carbonyl activation of Oe by CDr I and NBS III.
1.13.2 Substitution of the carboxylic acid moiety of L-phenylalanine.
The free carboxylic acid functionality of the L-phenylalanine in OA has been extensively
probed for its role in toxicity (Figure 1.14). Xiao et al., 1995; used NBS for the synthesis
of a reactive acyl intermediate, the NBS-ester of OA, which could be substituted by
ethyl amine to furnish the ethyl amide of OA I without forfeiting steric integrity.
Alternatively, the decarboxylated form of L-phenylalanine, phenyl ethyl amine II, reacted
readily with Oa-CI, to form the phenylethylamide of Ou III.
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Figure 1.14 The synthesis of OA analogues with modification to the carboxylic acid
group.
The methyl ester of OA IV can easily be obtained by the rapid treatment of the acid with
a borontrifluoride-methanol solution (Figure 1.14). This method is widely used for the
confirmation of the presence of OA in high performance liquid chromatography (HPLC)
assays. Alternatively, the OA methyl and ethyl esters V can be attained by treatment of
OA with sulphuryl chloride in methanol and ethanol solutions, respectively (Steyn et al.,
1967)(Figure 1.14).
1.13.3 Substitution of the phenolic hydroxyl
The O-methylochratoxin A methyl ester can be obtained by the treatment of OA with
ethereal diazomethane (van der Merwe et al., 1965). Furthermore, O-methylochratoxin A,
can be obtained upon hydrolysis with O.5MNaOH (Xiao et al., 1995)(Figure 1.15).
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OJ:: 0 OH 0 OJ::' 0 OMeII
I
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IH HCH} CH}
Cl Cl
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OJ::'O OMe 0 OJ:: 0 OMeIO.SMNaOH NI IH HCH} CH3
Cl Cl
II
Figure 1.15 The synthesis of OA analogues with modification to the phenolic hydroxyl
group.
1.13.4 Substitution of the chloro group.
OB, the dechloro analogue of OA, provides the substrate for aromatic halogenation.
Alternatively, halogenation could occur via a halogen-exchange route, where the chloro
substituent is directly replaced by another halogen (see section 2.6.1). These reactions
only proceed at an acceptable rate if the leaving chloro group is activated by ortho-
and/or para- electron withdrawing substituents. It is clear that this will not be feasible in
the case ofOA (Figure 1.16).
Figure 1.16 Directing effects of activating (OH, C4) and deactivating (C2, CII)
substituents towards electrophilic substitution ofOB.
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1.13.4.1 Hydrogenolysis of OA (as a route to OB).
Replacement of aromatic halogens by hydrogen can be accomplished by catalytic
hydrogenation and reduction with complex hydrides such as LiAIH4 (Beckwith and Goh,
1983), NaAIH4 (Zakharin et al., 1972) with inorganic (Zn-Ag couple Chung et al., 1988)
or organic reducing agents (p-toluenesulfonylhydrazine in chloroform, Sakamoto et al.,
1984).
Hydrogenolysis of aromatic halides using catalytic hydrogenation readily takes place
with rates of replacement of halogen decreasing in the order I > Br > Cl > F (March,
1992). A general method for the replacement of aromatic chlorine by hydrogen involves
catalytic hydrogenation over palladium on carbon, calcium carbonate or silica gel (Roth
and Schleyer, 1983). Dehalogenation can also be achieved over platinum oxide (Adams'
catalyst) and over Raney nickel. Reduction, especially those using Raney nickel, has to
be carried out in the presence of alcoholic potassium hydroxide to neutralize the liberated
hydrogen chloride (March, 1992).
In catalytic hydrogenation, chlorine is replaced by hydrogen in chlorinated aromatic
hydrocarbons, phenols (Anwer and Spatola, 1985) and nitro benzenes (Akita et al., 1986).
Hydrogenolysis of chlorine in multifunctional aromatic compounds such as chloro -nitro
and -carbonyl compounds, takes precedence over the reduction of nitro or carbonyl
groups, provided that the halogen free compound is not over exposed to the reducing
agent. The reaction IS achieved usmg palladium on carbon or
tetrakis(triphenylphosphine)palladium. Hydrogen donors, sodium hyposphite (Boyer et
al., 1985) or ammonium formate (Anwer and Spatola, 1985) can be employed in catalytic
hydrogen transfer.
In a similar, more complex manner OA is highly functionalised containing carboxylic
acid, lactone and amide carbonyl groups, which would easily be reduced by most of the
mentioned reducing agents. Steyn and Holzapfel, 1967, employed Raney nickel in an
alkaline solution in the dehalogenation of Oa to O~. The method described by
Bredenkamp et al., 1989, in which OA was dehalogenated over Pd/C in the presence of
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ammonium formate and methanol proved to be fast and almost quantitative in yield
(Figure 1.17).
OJ:0
I
H
Cl
Figure 1.17 The catalytic hydrogenolysis of OA (Bredenkamp et al., 1989).
1.13.4.2 Bromination of OB
The bromination of aromatic compounds is usually achieved by treatment with bromine
in the presence of a catalyst. For aromatic compounds activated towards electrophilic
bromination such as anilines, phenols and naphthalenes, bromination proceeds very
rapidly and in the absence of a catalyst (Baciocchi and Illuminati, 1967). Phenols can be
brominated exclusively in the ortho position by treatment with bromine at -70°C in the
presence of z-butylamine or triethylenediamine, which conveniently precipitates the
liberated HBr (Pearson et al., 1967). Certain alkylated phenols can also be brominated in
the meta position by bromine in a superacid solution ofSbFs-HF.
The conversion of the phenol group by the strong acid to a OH2+ group results in the
activation of the meta position (deactivation of ortho and para position) to bromination
(Jacquesy et al., 1980). Para bromination of phenols can be achieved by bromine in the
presence of S-chlorodimethylsulfonium chloride, Me2S+CI cr (Olah et al., 1986).
Bromine thus provides an effective source of electrophilic bromide (Br+) for the
treatment of phenols. However, for the bromination of small amounts of OA, free
bromine does provide difficulty in handling. Fieser and Fieser, 1967, reported on
pyridinium hydrobromide perbromide (PPB) as a stable, crystalline, easily prep arable
source of bromine, which with respect to reactivity, is comparable to bromine. The
controlled reactivity of PPB is ideal for monobromination of activated aromatic ethers
and phenols such as pyrogallol (Steenkamp et al., 1985). Steyn and Payne, 1999,
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employed PPB in the bromination of salicylic acid which afforded 5-bromo salicylic acid
in 19% yield. The very efficient bromination of OB followed which produced BrOB
almost in quantitative yield (Figure 1.18).
OH o
II
C....__ o
Br
Figure 1.18 The bromination ofOB (Steyn and Payne, 1999)
Furthermore, the first biosynthetic production of BrOB by Aspergillus ochraceus Wilh.
was reported by Stander et al., 2000.
1.13.4.3 Iodination of OB
Elemental iodine is the least reactive halogen towards electrophilic aromatic substitution
(Merkushev, 1988). In most cases iodine needs to be oxidised by an oxidising agent e.g.
HN03, HI03, S03, peracetic acid or H202, to render it more electrophilic. This, however
allows for limited use in sensitive multifunctional compounds.
ICI is a better iodonating agent than iodine due to the net polarisation of the molecule.
The more electronegative chlorine atom (8-) increases the partial positive charge on the
lesser electronegative iodine atom (8+). Woollet and Johnson, 1943, have shown that
salicylic acid upon treatment with ICI could easily be iodonated to 3,5- diiodosalicylic
acid. Payne, 1999, extended the method to iodonation ofOB, but with little success. Iodo-
ochratoxin B was eventually isolated in good yield, employing the method used by
Venter and Langenhoven, 1996 (Steyn and Payne, 1999). This method entails the use of
RgO and iodine in a methanol:ethanol (1:1) solution (Figure 1.19). Schmiedova et al.,
1989, had previously reported on the synthesis of 125IOB from OB by the use of
chloramines and N125r. The 125IOB was used in the radioimmunoanalysis of OA.
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Figure 1.19 The iodination of OB (Steyn and Payne, 1999).
In order to rationalise the role of the halogen substituent in OA toxicity it is important to
relate the electronic nature of the halogen (and its effect on the aromatic ring substituents)
to the observed toxicity. Preliminary tests have shown that the toxicity of the ochratoxins
increases in the order of OA < BrOB < lOB. The electronegativity of the halogens
increases in the order I < Br < Cl. Thus the smaller the electronegativity of the halogen
the higher the toxicity of the ochratoxin. OB, with a proton substituent less
electronegative than any of the halogen substituents, is less toxic than OA and is not in
agreement with this analogy. The electronegativity of the halogen group has a direct
bearing on the dissociative property of the phenolic hydroxyl group (Chu, 1974) and has
been implicated in lipid peroxidation (Rahimtula et aI., 1988). It could thus be
hypothesised that fluoro-ochratoxin B, with the greatest electronegativity, could have the
lowest toxicity. More importantly though, would be the relative observed toxicity of
fluoro-ochratoxin B to OB. It was proposed that the toxicity of OA in vivo, was defined
by the rate of hydrolysis by carboxypeptidase to the non-toxic Oa (Bredenkamp et al.,
1989) (section l.5). In this mechanism the sterical bulk of the C-6 substituent should be
taken into consideration. The difference in size of chlorine and hydrogen atoms is much
greater than that of fluorine relative to the hydrogen atom. The syntheses of fluoro-OB
will thus not only provide a probe for the reactivity of the halogen substituent but also
ascertain by which mechanism the substituent exerts its role in toxicity.
An attempted synthesis of fluoro-OB demands a thorough understanding of the chemistry
involved in introducing a fluorine atom into an organic substrate. As the main focus of
our research effort, the biological aspects and synthesis of organofluorine compounds
will be dealt with in detail in chapter 2.
55
Stellenbosch University http://scholar.sun.ac.za
CHAPTER2
SECTION A: FLUORINE IN BIO-ORGANIC CHEMISTRY
2.1 Introduction
Since the discovery of hydrogen fluoride by Scheele in 1771, and the more
importantly the isolation of elemental fluorine by Henri Moissan in 1886, synthetic
fluorine chemistry has seen an enormous and diverse growth. But it was the
contribution of Swarts in 1892 that accelerated the growth of organofluorine
chemistry with his work on the preparation of fluorinated materials by metal fluoride
promoted halogen-fluoride exchange reactions. Industrial incentives manifested in the
commercial utility of organofluorine compounds as coolants, developed by Midgley
and Henne in 1930, led to the further development of synthetic fluorine chemistry
(Banks and Tatlow, 1994, and references cited). Fluorine containing compounds find
application not only in the inorganic but also in the polymer, pharmaceutical, and
organic chemical industry with organofluorine compounds being the most prevalent.
The vast differences in the number of industrial applications can solely be ascribed to
the dramatic changes in the physical and chemical properties of compounds upon
fluorination. These properties are manifested in commercial products which range
from agrochemicals, medical and health care products to surfactants, textiles, dyes
and polymers (Figure 2.1).
°ONHCH3
F3C I "'-':::
//
Ciprofloxacin
Broad-spectrum fluoroquinolone antibacterial drug
Fluoxetine
Anti -depressant drug
F OH
o
HN~F
oAN)1
I
H
5-Fluorouracil
Anti-cancer agent
F
Diflunisal
Analgesic, anti-inflammatory, anti-pyretic drug.
Figure 2.1 Representative commercial organofluorine compounds.
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Figure 2.1 Continued
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The profound and often unexpected effects that fluorine can have on the biological
activity of compounds are well-documented (Fried and Sabo, 1954; Welch, 1987).
Selective fluorination has been an extremely effective synthetic tool for modifying
and probing reactivity. By substituting a hydrogen or hydroxyl group for a fluorine
group in biologically relevant molecules often yields a derivative with increased
selectivity or a modified spectrum of activity not in coherence to other halogens (Kirk
et al., 1971)
It was the pioneering work of Fried and Sabo, 1954, on the synthesis of 9a-fluoro-
hydrocortisone acetate that led to the first successful application of selective
fluorination for the purpose of modifying biological activity (Figure 2.2).
o
Figure 2.2 9a-Fluorohydrocortisone acetate
Recognition of these properties has induced extensive interest in the synthesis and
biological assaying of fluorinated analogues to biologically significant compounds.
2.2 Structural and bonding characteristics of fluorine.
Fluorine contains nine protons in its nucleus which interacts strongly with the same
number of electrons due to the occupancy of both protons and electrons of the inner
shell. Thus the Van der Waals radius of fluorine (rF ~1.35) is contracted to such an
extent that it closely resembles that of an hydrogen atom (rF ~ 1.10), allowing fluorine
to be the only element to replace hydrogen without notable steric consequences
(Schlosser, 1977). In contrast to their similarities in size, fluorine and hydrogen are
quite different in their reactivity.
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The high effective nuclear density and the tendency to complete its valence orbital
renders fluorine strongly electronegative and reactive. Attached to a reactive centre it
proves to be a moderately active leaving group. Placed in the vicinity of a reaction
center it proves to substantially influence reaction mechanisms via its strong inductive
electron-withdrawing effect. This is illustrated in the example of fluoroacetic acid,
that acts as an anti-metabolite to acetic acid, which mimics acetic acid in the entering
of the tricarboxylic cycle (Krebs cycle).
Structural and bonding characteristics of organofluorine compounds are thus derived
from three essential factors: (l) the extreme electronegativity of fluorine (2) the
strength of the C-F bond (3) the small size of the bound fluorine.
Excluding unreactive neon, fluorine is the most electronegative element with a
Pauling electronegativity of 4 as compared to 3.5 for oxygen, 3.0 for chlorine or 2.8
for bromine. It is this property that is the apparent source of the marked differences
that are observed if fluorinated and non- fluorinated molecules are compared.
Of all the halogens bound to carbon, fluorine forms the strongest bond, seen from the
carbon-fluorine bond energy of 456-486 kj per mole compared to the carbon-chlorine
bond of 350 kj per mole, and the carbon-hydrogen bond which varies between 425-
435 kj per mole. At the same time it is important to note that the bond lengths
associated with the bond dissociation energies differ with the respect to the different
halogens bonded to carbon. The much shorter fluorine-carbon bond, 1.31 Á,
substantiates the difference in bond dissociation energies if it is compared to the other
carbon-halogen bond lengths, eg. carbon-chlorine bond length of 1.78 Á.
Another interesting phenomenon is the relative difference in the bond lengths of
perfluoro methanes (Table 2.1) if compared to the carbon-hydrogen bond. The
decrease of bond lengths are again accompanied by the increase in dissociation
energies.
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Table 2.1 Bond lengths (A) and bond dissociation energies (kj/mol) of halogenated
methanes (Source:Banks, 1998).
Halogen CH3X CH2X2 CHX3 CX4
F 1.385 A 1.358 A 1.332 A 1.317 A
456 kj/mol 510 kj/mol 535 kj/mol 543 kj/mol
Cl 1.782 A 1.772 A 1.767 A 1.766 A
350 kj/mol 339 kj/mol 325 kj/mol 301 kj/mol
Br 1.939 A 1.934 A 1.930 A 1.942 A
289 kj/mol 267 kj/mol 259 kj/mol 295 kj/mol
Smart, 1983, rationalized this decrease in bond lengths as the result of an increase in 7t
character, i.e. that any p-carbon electrons would be shared by the fluorine atom and
that this will lead to an increase in s-character of the carbon-fluorine bond and
subsequent decrease in bond lengths. Furthermore, the carbon-fluorine bond in
fluoromethane would be more p-electron rich and longer in bond length than
fluoroform. Friesen and Hedberg, 1980, reported on the pronounced differences in the
gauche effect, manifested in the molecular conformation, of vicinal electronegative
substituents. This phenomenon is shown in the presence of 1,2- difluoroethane to exist
in the synclinical conformation as opposed to the antiperiplanar position. This feature
is a common occurrence of halogenated compounds but is amplified most in the
fluorine substituted compounds.
Finally the electronegativity of fluorine can also effect distribution within a molecule
substituted by other groups and thereby effecting the polarity (dipolar moment),
reactivity and stability of the entire molecule, and the acid characteristics of adjacent
groups.
2.3 Influence of fluorine on the physical and chemical reactivity of
molecules.
The difference in the physical, chemical and biological activity of fluorinated and
non-fluorinated compounds can be directly attributed to the difference in
electronegativity of fluorine and hydrogen, the greater carbon-fluorine bond strength
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relative to the carbon-hydrogen bond strength, the ability of fluorine to donate a free
electron pair and form intermolecular hydrogen bonds.
The high electronegativity associated with fluorine has pronounced electron
withdrawing effects via (a) the creation of an induced dipole along a chain of bonded
atoms known as a sigma withdrawing effect, Ic, or (b) through space electrostatic
interaction known as the field effect. These two effects are well illustrated in the
example of the relative difference in acidity of trifluoroacetic acid and acetic acid. In
an aqueous medium trifluoroacetic acid (pKa 0.3) exists as a stronger acid than acetic
acid (pKa 2.24). But in the gas phase this tendency is not constant with trifluoroacetic
acid being less acidic than trichloroacetic acid. This irregularity can be ascribed to the
smaller polarisability of carbon-fluorine bond (0.53 Á) relative to that of the carbon-
chlorine bond (2.61 Á). This decrease in polarizability renders a carbon-fluorine more
comparable to that of an carbon-hydrogen bond (Welch, 1990, and references cited).
The influence of the TC system on the electronic effects of fluorine directly opposes the
charge induced dipole effect described above by the back donation of non-bonded
electrons from the fluorine atom to the TC system in an lIT repulsive interaction. These
interactions are manifested in the reactivity of c-fluorinated anions toward radicals
and the addition reactions of nucleophiles to fluorinated alkenes. a-Fluorinated
cations on the other hand are stabilized by the presence of fluorine by the interactions
of the empty p-orbital of the carbon atom and the filled orbitals of the fluorine atom.
Another chemical reactivity that prevails from the properties of fluorine is the
capability of fluorinated carbon-carbon bonds in determining the stereochemistry of a
specific reaction (Lin et al., 1988; Cheung et al., 1986; O'Hagan and Rzepa, 1997).
The carbon-carbon bond with no fluorine substituents and subsequently the higher
electron density has the ability to donate electrons to bond forming orbitals and thus
control the stereochemistry in such a manner.
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2.4 The influence of fluorine on the biological reactivity of molecules.
Selective fluorination of organic compounds has been an extremely effective synthetic
tool for altering biological activity and probing structural activity relationships. The
suitability of fluorine as substituent for hydrogen in biologically potent compounds is
twofold.
Firstly, as explained in the foregoing discussion, the pronounced difference in the
electronic effects brought upon by fluorination. Secondly the inability of this effect to
be neutralise by a sterically hindered substituent, i.e. fluorine is comparable in size to
hydrogen, the Van der Waal's radii being 1.35 A and 1.20 A respectively. From a
potential substitution point of view the carbon-fluorine bond length of 1.39 A is
comparable to the carbon-oxygen bond length of 1.43 A which leads to the
assumption that these substitution could be energetically feasible.
Fried and Sabo, 1954, explored the reactivity of organofluorine compounds by the
introduction of fluorine into biologically active metabolites, which led to the blocking
of reactivity. Fluorine hydrogen-substitution synthetic methods has been used
extensively to elucidate the role that intra- and inter-molecular bonding plays in
rendering compounds biologically active. Fluorine has the ability to mimic the role of
the electron pair accepting hydrogen by its ability to donate non-bonded electrons to a
species with a vacant orbital.
Fluorine can act in the capacity of a leaving group in enzyme inhibition and thus
contribute in clarifying the susceptibility of the compound to enzymatic action. The
step-wise fluorine substitution of hydroxyl groups reveals the effect that
hydroxylation has in a molecular system as was done in the successful study of
vitamin 03 analogs. To many of the metabolic transformations the strongly carbon
bonded fluorine is rendered resistant. But at the same time fluorine may also be
employed in addition-elimination reactions where its greater leaving group
capabilities relative to that of hydrogen is exploited. The ability of fluorine to increase
lipophilicity and hence the increase in the bioavailability of the compound underlines
its pharmacological application (Welch, 1990, and references cited).
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Finally the natural stable isotope of fluorine, 19F,a spin quantum number of one-half
and chemical shift range of about 300 ppm, provides a very sensitive analytical tool in
nuclear magnetic resonance studies. The pharmokinetic profiles of certain compounds
can be defined by the selective introduction of the fluorine probe into the desired
compound. The synthetic short-half life isotope, 18F, allows for the in vitro study of
living tissue by its positron emission. The technique, positron emission tomography
(PET), provides a non-invasive diagnostic tool which complements existing
techniques such as X-ray analysis, and supercedes such techniques with respect to
time (PET allows for real time assays) and the health aspects concerned.
The success of PET relies on the half-life of the administered isotope. 18Fhas a half
life of 110minutes which makes it suitable for the brain imaging of patients suffering
from Parkinsons disease, compared to 20 minutes of IIC, 10 minutes of 13N and 2
minutes of ISO. 18F labeled fluorodopa PET studies have revealed an considerable
amount of information concerning the chemistry and metabolism present in the brain
tissue. This has also led to a further application in the diagnosis of breast tumours in
the form of 18F-labeled estrogen probe (Reivich and Alavi, 1985).
2.5 Applications of organofluorine compounds in bio-organic
chemistry.
2.5.1 Amino acids and amines.
The importance of enzymatic decarboxylation of ammo acids in biosynthetic
pathways may be obtained by the use of a specific fluorinated analogue as inhibitors
of the decarboxylation enzymes in studying these pathways. Examples of
physiologically important amines formed by decarboxylation are dopamine, 5-
hydroxytryptamine, histamine and gamma-aminobutyric acid (GAB A) (Figure 2.3).
Catecholamines are essential in the regulation of central and peripheral blood pressure
(Versteeg et al., 1977). Douglass, 1975, observed elevated histamine levels in
diseases such as allergies, hypersensitivity, gastric ulcers and inflammation. Elevated
putrescine levels are known to be associated with rapid cell proliferation, including
tumour growth (Dunzendofer and Russell, 1978).
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Tyramine
Dopamine
Gamma-aminobutyric acid (GABA)
HO
Seratonin (5-hydroxytryptamine) Histamine
Figure 2.3 Physiologically important amines formed by decarboxylation of the
respective amino acid.
Fluoromethylated amino acids have been recognized as potent suicide inhibitors of
enzymatic decarboxylation reactions ( Kollonitsch et aI, 1978) as seen in Table 2.2.
The enzymatic inactivation is thought to be dependant on the loss of fluoride from the
methyl group, which leads to the formation of a reactive Michael type acceptor. The
acceptor covalently bonds to the decarboxylase enzyme, thus inhibiting any further
binding to substrates.
Table 2.2 Fluoromethylamino enzyme inhibitors (Source: Welch, 1987).
Amino acid analogue Inhibited enzyme
Fluoromethylglutamic acid
Fluoromethylornithine
Fluoromethyldopamine
Fluoromethyltyrosine
Fluoromethylhistidine
Fluoromethylhistamine
Glutamate decarboxylase
Ornithine decarboxylase
Dopa decarboxylase
Dopa decarboxylase
Histidine decarboxylase (mammalian)
Histamine decarboxylase
Kingsbury et al., 1983, reported on the incorporation of m-fluorophenylalanine in the
synthesis of di- and tri-peptides. The resultant fluoro-peptides have the ability to
easily penetrate fungal cell walls, which leads to the release of the toxic m-
tluorophenylalanine into the cell plasma. Tn contrast m-fluorophenylalanine is
inherently non-toxic to Candida Albicans as can be seen from Table 2.3.
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Table 2.3 m-Fluorophenylalanine-containing peptide as agents against
Candida Albicans (Source: Kingsbury et al., 1983).
m-Fluorophenylalanine
containing peptides
MICa against C. albicans strain
B311 759
L-mFPhe
L-mFPhe-L-Ala
L-mFPhe-L-Ala-L-Ala
L-mFPhe-L-Met-L-Met
L-mFPhe-L-Ala-L-mFPhe
>250
2
0.5
8
2
>250
4
2
63
63
a Minimum inhibitory concentration in ug/ml.
In contrast to the above, cc-monofluoromethyl- and difluoromethyl- amino acids have
been defined as stringent enzyme-activated irreversible inhibitors of the parent u-
amino acid decarboxylase. Versteeg et al., 1977; reported on the importance of
catecholamines in the regulation of central and peripheral blood pressure. Fluorine
substitution on the aromatic ring of catecholamines has a striking effect on there
selectivities for u- and ~-subtypes of adrenergic receptors. This led to the progressive
testing of new analogues in the quest to determine the submolecular mechanisms at
work at the cathecholamine-adrenergic receptor interface. The results obtained
indicated that the direct effect of the carbon-fluorine bond on antagonist-receptor
interaction may be more important than the indirect effect of the carbon-fluorine bond
on neighbouring side chains.
Walborsky et al., 1955, discovered that amino acids substituted with trifluoromethyl
groups can act as possible antimetabolites. The synthesis of amino acid analogues, i.e.
the substitution of a methyl group for a trifluoromethyl groups, is essential for probing
enzyme activity. The resultant high electron density that exists on the trifluoromethyl
groups may initiate the association with enzymes and the subsequent formation of
strong hydrogen bonds that could render the enzyme inactive due to the blocking of
functional groups responsible for metabolic responses.
Initially the fluorination of amines was found to be problematic due to the non-
selective fluorination of the compounds by the then available fluorination reagents.
The careful optimisation of the reaction conditions with respect to the solvents used in
the synthesis, i.e. the use of hydrogen fluoride employed to protect the amine
functionality, has led to the successful synthesis of ~-fluorinated amines which are
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important substrates in the design of the antimetabolites and drugs because of the
optimal change in electron distribution and minimal effect on the structural design of
the molecule.
2.5.2 Steroids
As mentioned, the fluorination of steroids manifested in the work of Fried and Sabo,
1954, was indicative of the effect that fluorine substitution can have on biologically
active molecules. The synthesis of fluorinated analogues of vitamin D3 has been
employed to prevent the metabolic hydroxylation (fluorination at Cl, C3 or C25, see
Figure 2.4) and thus the subsequent activation of the vitamin D3 analogues of the
active steroid hormone, I. The selective fluorination of the hydroxylation positions
allows for the elucidation of the role of each hydroxyl group in the reactivity of the
molecule.
cis"
I OH
cis"
I 'F
Figure 2.4 The activation of Vitamin D3 by hydroxylation. Hydroxylation is inhibited
in fluoro analogues.
2.5.3 Carbohydrates
The selective fluorination of carbohydrates has found wide application in the probing
of biochemical mechanisms. These resultant fluoro-glycosides have many
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applications in biochemistry, medicinal chemistry and pharmacology (Bessel et al.,
1973).
In addition 18F-labelled sugars have found utility as in vivo imaging agents for
carbohydrate metabolism. 2-Deoxy-2-fluoro-glucose-(18F) has been established as a
useful radiopharmaceutical for studying glucose metabolism in both healthy and
diseased tissue (Schelvert et al., 1982). Radio labeled 2-deoxy-2-fluoromannose was
shown to be effective in the application of positron emission tomography for the
imaging of subcutaneous AHI09 A tumor in rabbits (Fukuda et al., 1982, see Figure
2.5).
Figure 2.5 The naturally occurring fluorosugar constituent of nucleocidin.
The importance of fluorine substitution of hydroxyl groups in carbohydrates IS
manifested in the profound difference obtained by this substitution in the electronic
effects experienced by neighbouring groups in their constant immediate steric
environment. These substitutions are accomplished without the loss of the potential
hydrogen bonding. At the same time this contributes to difficult synthesis and the total
synthesis is virtually impossible because of the stereochemical control needed in
adjacent asymmetric centers of the fluorinated carbohydrates (Chmielewski et al.,
1982). Von der Osten et al., 1990, reported on the role that aldolase can play in a
convergent enzymatic synthesis of fluorosugars via easily fluorinated building blocks.
2.5.4 Nucleic acids
Fluorinated nucleic acid analogues have been found to exhibit a wide spectrum of
biological activity. Bergstrom et al., 1984, observed antiviral activity of some of the
fluorine substituted naturally occurring nucleic acids, whereas Shimizu et al., 1984,
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Yeatts et al., 2000; Mehta et al., 2000, reported on antitumor and antifungal activity
of 5-fluoruracil. The electronic effect brought about by fluorine substitution is again
responsible for the marked difference in reactivity. Fluorine acts as replacement for
both hydroxyl and hydrogen groups, whereas difluoromethylene probes the oxygen
activity.
2.S.S Aromatic compounds
Fluorinated aromatics have found wide application as antibiotics, sedatives, essential
agrochemieals and radioactive imaging agents. Henkin and Washtien, 1983 reported
on the improved antitumor activity of 2', 3'-fluoroaminopterin (Figure 2.6) on LI210
cell or human cancer HuTu80 cells as compared to methotrexate. 3',5'-
Difluoromethotrexate (Figure 2.6) has been used successfully to study the binding of
materials to dihydrofolate reductase. When bound to the enzyme, the fluorine
substituents are in different chemical environments and it is possible to observe the
effect of added NADH or NADPH to the bound methotrexate analogue (Welch,
1987). Radio labeled fluorotamoxifen (Figure 2.6) was found to be a good estrogen
receptor binding agent, allowing for the study of estrogen distribution patterns.
3' ,5' -Dill uoromethotrexate
18F
t8F-labelied Fluorotamoxifen
3'-Fluoroaminopterin Eperezolid
Figure 2.6 Biologically active aromatic fluorides.
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The remarkable impact of a new found antibiotic class, the oxazolidinones, on the
treatment of multiple resistant strains of Staphylococcus aureus, Staphylococcus
epidermidis, Streptococcus pneumoniae and certain Enterococus species, has been
reported (Zurenko et al., 2001; Dailey et al., 2001 and Oramus-Shirley et al., 2001).
The lead agents, linezolid (Figure 2.1) and eperezolid (Figure 2.6) were found to be
highly effective against methicillin-resistant S. aureus strains. Methicillin together
with vancomycin and ticoplanin are seen as the last line of defence against life
threathening infections including pneumonia, surgical infections and other hospital
acquired opportunistic infections. The reports on intermediate resistance to
vancomycin resistance, emphasize the need for a new class of antibiotics such as the
oxazolidinones. Structure activity relationship studies revealed that the aromatic
fluorine improved the antibacterial activity and efficacy.
2.6 Synthesis of organofluorine compounds
The numerous fields of application of selective fluorination, as a tool to probe
biological activity, testify to the importance of a good understanding into the
chemistry of the fluoro substrates and more importantly the fluorinating reagents and
methodologies employed. The optimization of these methodologies will lead to an
even greater elucidation of certain structure activity relationships contained in the
biologically active molecules.
Two distinct strategies are available when planning the synthesis of a fluorinated
molecule: (1) incorporate a starting material already containing the fluoro group
needed in a de novo synthesis of the desired compound (the "building-block"
approach); or (2) insert the fluoro group required at a convenient stage using a
fluorinating agent. Depending on the target molecule, either or both approaches may
be meaningful. In our research effort emphasis was placed on the latter of the two
strategies, since in principle, it is always more convenient, if possible, to incorporate
fluorine in an existing natural product than building the desired molecule from
simpler constituents.
It remams a challenge, however, to selectively incorporate fluorine into a
multifunctional compound. This section reviews modem methods available for
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selective aromatic fluorination, with specific reference to the synthetic approaches
employed in our attempts to fluorinate ochratoxin.
2.6.1 Halogen replacement
From fluorine's chemical nature it can be appreciated that most of its application in
synthetic chemistry revolves around the fluoride species (F). In contrast to the
relative ease of chlorination and bromination of aromatic hydrocarbons, in which an
aromatic hydrogen is electrophilically substituted and therefore lost as a proton, the
introduction of fluorine is normally achieved via nucleophilic attack by an F- species
under more severe conditions. The halogen-exchange methodology involves the
displacement of a larger halogen from the aromatic carbon by a fluorine substituent in
the form of an F species via an addition-elimination mechanism. As mentioned before
the reaction proceeds at an acceptable rate only if the leaving halogen group IS
activated by an ortho- or para electron-withdrawing substituent (Figure 2.7).
Cl F Cl F Cl F
¢ F- IC;)I IQ -Cl ¢OIl( ~ OIl( Jo etc.
N02 N N, N020-:/+ '0- -0"" + 0-
Figure 2.7. Fluorination by the halogen-exchange route.
The most effective activating groups (N02, CN, COF, CHO, S02F) withdraw electron
density from the aromatic ring (specifically the ortho and para positions) via both the
inductive (-I) and the mesomeric (-M) effects (March, 1992). Since the C-X bond is
not broken in the initial rate determining step, the order of ease of nucleophilic
displacement of halogen from activated aromatic systems (N02-Ar-X) is X= F > Cl >
Br > I. This allows for the synthesis of fluoroaromatics from the corresponding
inexpensive chloro-compound using a large excess of alkali-metal fluoride sources
viz. CsF, RbF, KF, NaF and LiF (Moilet, 1994). Although the fluoride is a better
leaving group the dynamics of the equilibrium allows for washing out of the chloride
by the sheer excess of the fluoride. Halogen replacement via arylmetallic intermediates
are discussed in section 2.6.4.
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2.6.2 Nitrogen replacement -The Balz-Schiemann Reaction
This was the first widely used method for the introduction of a fluorine atom onto an
aromatic ring (Balz and Schiemann, 1927). It involves a three stage process starting
with the diazotization of an aromatic amine I to produce a diazonium fluoride or
tetrafluoroborate II, which is then decomposed thermally (the fluorodediazotization
step) to afford the fluoro aromatic III, nitrogen and boron trifluoride in the case of
tetrafluoroborate (Figure 2.8).
G-R
I
HX
NaN02
F
G-R
II III
X=F,BF4-
R = H or one or more substituents.
Figure 2.8 Fluorination by the diazoroute.
The key to the method is the relative ease III which the highly insoluble
arenediazonium tetrafluoroborate can be isolated in an aqueous medium. The yields of
the isolated arene diazonium salts are generally high, often exceeding 90%. However,
it has been shown that the presence of hydroxyl or carboxylic acid ring substituents
could adversely affect yields by increasing the aqueous solubility of the salts (Moillet,
1994). The lower product yields in the dediazotization step can be ascribed to
numerous factors. Arenediazonium tetrafluoroborates containing electron-donating
groups ortho or para to the diazonium substituent are less stable and decompose at
lower temperatures than those containing meta substituted equivalents and electron
withdrawing groups. The presence of boron trifluoride as a strong Lewis acid as well
as the role that the diazonium group plays as a powerful activator for the displacement
of nucleophillic groups in ortho and para positions is evident in the resultant
byproducts observed.
As an extension of the Balz-Schiemann reaction, F has been tried as an alternative to
the tetrafluoroborate. In this approach an aromatic amine is diazotized with nitrosyl
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fluoride, generated in situ from hydrogen fluoride and sodium nitrite. This method
avoids the isolation of the fluoride salt prior to decomposition, and no recycling of
gaseous products as in the case with tetrafluoroborate.
It is obvious from the reaction conditions employed in the Balz-Schiemann reaction
that this approach is limited to the fluorination of relatively simple aromatic
compounds. It could thus only feature in the early stages of a de novo synthesis of a
highly functionalised molecule.
2.6.3 Hydrogen replacement
2.6.3.1 Direct elemental fluorination of aromatic systems.
From its discovery in 1886 by Henri Moissan until the 1960's elemental fluorine had
been considered too reactive and dangerous to be practical for the fluorination of
organic molecules. Fluorine is such a strong oxidizing agent that it reacts with almost
any organic substrate, usually exothermically, and often with explosive results
(Grakauskas and Baum, 1970). In addition the poor solubility of fluorine in organic
solvents leads to reactions taking place at the liquid-gas interface which subsequently
afford several unwanted side reactions (Cacace et al., 1980). These effects have been
minimized by the use of dilute solutions of fluorine in inert gases such as nitrogen or
argon, which allows for greater control and selectivity.
The applications of fluorine in organic synthesis have flourished with the advent of
high quality fluorine and fluorine-nitrogen mixtures being commercially available as
well the development of moderating fluorine carriers (section 2.6.3.2). The great
expense of user-friendly fluorination agents such as acyl hypofluorites, caesium
fluoroxysulfate and xenon difluoride as well as the fact that elemental fluorine is used
in the production of these reagents, has prompted renewed interest in the use of
elemental fluorine in the direct fluorination of especially aromatic compounds
(Chambers et al. 1999; Moillet, 2001).
The first attempts to substitute an aromatic hydrogen for a fluorine group was met
with limited success. Cacace et al., 1980; employing molecular fluorine «0.76% F2 in
N2) in CFCb at low temperatures, substituted a variety of aromatic rings (benzene,
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toluene, anisole and nitrobenzene) at low conversions (0.01%). Grakauskas, 1970,
reported that the substitution reactions followed first-order kinetics, in which the
conversion is only determined by the amount of aromatic substrate present. The
mechanism proposed involves the attack on the benzene ring by a polarized fluorine
molecule leading to an arenium ion (See figure 2.9).
OH
~F~---
R
+
OH O-H
~R-··9R
H F H F-- F
R= COOH, CHO, CH3
Figure 2.9 SN2-type reaction mechanism for the fluorination of substituted phenols as
proposed by Cacace et al., 1980.
In addition to the proposed mechanism by Cacace and coworkers, Chambers et al.,
1997, suggested that fluorination occurs by both one (See figure 2.10) and two
electron transfer processes. This explains to a great extent the multitude of secondary
reaction products obtained in the fluorination of aromatic compounds by early
researchers.
[0 +F;J o + HF
~ other radical
derived products
Figure 2.10 Aromatic fluorination via I-electron transfer (Hutchison and Sanford,
1997).
Grakauskas, 1970, reported on the fluorination of methyl benzoate in acetonitrile at
-20°C. The reported yields (74% p-, 0- and m-fluorobenzoates) were the first to be of
a synthetically useful scale and the isomer ratios (1:3 :5, respectively) suggest that the
fluorination occurs via electrophilic aromatic substitution analogous to the ionic
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reaction of other halogens. Sams et al., 1978; employed molecular sieves in an
attempt to minimize polymer formation, a secondary reaction that was prone to occur
at high conversions. At optimized reaction conditions (-78°C, no solvent), Sams
obtained almost 20% 0- and p-difluorobenzenes from fluorobenzenes.
Misaki, 1981 and 1982, reported on the monofluorination of oxygenated aromatic
substrates in high yields using molecular fluorine (11% in nitrogen) at various
temperatures. For the fluorination of a 10% solution of phenol at -20°C, alO %
conversion to the monofluorinated product afforded an ortho to para ratio of 22: 1,
whereas during higher conversions the substitution of the para position was favoured.
This was ascribed to the fact that the ortho isomer underwent secondary reactions to
an experimentally observed byproduct. Misaki, 1982, further emphasized that
temperature also played an important role in the isomeric ratios. For the fluorination
of phenol at lower temperatures increased conversion and fewer side reactions altering
the isomeric ratios occurred.
Misaki, 1982, also reported on the fluorination of methyl substituted phenols. For 0-
eresols the ortho/para substitution was approximately 1:1 irrespective of solvent used
or temperature employed. The fluorination of m-cresol furnished a mixture of 0-
substituted products, the 2-fluoroderivative being the major product. The fluorination
of p-cresol I, were accompanied by the formation of the o-derivative II but also of
fluorocyclohexadienyl ketone III as a major byproduct (Figure 2.11).
OH
¢
I II III
Figure 2.11 The fluorination ofp-cresol by F2 (Misaki, 1982).
Misaki, 1982, extended his studies to the fluorination of substituted phenols such as,
salicylic acid, salicylaldehyde and phenyl salicylate with addition of hydrogen
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fluoride. 5-Fluorosalicylic acid was isolated in good yield (73%) from salicylic acid in
hydrogen fluoride, while phenyl salicylate fluorination afforded a mixture of phenyl
3- and 5-fluoro salicylate in an even greater yield (89 %) under similar conditions. Of
interest was the fact that no oxidation of the aldehyde group occurred in the
fluorination of salicylaldehyde as opposed to the oxidation of salicyl alcohol to the
fluoro salicylaldehyde during fluorination in acetonitrile (Figure 2.12)
OH OH OH(yeO'H ¢reo,,, F*eO'H-F2,HF +
~
F F
(73%) (10%)
OH OH OH(yeO'Ph F),HF F'(JeO'Ph ¢reO'Ph;:/" -
I +
~
F
(89%)
OH OH OH(yeHO ¢reHO F'(JCHOFz, HF.
+
~
F
(60%) (19%)
OH OH OH OH(yeH'OH Ó ¢reHO qell'OHFz,CH3CN + +~F FF
(37%) (20%) (10%)
Figure 2.12 The direct fluorination of aryl oxygen compounds using F2 (Misaki,
1982).
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With a view to promoting the two electron process, i.e. encouraging the apparent
electrophilicity of fluorine, Chambers et al., 1996, investigated the effect of strong
acids as solvent on fluorination of aromatics. Itwas found that for formic and sulfuric
acid, both strong acids of high dielectric constants, fluorine was polarised to such an
extent, that the electronegative end of the molecule is protonated by the acid and the
electropositive end is free to react with the nucleophilic aromatic substrate. The
preferred solvent is therefore one which assists electrophilic reactions while
suppressing radical reactions. Although formic acid is not inert to fluorine, the
product of the reaction i.e. hydrogen fluoride and carbon dioxide are easily removed
from the reaction chamber. Ring sulfonation, competing with the fluorination
reactions involving sulfuric acid, proved to be of no advantage yet marked success has
been achieved, particularly with aromatic fluorination reactions involving a relatively
electron deficient ring (Chambers et al., 1996). Side reactions of sulfonation, due to
greater nucleophilicity, are prone to react with electrophilic fluorine.
Chambers et al., 1999, reported an increase in both yields and selectivity when
replacing acetonitrile with sulfuric, or formic acid in the fluorination of the
compounds employed by Misaki, 1981 and 1982. The selectivity is particularly high
when both groups in a disubstituted aromatic compound direct the attacking
electrophile to the same ring carbon atom. For example 3,4-difluorobenzoic acid can
be obtained in good yields (80%) from 4-fluorobenzoic acid in the presence of high
concentrations of sulfuric acid (Figure 2.13).
In addition direct fluorination of 4-chloronitrobenzene to yield 4-chloro-3-
fluoronitrobenzene in good yield (68%), which in tum is an isomer of 3-chloro-4-
fluoronitrobenzene (produced with relative ease by the Halex process, section 2.6.1),
illustrates the use of this methodology to produce different isomers that would
otherwise have been synthesized with great difficulty (Chambers et al., 1999)(Figure
2.13).
Chambers et ai, 1999, reported the fluorination of a benzaldehyde in which the ring is
substituted with an electron donating group, e.g. 4-methoxybenzaldehyde, could be
fluorinated in a satisfactory yield (60%) by the addition of sulfuric acid. In contrast in
the fluorination of 4-fluoro-benzaldehyde, the major reaction was the oxidation to 4-
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fluorobenzoic acids followed by the fluorination in the 3-position. Furthermore, the
presence of methyl groups as ring substituents lowers the yield of aromatic ring
fluorinated products due to the reaction of fluorine with benzylic hydrogens and the
subsequent increase in tar formation.
..
F
(38%)
Figure 2.13 Direct aromatic fluorination by F2 in the presence of H2S04 (Chambers et
al, 1996).
OH
¢
F
Q
Cl
OH
¢ F2' H2SO4
OCH}
CHO
¢ F2, H2SO4
F
OH
~F
F
(80%)
..
Cl
(68%)
OH
~F
OCH3
(60%)9" F" ",SO,
F
The synthesis of2-fluoro-vanilin (4-hydroxy-3-methoxybenzaldehyde) is an example
of the high selectivity obtained in employing fluorine together with sulfuric acid for
direct fluorination of multifunctional aromatic compounds (Moilliet, 2001). From the
directing effects of the substituents it would normally be expected that the 5-fluoro
isomer would be produced in highest yield. It was established that aromatic
compounds containing a carbonyl group in the l-position and an alkoxy or hydroxy
group in the 3-position preferred the formation of the 2-fluoro isomer. This was
illustrated In the synthesis of 2-fluoro-3-methoxybenzaldehyde from 3-
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methoxybenzaldehyde in almost quantitative yield (>90%). Moillet et al., 2001,
rationalised this phenomenon by the protonation of the carbonyl group leading to a
positive charge on the carbonyl carbon together with an association with the alkoxy-
or hydroxyl group at the 3-position. This leads to the polarized fluorine molecule
being kept close to the 2-position, which allows for subsequent fluorination of the 2-
position (60%).
Elemental fluorine is therefore of use as a selective fluorinating agent for aromatic
molecules where the electrophilic directional effects of the substituents on the ring are
complimentary. This gives a selection of products which is unusual in the sense that
the orientation is different from those made by nucleophilic fluorination.
2.6.3.2 Electrophilic fluorination with fluorine carriers
The difficulties associated with direct fluorination using elemental fluorine, with
regard to the highly specialized apparatus and operational expertise needed in its
application as well as other factors discussed above, stimulated the development of
alternate sources of electrophilic fluorine that can easily and safely be handled in
orgarue synthesis. Perchloro fluoride, j fluoroxytrifluoromethane, acyl- and
perfluoroacyl hypofluorites and xenon difluoride were among the first fluorine carrier
reagents available.
Apart from increased selectivity of electrophilic fluorination (as compared to fluorine)
displayed by these reagents, a number of limitations have precluded their widespread
use. Virtually all of these reagents are strong oxidizing agents and are either very
expensive or require the use of fluorine for their in situ generation. In recent years, a
number ofN-F fluorinating agents have emerged as generally safer, cost effective and
easier to handle, sources of selective fluoronium (F+) ions.
2.6.3.2.1 N-F reagents
Banks and Williamson, 1964, first reported on the potential of compounds containing
N-F bonds to act as electrophilic fluorination agents (see Figure 2.14). This was
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illustrated by conversion of the sodium salt of 2-nitropropane to 2-fluoro-2-
nitropropane using perfluoro-N-fluoropiperidine (1).
8 (lo 9 0N -N I XI I
F F S02NFR F
(1 ) (2) (3) (4)
X-= TfO-,BF4-
(Cl
OF-
N esa;C~~BF) (CF3S02hNF N-F(7) /S02
I I 4 2 (PhS02hNFF F
(5) (6) (8) (9)
Figure 2.14 Various electrophilic N-F fluorinating agents
Other applications with N-F reagents, structurally altered to suit certain synthetic
needs, were soon to follow. Purrington and Jones, 1983, reported on the use of N-
fluoropyridin-2(IH)-one (2); and Barnette, 1984, on N-fluoro-N-alkylsulfonamides
(3). This was superceded in reactivity by both N-fluoropyridinium salts, 4 (Umemoto
et al., 1986) and N-fluoroquinclidinium fluoride (5) (Banks et al., 1986). Finally, in
1987 Demarteau reported that N-fluorotrifluoromethylsulfonimide (7) was the most
powerful F+ delivery agent of the N-F class (Lal et al., 1996 and references cited).
There are clearly two types of N-F fluorinating reagents available for electrophilic
fluorination: a) neutral, R2NF compounds and b) quaternary ammonium R3N+F A-
salts where k is a non-nucleophilic anion. In both cases the R2N-- and R3N are
designed to be good leaving groups, thus facilitating the reactivity of the bound
fluorine with the nucleophiles.
2.6.3.2.1.1 l-Chloromethyl-4-fluoro-l,4-diazoniabicyclo [2.2.2] octane
bis(tetrafluoroborate), Selectfluor™ (F-TEDA-BF4) 6.
Banks and coworkers developed the Selectfluor™ class of compounds in 1992, as a
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more potent electrophilic fluorinating agent relative to the previously developed N-
fluoroquinuclidinium fluoride (Banks et al., 1988). The commercially available
compound, F-TEDA-BF4 6, is a white, free-flowing crystalline solid which can be
handled safely in ambient atmosphere. It incorporates a chloromethyl group, two
quaternary ammonium groups of which one carries the electrophilic fluorine atom and
two tetrafluoroborate counter anions, rendering the compound neutral. The
combination of these properties allows for a balance between the F-electrophilicity
(F+-strength) and overall thermal stability of the compound.
Compared to other N-F reagents, it is second only to the well-known DesMarteau
compound [(CF3S02)2NF (7)] in terms of its fluorinating capacity and thermal
stability (up to about 195°C) (Banks et al., 1996). Furthermore, the electrophilicity of
the F-group can be modulated by simply substituting the methyl chloride group with a
stronger or weaker electron withdrawing group. Within the F-TEDA class the order of
reactivity follows the relative electron withdrawing power of the alkylating organic
group (e.g. CF3CH2> CICH2> Me etc.). In addition, a variety of anion combinations
can be selected which allows for different solubility characteristics.
For the past decade Selectfluor™ has become the electrophilic fluorination agent of
choice for a wide variety of applications (Figure 2.15). The diversity in applications is
illustrated by the array of functionalities incorporated in compounds fluorinated.
These include alkenyl boronic acids and trifluoroborates (Petasis et al., 1997), steroids
(Godard, 1994) and pyrimidine bases (Brunavs et al., 1994; Lal et al., 1995), the
synthesis of fluoro-carbohydrates and glycosides (Vincent et al., 1999) and important
aromatic substrates (Banks et al., 1996; Zupan et al., 1995 and Lal, 1995, see figure
2.15).
Electrophilic fluorination of aromatic compounds is enhanced by the presence of
electron releasing ring substituents (+1, +M). This is evident in the unsuccessful
fluorination (under reasonable conditions) of benzene compared to that of toluene and
xylene (see figure 2.15).
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OH
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F-TEDA-BF4
CH3CN, reflux
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Figure 2.15 Selective aromatic fluorination using Selectfluor™,
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2.6.3.2.1.2 N-fluorobenzenesulfonimide
N-fluorosulfonimides became of increased importance as electrophilic fluorination
reagents by the development of the most reactive N-F reagent, N-
fluoro(trifluoromethylsulfon)imide (see Figure 2.14, 7), by Desmarteau and
coworkers in 1987. Examples of selective fluorination with (CF3S02)2NF at room
temperature includes benzene (50%), toluene (80%, op = 3.5:1), anisole (100%, op =
3: 1) phenol (high, op = 3 :2) as well as other aromatic compounds. Unfortunately this
compound, which is a low-boiling liquid (b.p. 90-91°C), is not commercially available
and its five-step synthesis requires the use of liquid fluorine in a highly specialised
apparatus (Singh and Desmarteau, 1987).
To circumvent these limitations N-fluorobenzenesulfonimide (NFBS), 8 (Davis et al.,
1995) and its closely related analogue, N-fluoro-o-benzenedisulfonimide (NFOBS), 9
(Davis and Han, 1991) were developed. These compounds are stable, easy to handle
and find application as site-selective, e1ectrophilic monofluorinating agents of
enolates and silyl enol ethers, alkyl phosphonate carbanions (Differding et al., 1991)
as well as aromatic compounds (Davis et al., 1995) (Figure 2.16).
61' NFBS eYF .:+
F
(25%) (17%)
(S' NFOBS eYF ¢'+
F
(20%) (13%)
.: NFBS ..
OCH3 OCH3
(48%)
Figure 2.16 Fluorination of aromatic compounds by NFBS 8 and NFOBS 9.(Davis
and Han, 1991)
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The fluorination of anisole by NFOBS yielded 42% of a 3:2 mixture of 0- and p-
fluoroanisole. Lower yields (33%, o:p = 3:2) were reported for NFBS under similar
reaction conditions. With 1,4-dimethoxybenzene, NFOBS afforded 2-fluoro-l,4-
dimethoxybenzene in 48% yield.
Alternatively, the regioselective synthesis of fluorinated aromatics can be
accomplished by fluorination of ortho-lithiated aromatic substrates (Sniekus, 1994).
These substrates, generated from the reaction of directive metallation group aromatics
and alkyllithiums, when reacted with NFOBS or NFBS furnishes the corresponding
ortho-fluorinated compounds in good yields (see Figure 2.17). In this case NFBS
proves to be a more effective, affording higher yields of the fluorinated compound
(Sniekus et al., 1994).
DMG
~ i)RLiJY ~ii)-=-N=F=O-=B-=S/N-=-=F"~I
R
DMG = CONH'Bu, OMe,
OCSNEtz, S02NHMe,
S02NR2 (R2 = Me, Et)
Figure 2.17 Directed ortho-metallation-mediated fluorination.
Sniekus et al, 1994, reported that fluorination of ortho-lithiated diethylbenzamide by
NFOBS gave a 10% yield of the N,N-diethyl-o-fluorobenzamide. Furthermore the
fluorination of N-tert-butyl-2-lithio-3-methoxybenzamide with NFBS afforded 2-
fluoro-3-methoxy benzamide in 56 % yield.
2.6.3.2.2 O-F reagents
Perchloryl fluoride (FCI03) was the first of the class of O-F reagents to emerge as a
source of fluorine to electron-rich sites. The severe toxicity and health risks involved
in its handling hampered its further applications and led to the development of
e fluoroxytrifluoromethane, CF30F (Barton et al., 1968) and other reagents possessing
the O-F moiety such as trifluoroacetyl hypofluorite, CF3COOF and acetyl
hypofluorite CH3COOF (Rozen et al., 1996).
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Fifolt et al., 1985, illustrated that aromatic derivatives, especially anilines, could be
successfully fluorinated by using CF30F (produced in situ), at low temperatures for
short periods of time. It was found that for reactions carried out in non-polar solvents,
artha-substitution was preferred almost exclusively. The proposed reaction
mechanism includes a complex formation between the amino group and the CF 30F
(Figure 2.18). The reported yields of between 37-60% for the different fluorinated
aniline derivatives were in agreement with the relative reactivity of the R-group
towards hydrogen bonding.
-
+ F2CO+HF
R = COMe, COCF3,
S02Me, S02CF3
Figure 2.18 Proposed mechanism of fluorination of aniline derivatives by CF30F
(Fifo It et al., 1985).
Reactions involving toluenes, xylenes, anisole and eresols were less selective and
were prone to low yields. However, Belanger et al., 1988; reported on the formation
of mono- and difluorinated 1,3-dimethoxybenzene in 60% overall yield from 1,3-
dimethoxybenzene. Barton et al, 1972 illustrated by the fluorination of the antibiotic,
griseofulvin (see Figure 2.19) that the use of CF30F as a selective electrophilic agent
is not limited to simple mono or di-substituted aromatic rings only, but could also be
applied to fairly complex molecules containing multiple sensitive functional groups.
=0 CF,OF •
CH3CN, -78°C
CH30
F
Cl Cl
(67%)
Figure 2.19 The fluorination of griseofulvin by Barton et al., 1972.
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Apart from the fluorination of aromatic compounds, fluoroxytrifluoromethane was
also used for the highly selective fluorination of pyrimidines such as uracil, cytosine
and thymine at temperatures from -78 to 25°C in very good yields, using aqueous
trifluoroacetic acid as solvent (Barton et al., 1972). The area where CF30F finds its
most intense use, involves its reactions with various enols and silyl enol ethers,
forming the c-fluorocarbonyl moiety through electrophilic fluorination (Middleton
and Bingham, 1980).
Lerman et al., 1984, observed that for the reaction of activated aromatic rings with
acetyl hypo fluorite the ortho-fluoro derivative was favoured with yields of up of 85%.
The dominant ortho-substituent was a result of the addition of AcOF across the most
electron-rich region of the aromatic ring (Figure 2.20). A subsequent spontaneous
elimination of AcOH restored the aromaticity, but in the cases where this last step was
not possible, the resulting cyclohexadiene reacted very rapidly with the reagent and
tars were obtained. Examples of good conversions include 4-fluorosteroids and 3-
fluoro tyrosine (Hebel et al., 1986).
x
Ó AcOF -AcOF
X=OR, NHCOR
Figure 2.20 The mechanism of aromatic fluorination by AcOF as proposed by
Lerman et al., 1984).
The fluorination of aromatic rings more activated than tyrosine, such as catechol
derivatives, provide difficulty in fluorination owing to the fact that the AcOF adds
across the most electron-rich area, in this case between the two adjacent hydroxyls.
Nevertheless, in the fluorination of protected dopa derivatives with radiolabelled
ACOl8F two main fluorodopamine compounds were isolated and identified as 2- and
6-fluorodopamine (Rozen et al., 1996).
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Furthermore the reaction of phenol itself with acetyl hypofluorite is very vigorous and
produces various oligomers, polymers, and carbonyl-containing compounds. The
reaction can be controlled by introducing an electron-withdrawing group ortho to the
phenolic hydroxyl group. This was illustrated by Lerman and Rozen, 1981, in the
fluorination of methyl salicylate to afford the 5-fluorosalicylate in 20% yield. Barton
et al., 1968, reported on even higher yields (58%) for the synthesis of 5-fluoro
salicylic acid directly from salicylic acid employing fluoroxytrifluoromethane as
fluorinating agent.
By protecting the phenolic hydroxyl as an alkoxy group the fluorinated alkoxy
derivative of methyl salicylate can be afforded in up to 40% yield (Lerman et al.,
1981). Belanger et al., 1988, found that the fluorination of 2,6-
dimethoxyacetophenone by fluoroxy trifluoromethane in Freon Il at -78°C yielded
2,6-dimethoxy-3-fluoroacetophenone in almost quantitative yield.
The erratic yields obtained in the fluorination of electron rich aromatic compounds
justified the search for other synthetic routes. Routes to consider include the reaction
of acetyl hypofluorite with organometallic compounds such as aryl tin, silicon and
mercury compounds resulting in the corresponding aryl fluorides. (2.6.4.2).
2.6.3.2.3 Xenon difluoride
XePtF 6 was the only reported stable compound derived from a noble gas before the
synthesis of xenon tetrafluoride, XeF4 and xenon difluoride, XeF2 (Tius, 1995, and
references cited). Comparable to elemental fluorine in its reactivity towards organic
compounds, xenon difluoride by contrast is a colourless crystalline solid (mp 129°C)
which provides an easy to handle source of fluorine. By taking special care in the
design of the synthesis (i.e. in the choice of solvent, whether to use a catalyst or not,
substrate and reagent concentration, the reaction vessel used) fluorination by xenon
difluoride provides an easy route to fluorinated substrates (Dukat et al., 1993;
Ramsden and Smith, 1998). This is evident in the broad spectrum of applications,
which include the fluorination of enol derivatives (Rozen and Filler, 1985), thioethers
(Guilerm and Gátel, 1994), sugars (Geilen et al., 1992), aryl ketone and aldehydes
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(Tius, 1995). Both homolytic and heterolytic Xe-F bond cleavage have been
suggested in the elucidation of the mechanism of action in xenon difluoride reactions.
Several groups have reported fluorinations of aromatic rings using XeF2. Shaw et al.,
1970, reported on the fluorination of several aromatic compounds in the liquid phase.
Xenon difluoride was shown to react with benzene in CCl4 to produce fluorobenzene
in 68% yield. This was accompanied by the formation of biphenyl, fluorinated
biphenyls and tars. Shaw and coworkers, further reported on the fluorination of
toluene (32%, o:p = 1:3), anisole (65%, o:p = 1:2), nitrobenzene (81%, o:m:p = 1:3:1),
trifluoromethylbenzene (71%, meta fluorinated) and aniline (51%, o:p = 4:1). Stavber
and Zupan, 1983, emphasized the effects of catalysts on the fluorination of methyl
substituted benzenes. It was found that in the presence of a catalytic amount of
hydrogen fluoride, the fluorination of 1,2,4,5-tetramethylbenzene with an equimolar
amount of xenon difluoride afforded the difluoro product. At higher concentrations of
xenon difluoride (2 equiv.), the difluoroproduct was accompanied by the
demethylated derivative, l-fluoro-2,4,5-trimethylbenzene. Mackenzie and Fajer,
1970; employed xenon difluoride in the vapour phase successfully in their attempts to
fluorinate aromatic compounds such as nitrobenzene and various fluorinated benzene
derivatives.
The selective fluorination of phenols with xenon difluoride proved difficult, usually
rendering mixtures of 0-, m- and p-fluorophenols in low yields. This has led to
alternate synthetic approaches being taken in the selective fluorination of phenols with
XeF2. Takemoto and Yamasaki, 1994, attempted to Improve the selectivity by
utilizing tertiary butyl protective substituents on the aromatic ring to avoid the
formation of unwanted isomers (Figure 2.21). Regioselective direct fluorination was
achieved by the reaction of 2,6-di-tert-butylphenol with xenon difluoride, affording
2,6-di-tert-butyl-4-fluorophenol in 49% yield. In contrast, under similar conditions
reaction with elemental fluorine or acetyl hypofluorite with the protected phenol
furnished biphenol as the major product. It was suggested that the size of fluorine or
acetyl hypofluorite allows for interaction with the phenolic hydroxyl group, which
leads to the formation of a phenoxy radical. Owing to the much larger size of xenon
difluoride, similar interaction is not possible, which allows for para-substitution to be
favoured. The subsequent removal of the protective groups did not prove difficult.
87
Stellenbosch University http://scholar.sun.ac.za
LITERATURE REVIEW: FLUORlNE IN BIO-ORGANIC CHEMISTRY
OH OH Q
F
(42% total yield)
AcOF
F
(49%)
Figure 2.21 The synthesis of 4-fluorophenol via 2,6-di-tert-butyl-4-fluorophenol
(Takemoto and Yamasaki, 1994).
Fimau, et al., 1980, reported a simple and rapid synthetic route to L-6-fluorodopa.
Direct fluorination of L-dopa with xenon difluoride was not possible, owing to the fact
that the catechol constituent is susceptible to oxidation and will convert to a-quinone.
Starting from the protected L-3-methoxy-4-hydroxyphenylalanine ethyl ester,
selective fluorination of the 6-position by xenon difluoride in methylene chloride was
achieved. The subsequent hydrolysis of the reaction mixture afforded L-6-fluorodopa
in 25% overall yield.
Xenon difluoride reactivity towards aryltrimethylsilanes to yield the corresponding
aryl mono fluorides via fluorodesilylation provides an excellent route for the specific
introduction of fluorine into an aromatic ring. These reactions and other aspects of
organometallic fluorination will be dealt with in the following section.
2.6.4 Fluorodemetalation reactions.
Although aromatic halodemetalation reactions have been known for a long time, these
reactions do not feature prominently in organic synthesis. In recent years interest in
the application of organometallic aryl compounds for the labeling of aromatic
compounds, with especially radiobromine and radioiodine, has been prompted
(Coenen and Moerlein, 1987).
These demetallation reactions allow for the site-selective halogen substitution of the
labile metal functionality with high yield, which make them ideally suited for the mild
and effective halogenation of short lived radionucleotides. For these purposes,
however, positron-emitting fluorine-18 is an even more ideal candidate with respect to
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radionucleotide half-life (110min) and subsequent application as a
radiopharmaceutical for positron emmision tomography. This has led to numerous
applications of fluorodemetallation, for both radiofluorination as well as stable isotope
aromatic fluorination, utilizing aromatic compounds containing tin, silicon,
germanium, lead, and mercury substituents as precursors (Adam et al., 1981, 1983
and 1984; Speranza et al., 1984).
The rationale of this process is based on the lower stability of the metal-carbon bond
as well as an increase in bond polarity relative to the corresponding carbon-hydrogen
bond. Accompanied by the halophilicity of certain alkylmetal species, the
electrophilic attack on the aromatic carbon is much more pronounced, giving higher
yields and regioselectivity and is readily achieved even on deactivated aromatic rings.
In the synthetic design consideration needs to be taken for the type of alkyl metal
species used, its synthesis, the stability towards fluorodemetalation and the effect that
the fluorination reagent can have on ring substituents.
2.6.4.1 Synthesis of aryl tin and aryl silicon compounds.
Group IV metals share common characteristics which allow for their application in
fluorodemetallation reactions. Nucleophilic substitution at especially silicon is more
facile than the corresponding nucleophilic substitution at carbon. This enables an
electrophilic attack of the specific aryl carbon by a fluorine species. More importantly
though is the extreme halophilicity of group IV elements, especially silicon towards
fluorine. Furthermore, single bonds from these metals to the electronegative elements
oxygen, chlorine and fluorine are very strong and thus allows for the complete
substitution of the alkylmetal species on treatment with an electronegative fluorine
specie. The steric effects of a trialkylmetal specie, e.g. Me3Si are often not very large,
which facilitates substitution of the aryl halide in the preparation of the arylmetal
compound.
The most preferred preparative routes to aryl-group IV metal derivatives are shown in
Figure 2.22.
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Ar-Li R3MCI ,.. Ar-MR3 (M = Si, Sn, Pb, Ge) (1)
R1MLi
(R= Me, Bu)
Ar-X ~ Ar- MR3 (M = Si, Sn, Pb, Ge) (2)
Pd(PPh3)4
(R = Me, Bu; X = Cl, Br)
Ar-X + (R3Mh Ar-MR3 (M = Si, Sn) (3)
(R = Me, Bu; X = Cl, Br)
Ar-SiCI3 +KF Ar-SiFs (4)
Figure 2.22 Preparation routes to aryl-group IV organometallics. (1) Sharp and
Sniekus, 1985; (2) Shankarian et al., 1985; (3) Azizian et al., 1981; (4) Adam, 1986.
Of these methods the transmetallation reaction using either lithium or magnesium
metallated aromatics are the most prevalent in organic synthesis. These compounds
are normally synthesized from the corresponding halogenated (Br or I) aromatic
derivative. Analogous to this method, the nucleophilic displacement of a halogen
substituent by a tri-alkyl-metal species affords a route to prepare the arylmetal species
with one less step. Both these methods have been limited to non-sensitive aromatic
compounds, thus compounds containing no acid or base labile functional groups.
Although shown to be successful in radio halogenation, the widespread use of
pentafluorosilicates is hampered by their poor solubility in most solvents.
The palladium catalysed metallation of halogenated aromatic compounds usmg
hexaalkyldistannanes or hexaalkyldisilanes provides a mild and efficient method for
application to sensitive, multi-functional compounds. Duelfer et al., 1991, illustrated
this by the selective 18F-Iabelling of2-oxoquazepam via the fluorodemetalation of the
easily prepared trimethylstannyl derivative (see figure 2.23). The organometallic
compound was prepared under mild conditions by the catalytic stannylation of the
bromo-oxoquazepam derivative in 64% yield.
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Cl Cl
(64%)
Figure 2.23 Selective 18F-Iabelling of 2-oxoquazepam (Duelfer et al., 1991)
Babin et al., 1993, reported on the synthesis of various arylsilanes from aryl bromides
using a catalytic amount of tetrakis(triphenylphospine)palladium(O) [Pd(PPh3)4]
hexamethyldisilane, and hexamethyl phosporamide as solvent under stringent
conditions (160°C for 96 hours). These include the following precursors: 2-
trifluoromethyl bromobenzene (50% of the trimethylsilyl derivative), 3-
trifluoromethyl bromobenzene (75%), 4-trifluoromethyl bromobenzene (80%), 2,4-
difluoro bromobenzene (95%), 3-bromoacetophenone (40%) 1-bromo-3-
cyanobenzene (50%) and for 1-bromo-4-cyanobenzene (95%). It is evident that
electron withdrawing groups, situated para to the halogen substituent, increase the
formation of the trimethylsilyl derivatives.
Goossen and Ferwanah, 2000, proposed a milder more efficient protocol for the
catalytic silylation of both electron-rich and electron-poor aryl bromides (see Table
2.4). The catalytic system [tris-(dibenzylideneacetone)dipalladium(O), dba3Pd2 ] as
catalyst, proposed included the use of two different sets of ligands (L) and bases
tailored to suit the electronic nature of the different aryl bromides. For electron-rich
substrates, diphenyl-Z' -pyridylphospine (PPh2Py) in combination with K2C03 gave
the best results, whereas for electron-poor substrates, 2-( di-z-butylphosphino )biphenyl
(P[t-Bu]2biPh)/KF was preferred. The reactions were carried out in either DMF or
1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyridinone (DMPU), as solvent at 100°C for 2
hours.
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Table 2.4 Pd-catalysed silylation of acetophenone under different conditions (Source:
Goossen and Ferwanah, 2000).
Entry R Ligand Base Conversion Arylsilanes Reduction Biaryl
(%) (%) (%) (%)
C(O)CH3 PPh3 K2C03 95 27
2 C(O)CH3 PPh3 KF 100 7 93
3 C(O)CH3 PPh2Py KF 69 10 91
4 C(O)CH3 P(t-Bu)2biPh KF 98 86 10
5 C(O)CH3 P(t-BuhbiPh K2C03 98 3 7
Condition: 3 11101 % Pd, 9 11101 % ligand, 5 equiv. base, 2 equiv. H20, 1000, DMPU.
It was proposed that the aryl halide would oxidatively add to the palladium-phosphine
complex, followed by activation of hexamethyldisi lane by the resultant Pd(II) species,
PdL"ArBr. It was further suggested that the electronic nature of the aryl group
strongly affected the reactivity of this species towards hexamethyldisilane, which if
not corrected could lead to unwanted side reactions. By employing different
phosphines in the catalytic systems, the electronic nature of the palladium species
could be balanced, and improved selectivity could be achieved. For 4-
bromoacetophenone, the trimethylsilyl derivative was obtained in 86% yield, for 4-
bromotoluene (87%), 4-bromoanisole (74%), I-bromo-4-cyanobenzene (82%) and for
ethyl 4-bromo-benzoate (84%).
2.6.4.2 The cleavage of aryl-metal bonds by fluorination.
Aromatic fluorodemetalation of trialkylaryltin and -silicon compounds has been
achieved by various electrophilic fluorination reagents, including elemental fluorine
(Adam et al., 1983), acetylhypofluorite (Duelfer et al., 1991) and xenon difluoride
(Lothian and Ramsden, 1993). Yields of the fluorinated aryl compounds are affected
by various factors. These include, the stability of the metal-aryl bond, electronic
effects of other ring substituents and the formation of side products.
Coenen and Moeriein, 1987; evaluated the influence of the displaced metal and
aromatic substituents on the fluorodemetallation of various group IV aryl metallic
compounds using elemental fluorine and acetyl hypofluorite. They observed that for a
given substituent, all fluorodemetallation yields decreased in the order Sn> Ge > Si.
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The decrease in the fluorination yield by a factor of approximately three when going
from stannylated to the silylated substrates corresponds with the increase in carbon-
metal bond energies (Sn-C, 257 kJ/mol; Ge-C, 308 kj/mol; Si-C, 352 kj/mol) (Pilcher
et al., 1982) and the decrease in carbon-metal bond lengths (Sn-C, l.54 Á; Ge-C, 1.36
Á; Si-C, 1.31 Á) (Dean, 1979).
For a given trimethylmetal substituent, the reactivity towards defluorometallation
increased as electron withdrawing groups (N02, CF3, Br) were replaced by electron
donating groups (H, F). In contrast, no further increase in yield was obtained in the
replacement with methyl and methoxy groups. In fact a decrease in the overall yield
of the fluoroaromatic compound was observed. It was suggested that due to the
relative low reactivity of silylated aryl compounds, certain side reactions are
manifested. In the case of anisole, direct fluorination of the aromatic ring occurs in the
ortho position (16% of2-fluoroanisole). The reactivity of benzylic hydrogen towards
fluorine radicals are evident in the small amounts of cc-fluoro-toluene formed in the
reactions oftoluyl derivates.
2.7 Conclusion
From the foregoing discussion it is evident that a wide range of fluorinating reagents
and protocols are available for synthesis of organofluorine compounds. In our
research effort the choice of fluorinating reagent was based on not only the
commercial availability of the reagent but also the extent to which the sensitive
functional groups of OB would be tolerated by the reagent and reaction conditions.
As mentioned before, the use of elemental fluorine in synthesis requires specialised
equipment and expertise not available to us. Furthermore, it has not yet been
illustrated that the conditions employed in the use of F2/N2 mixture are mild enough to
preserve sensitive functional groups such as found in OB. The fluorination of
sensitive organic substrates has been achieved using CF30F and AcOF, however,
these reagents are either not commercially available or require F2 for their in situ
prepara tion.
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Elemental fluorine earners such as N-F reagents, Selectfluor™ and N-
fluorobenzenesulfonimide are widely available and provide for an easy to handle
source of fluorine. These compounds have been used extensively in the electrophilic
fluorination of aromatic compounds and show a moderate reactivity to functional
groups. The use of other fluorine carriers, such as xenon difluoride, in the synthesis of
aromatic fluorides provide for high reactivity (comparable to F2) and requires
relatively simple laboratory techniques. The wide range of aromatic compounds
fluorinated using XeF2 is testimony to its efficiency as fluorinating reagent.
Finally, the palladium catalysed metallation of halogenated aromatic compounds
using hexamethyl- and hexabutyldistannanes provides a mild and efficient
fluorination method for application on sensitive, multi-functional compounds such as
OA and BrOB. The demetallation reaction allows for efficient halogen substitution of
the labile metal functionality, which suggests a viable route for the synthesis of
fluoro-OB.
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2.8 Structure activity relationship studies of Ochratoxin A analogues.
Natural analogues of OA, i.e. OB, OC, Oe and 4-0H-OA provide an insight into not
only the nature of OA toxicity but also the biological processes by which they are
derived. In order to elucidate the role that a certain functional group plays in the
toxicity of OA, numerous synthetic analogues are synthesised. The design and the
synthesis of these analogues are directed to remove or to block a certain functional
group in an attempt to ascertain the role the substituent plays in rendering the
molecule toxic.
In our research effort we attempt to probe the role of the halogen and the amino acid
groups in the biological activity of OA. Firstly, from the preceding discussion it is
evident that the halogen group is important in the observed toxicity of OA. This is
clearly illustrated in the substantial difference in toxicity of OA compared to OB. The
synthesis of BrOB and lOB provided much to further rationalise the role that the
halogen plays in the reactivity of OA. To complete the spectrum of halogen
substituents, fluorine is still outstanding. Furthermore, from this chapter it is clear that
fluorine plays an important biological role in its own right. Apart from the high
electronegativity manifested by a fluorine substituent to an aromatic ring and the
subsequent electronic effect on neighbouring substituents, the importance of steric
bulk of the halogen group will be further clarified.
The regioselective introduction of fluorine into an aromatic compound thus becomes a
salient factor in this study. Comparitive toxicological studies employing previously
synthesized bromo-OB and iodo-OB, complemented by fluoro-OB should culminate
the study of the role of the chloro group in OA toxicity.
ClJ::: 0
I
R
OR 0
F
Fluoro-OB
Stellenbosch University http://scholar.sun.ac.za
STUDY OBJECTIVES
Secondly, the coupling of 0-, m- and p- fluorosubstituted phenylalanine to Oo, will
introduce another aspect in probing the reactivity of the hydrophobic side chain. The
fluorosubstitution of the phenylalanine ring will alter the chemical reactivity of the
relatively unreactive aromatic ring without significant change to its steric structure
and elucidate its role in the inhibition of protein synthesis.
OH 0
Cl
ortho-tluoroPheOa
''Q)::: 0
I
H
OH 0
F
~HO
I
H
OH 0
Cl Cl
para-tluoroPheOa meta-tluoroPheOa
Furthermore, the coupling of Ou to novel dipeptides, such as histidylhistidine
(available in our laboratory), could provide invaluable information with respect to
several aspects which include a comparison of histidine as such as a replacement for
phenylalanine, as well as the implications of a dipeptide as side chain, heretofore not
yet investigated.
o OH 0
Histidylhistidine-Oa
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3.1 Introduction - Section Overview
The different methodologies used in our attempts to synthesise fluoro-ochratoxin Band
other analogues are discussed in this chapter. It is important to note that both OA (10) and
OB (11) are extremely expensive and that most reactions were done on milligram scale.
All methods that were to be employed on these compounds were first studied and
optimised on model compounds. An important part of our research effort was
consequently focussed on the synthesis and modification of functionalised aromatic
compounds.
Our attempts included the direct electrophilic fluorination of OB (11) and different
analogous aromatic model compounds by various fluorinating agents (section 3.2). They
further involve a study to an alternative route to fluoro aromatic compounds from bromo
and chloro analogues via the replacement of a trimethyl- and tributyl- stannyl (section
3.3.1) and trimethylsilyl (section 3.3.3) groups with fluorine by means of xenon
difluoride (section 3.3.2). Efforts towards the direct catalytic fluorosubstitution of aryl
halides are proposed (section 3.4). The synthesis of a key intermediate,
fluoroacetoacetaldehyde, in a de nova synthetic route to fluoro-ochratoxin B is discussed
(section 3.5). Figures 3.1 and 3.2 show a scheme of the different synthetic routes studied,
including the route starting from the most important precursors, for both OA (10) and
model substrates.
The synthesis of novel OA analogues with respect to the replacement of the L-
phenylalanine moiety is discussed (section 3.6). This includes the conversion of OA (10)
to Oo., by acid hydrolysis (section 3.6.1), followed by the coupling of ortho-, meta- and
para- substituted DL-fluorophenylalanine to the lactone acid (section 3.6.2). This is
followed by the synthesis of histidylhistidine methyl ester (section 3.6.3) and attempted
coupling to ochratoxin a (section 3.6.4). The coupling of halo salicylic acids and salicylic
Stellenbosch University http://scholar.sun.ac.za
METHODOLOGY, RESULTS AND DISCUSSION
Aromatic
Fluorodemetallation
R
(10) R = Cl Ochratoxin A
(11) R = H Ochratoxin B
(12) R = F Fluoro Ochratoxin B
(13) R = Br Bromo Ochratoxin B
(14) R = BU3Sn
(15) R = Me3Sn
(16) R = Me3Si
Direct Electrophilic Aromatic Fluorination
(10)
1 Dechlorination
(11)
TM 1
Selectfluor /. N-fluorobenzenej Xenon
sulfonimide j Difluoride
1
Fluoro
Ochratoxin B
(11) ---+ (13) ---+ (15) ---+
(13) ---+ (14)---+
i
Fluoroacetoacetaldehyde
De nova Synthesis
Catalysed Aromatic
Fluorodehalogenation
(13) +-- (11)
Figure 3.1 Synthetic routes employed in the attempted synthesis of fluoro-OB.
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(28)
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Figure 3.2 Synthetic routes employed in the attempted synthesis of fluoro aromatic compounds.
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acid to L-Phe, for use as model aromatic substrates for fluorination is discussed (section
3.6.5). Peptide coupling by DCC carboxyl activation, including the protection of the
phenolic hydroxyl group in 5C1SA for application on O« (34) concludes the chapter
(section 3.6.6).
3.2 Selective Electrophilic Fluorination
3.2.1 Selectfluor™ (6)
The methods described by Banks et al, 1996 for the fluorination of aromatic compounds
were utilised. Fluorination was attempted on methoxybenzene, salicylic acid (17) and its
phenylalanine coupled analogue, SAPhe (22). Although limited success was obtained by
this method, it was further applied to small amounts of OB (11) and OB methyl ester.
Most reactions were conducted at ambient temperature and in dry acetonitrile. Reactions
were further studied at higher temperatures, increased reaction times, large excesses of
reagents and in different solvents (e.g. water, methanol and 3-5% trifluoroacetic acid in
water). The reactions were monitored by HPLC and UV spectroscopy, by comparing
retention times and UV absorbance profiles with that of standards: salicylic acid and 5-
fluorosalicylic acid.
OH CH2Cl OH
CH2CI
II C02H Ct) BF~(rC02H NCC}BF4-h i) CH3CN, • ++ 15 h room temp.
~ ii) (CH3hO NN
I FF
(6) I
Figure 3.3 Fluorination of salicylic acid by Selectfluor™.
In all of the experiments conducted in this study with Selectfluor™ (6) the byproduct of
the reaction, l-chlomethyl-4-1-azoniabicyclo[2.2.2]octane tetrafluoroborate(I), was
precipitated from the reaction mixture with the addition of diethyl ether and isolated by
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filtration. ES-MS data corresponded with literature data (Banks et al., 1996), molecular
ion (Ml peak m/z 160/162 (C7HI5N2Cl requires 162.58).
Figure 3.4. 1-Chloromethyl-4, 1-azoniabicyclo[2.2.2]octane tetrafluoroborate.
IH-NMR of the salt indicated H-2, H-6 and H-7 to resonate as triplets at DH 3.60, H-3, H-
5 and H-8 as triplets at DH 4.30 and the methylchloride group as as singlet at DH 5.20. 13C
revealed C-2, C-6 and C-7 resonance at Dc 51.10, C-3, C5 and C-8 at Dc44.90 and the
chloro bearing carbon at Dc 69.80. These spectra are in perfect agreement with reported
spectra by Banks et al., 1996.
The attempted fluorination of methoxybenzene yielded an unidentified product (72%
yield). From IH-NMR data it is suggested that fluorination was limited to the methoxy
group accompanied by possible dimerisation at the ortho-position of the aromatic ring.
The ortho-substitution was established by the resonance of the four aromatic protons as
doublets (2-H) and triplets (2-H) at DH 6.7, 6.4, 6.3 and 6.2. Furthermore the resonance of
the methoxy protons, which appears as a characteristic singlet at D 3.8 and 3.9 for
methoxybenzene and 2-fluoromethoxybenzene respectively, was absent. EI-MS data
supported the presence of a dimeric analogue with m/z peaks at 260 and 204 (calculated
for monofluoro dimer CI4HI202F2= 250).
An attempt to fluorinate salicylic acid by the same method was met with limited success.
Salicylic acid (17) was reacted over a prolonged time (72 h), at higher concentrations of
the fluorinating reagent (reagent:substrate - 3:1) and at elevated temperatures (90°C). The
reaction was monitored by HPLC with a diode array detector by periodically injecting
samples of the reaction mixture and comparing the observed retention times with that of
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the internal standards (salicylic acid 17 and 5-fluorosalicylic acid 19). Figure 3.5 shows a
chromatogram of the reaction mixture after 72 hours. The compounds were identified on
the basis of their retention times.
320.00
300.00
280.00
260.00
240.00
220.00
200.00
180.00
mV 160.00
140.00
120.00
100.00
80.00
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Figure 3.5 HPLC chromatogram of the fluorination of salicylic acid by Selectfluor TM
after 72 h.
For salicylic acid at rt = 3.91 min, and fluoro salicylic acid at rt = 4.27 min. No attempt
was made to further isolate the fluorinated product.
The method was further extended to SAPhe and small amounts of OB. In both cases the
reactions were monitored by HPLC with a UV detector over a prolonged period of time
(20 days). There was no indication that fluorination took place in either of the cases.
These findings were confirmed by lH-NMR spectroscopy of the recovered starting
materials.
3.2.2 N-Fluorobenzenesulfonimide
The method described by Davis, 1995, for the fluorination of anisole was used in the
attempt to fluorinate salicylic acid. The method was further modified in the
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concentrations of reagent used (reagent: substrate, 3: 1) and the duration (72 h), in an
attempt to drive the reaction to completion. HPLC monitoring followed by 'H- and 13C_
NMR analysis of the reaction mixture indicated that no reaction had taken place. The
attempt to fluorinate SAPhe and small amounts (2 mg) of OB over a prolonged reaction
period (20 days), with an excess of reagent (reagent:substrate, 3:1) and under elevated
temperatures «70°C), was unsuccessful on the basis of HPLC monitoring. In both cases
'H-NMR analysis confirmed that the substrates recovered were unreacted SAPhe and
OB.
3.2.3 Xenon Difluoride
The method described by Ramsden and Smith, 1998, was utilised in the attempt to
fluorinate model substrate, salicylic acid. The reaction conducted at low temperatures
(-60 - O°C) in a glass vessel in the absence of a catalyst (e.g. HF) was monitored by
HPLC using a diode array detector. Extention of the reaction at higher temperatures
«50°C), and increased reagent concentrations did not drive the reaction to completion.
,
'H- and '3C-NMR analysis of the recovered product indicated a large proportion of
substrate decomposition and small amounts of unreacted product.
The attempted fluorination of SAPhe (22) and small amounts of OB (11) (21 days
reaction time), under similar rigorous condition was unsuccessful. In both cases the
recovered products were identified by 'H-NMR analysis as predominantly unreacted
substrate.
In an attempt to ascertain the role that the free carboxylic acid has to play in blocking the
reactivity of xenon difluoride, attempted fluorination was repeated on OB methyl ester
(21 days reaction time). In this experiment a,a,a trifluorotoluene was used as solvent, in
an attempt to suppress any radical process that accompanies the use of Xef-. The reaction
was monitored and the residue analysed in the same manner as described previously and
yielded predominantly unreacted OB methyl ester as determined by 'H-NMR.
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3.3 Fluorodehalogenation of aryl halides via a palladium catalysed metal
substitution followed by xenon difluoride fluorosubstitution.
The palladium-catalysed metallation of halogenated aromatic compounds usmg
hexamethyl- and hexabutyldistannanes provides a mild and efficient fluorination method
for application on sensitive, multi-functional compounds. The first intermediate in this
synthetic route is the trialkyltin aromatic species. The synthesis of analogous silyl
aromatic intermediates was attempted as alternative to the stannyl compounds. Bromo-
and chloro-aromatic compounds provide the starting material for this synthetic route.
These include halogenated salicylic acids (5CISA, 18; 5BrSA, 20), and their respective
phenylalanine analogs (CSAPhe, 23; BrSAPhe, 25) and 5-bromo-2-methoxy-4-methyl-
isophthalic methyl ester (27). The catalyst employed was tetrakis(triphenylphospine)
palladium (0). A further catalytic system, tris( dibenzylideneacetone )dipalladium(O), was
used in the attempt to trimethylsilylate BrOB (13). Fluorodestannylation was attempted
using xenon difluoride on the tributylstannyl specie of bromoisophtalic ester. The
rationale of the synthetic approach, including the important intermediates, is shown in
Figure 3.6.
ArX
I)
Figure 3.6 XeF2 fluorodestannylation of aryltrialkylstannanes formed by palladium
catalysed stannylation of aryl halides.
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3.3.1 Catalytic Stannylation of Aryl Halides.
The substrates for this synthetic route are chloro or bromo aryl compounds. Although
chlorides are not as readily replaced as the analogous bromo substituents during
palladium catalysed trialkylstannylation, reactions were conducted on both substrates.
This is exemplified in the attempt to replace the chloro group in OA (10), which will
allow for a shorter route to the trialkylstannyl species than to follow the route via BrOB.
Preparation of BrOB entails the dechlorination of OA to form OB, and then the
bromination of OB.
3.3.1.1 Dehalogenation of OA.
The method of Bredenkamp et al, 1989, was used in the dehalogenation of OA (10) to
OB (11). Modifications, concerning reaction periods (over night), to this method
suggested by Payne, 1999, were also adhered to. The method entails the treatment of the
aromatic halide with ammonium formate in methanol, in the presence of 10% Pd/C.
Furthermore, chloroform was replaced by ethyl acetate as solvent in the work up of larger
amounts of OB (250 mg) (As desribed by Payne, 1999).
The successful dechlorination is clearly observed in the IH-NMR where the aromatic
signal of OA (10) at OH 8.43 is replaced by two doublets at OH 6.82 and OH 8.33 showing
mutual a-coupling of 7.98 Hz. Similarly in the l3C spectra the Cl-bearing ipso singlet
signal in OA at Oe 123.2 is replaced by a singlet at Oe 118.5 in OB. These spectra are in
perfect agreement with the reported spectra of OA (Stander, 2000) and OB (de Jesus et
al., 1982).
Quantitative catalytic dechlorination was further applied to CSAPhe (23) in preparation
of the dechloro analogue, SAPhe (22). This provided an alternative route for the
preparation of SAPhe (22) since the coupling of phenylalanine to salicylic acid gave
problems not encountered with the analogous 5-chlorosalicylic acid.
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The successful dechlorination of CSAPhe (23) is clearly observed in the IH-NMR where
the resonance at bH 6.80, assigned to H-5 appeared as a td owing to the ortho coupling to
H-4 and H-6 (J = 8.9 Hz) and meta coupling to H-3 (J = 2.6 Hz). Furthermore the H-4 of
CSAPhe (23) which appeared as a dd at bH 7.48 is replaced by a td at bH 6.97 in the
dechlorinated product and shows mutual a-coupling to H-5 (J = 8.9 Hz). Similarly in the
l3C spectra the Cl-bearing ipso singlet signal in CISAPhe (23) at be 123.7 is replaced by a
doublet at be 119.0. These spectra are in agreement with the reported spectra of CSAPhe
and SAPhe (Payne, 1998)(Table 3.1).
Table 3.1 IH_ and 13C_NMR data (CDCb) for SAPhe (22).
15
C02H 0 OH
10 9 ~~]
H J~.)4
5
BH/ppm Bc/ppm
1 - 118.7
2 - 161.6
3 7.18 113.8
4 6.97 134.8
5 6.80 119.0
6 7.18 125.7
8 5.00 169.8
9b 3.28 53.0
9a 3.10 37.3
10 - 135.2
11/15 7.29 12.9.4
12/14 7.29 128.9
13 7.38 127.6
16 - 175.7
NH 9.20 -
3.3.1.2 Bromination of OB, Steyn and Payne, 1999.
Pyridinium hydrobromide perbromide (PPB), was prepared freshly in adequate yield
(67%), by the procedures reported by Fieser and Fieser, 1967. The process entails the
rapid treatment of a cooled mixture of pyridine and 48% hydrobromic acid with bromine.
The product was washed with an acetic acid:water (1:1) solution and recrystalised from
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the same solution to yield a red crystalline product, that provided a stable, easy to handle
source of bromine. OB (11) was subsequently treated with PPB in glacial acetic acid at
SO°Cfor 6 h. The reaction was monitored by TLC (toluene:acetic acid S: 1) and proceeded
smoothly and efficiently (98% yield). The successful bromination of OB (11) is clearly
observed in the IH-NMR where it reveals a close similarity to OA (lO)(Table 3.2). The
most important feature is the diagnostic singlet signal at OH 7.20 for the aromatic proton
(H-8). Similarly in the 13C spectra the Br-bearing ipso-singlet signal at Oe 112.3 for BrOB
(25) revealed a downfield shift compared to OA (10) (oel23.2). These spectra are in
perfect agreement with the reported spectra of BrOB (Steyn and Payne, 1999).
Table 3.2 IH_ and 13C_NMR data (CDCb) for BrOB (13).
13
0C02H 0 OH
12
14 N15 I
H
Br
bH/ppm bc/p1l_m
OH 12.7 -
NH 8.5 -
1 - 120.7
2 - 159.8
3 - 110.5
4 - 142.9
5 - 112.4
6 7.2 142.2
7a 2.8 34.9
7b 3.3 34.9
8 4.7 75.8
9 (3) 1.6 20.5
10 - 169.9
11 - 163.9
13 - 177.2
14 5.1 54.2
15 3.2 37.3
16 - 135.8
17 7.2 129.4
18 7.2 128.8
19 7.2 127.4
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3.3.1.3 Attempted synthesis of trialkylstannyl aromatic intermediates.
The method employed by Duelfer et al., 1991 for the selective '8F-Iabelling of 2-
oxoquazepam via the fluorodemetallation of the corresponding trimethylstannyl
derivative was used for stannylation. The tributylstannylation was first attempted on
5CISAPhe (23) and 5BrSAPhe (25). The limited success obtained on these compounds
prompted further application on an aromatic nucleus, electronically more closely related
to OA (10). A bromo substituted aromatic ester, 5-bromo 2-methoxy 4-methyl isopthalic
methyl ester (27), was available to us and it proved to be a succesfull canditate for
metallation. The method was further applied to BrOB (13).
For the stannylation of BrSAPhe (25), the reaction entailed treatment of the aryl bromide
with hexabutylditin in xylene in the presence of tetrakis(triphenylphospine)palladium (0)
as catalyst. The reaction mixture was heated under reflux in an argon atmosphere and
monitored by TLC (toluene: acetic acid 5:1). Multiple products with increased polarity
(rel, BrSAPhe, 25) formed after 17 hours and upon purification of the crude product by
column chromatography (silica I toluene: acetic acid 7:1) the fractions were isolated and
characterised by 'H-NMR and ES-MS.
Apart from the unreacted substrate recovered (BrSAPhe, 25), a byproduct of the reaction
was isolated at Rf: 0.75, and was identified as tributylstannylbromide. The isotope profile
at m/z 452 ('22Sn), 449 ("9Sn), 448 ("8Sn), 447 (' 17Sn)and 446 ("6Sn) agrees for a SnBr2
compound, C'2H27SnBr2 requires 448.38. The product at Rf: 0.30 was identified as the
debrominated compound, SAPhe (22). ES-MS of this product indicated m/z molecular ion
peak at 285. 'H-NMR-data were in agreement with reported results (see section 3.3.1.1).
The third product (R. 0.20) obtained was not identified. 'H-NMR data supported a
possible biaryl structure: the duplication of the phenylalanine protons (H12-16) and
salicylic acid ring protons (H-3, H-4, H-6) resonance signals and the absence of a H-5
resonance peak (see figure 3.8). ES-MS supported the presence of a biaryl structure m/z
peaks at 540, C32H28N208= 540.56). In the case where CISAPhe (23) was used as
substrate, no reaction occurred under similar condition. IH_ and '3C-NMR data obtained
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from the reaction mixture confirmed that the product isolated was predominantly the
unreacted substrate. In contrast to BrSAPhe no biaryl formation was observed.
The increased reactivity of the bromo substrate to the chloro analogue was in agreement
with literature findings. This prompted the use of a bromo aromatic compound
exclusively, 5-bromo-2-methoxy-4-methylisophtalic methyl ester (27) as model substrate.
Apart from the relatively inert phenylalanine ring, this compound represents the aromatic
nucleus of OA (10) more closely than the halogenated salicylphenylalanine substrates.
Using lH and 13C_NMR data from BrOB (13), and other analogous compounds the
chemical shifts were empirically assigned to the nuclei as shown in Table 3.3.
Table 3.3 IH_ and 13C_NMR data (CDCl]) for 5-bromo-2-methoxy-4-methyl- isophthalic
methyl ester, 27.
21
OCH30
II
C 20
lO""OCH3
Br
Dc/ppm DH/ppm
1 133.9 -
2 156.2 -
3 119.7 -
4 14l.8 -
5 124.8 -
6 136.2 8.05 (s)
7 20.3 2.35 (s)
10 165.1 -
Il 167.5 -
19 5l.9 3.95 (s)
20 5l.9 3.93 (s)
21 63.5 3.92 (s)
The methyl ester (27) (0.289 mmol) was treated with hexabutylditin (1.44 mmol) in
xylene in the presence of tetrakis(triphenylphosphine)palladium(O) (37.0 umol) as
catalyst. The reaction was protected from light and heated under argon at 115°C. The
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reaction was monitored by TLC (petroleum ether: ethyl acetate 10:1) and after 19 h the
reaction was complete. The solvent of the filtrate was evaporated under reduced pressure
and purified by column chromatography (silica gel/ petroleum ether: ethyl acetate 10:1)
to yield a colourless oil in 51% yield.
Chemical shifts were empirically assigned to the nuclei using lH and 13C-NMR data from
the bromoaryl methyl ester 27, and analogous stannylated compounds (Table 3.4). A
certain amount of the debrominated isophthalic methyl ester «40%) was also identified
in the fraction. It was represented by H-6 resonating as a doublet at <>H 7.86 (JH6,H5 = 8.9
Hz) and H-5 resonating as a doublet at <>H7.05 (JH5,H6 = 9.0 Hz).
Table 3.4 'n NMR data (CDCh) for 2-methoxy-4-methyl-5-tributylstannyl isophthalic
methyl ester
Proton <>H/ppm
6 8.95(s)
7 2.20(s)
19,20 3.95(s)
21 3.87(s)
22 1.10(m)
23 1.30(m)
24 1.51(m)
25 0.90(m)
The method employed for the methyl isophthalate, was applied to BrOB (13) and proved
to be unsuccessful. The reaction, monitored by TLC (toluene: acetic acid 5:1), showed
that multiple products had formed after 17 h. Upon purification by column
chromatography (silica! toluene: acetic acid 12:1) of the crude product, the fractions were
isolated and characterised by lH-NMR and ES-MS.
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o OH 0
15
Br
Figure 3.7 BrOB.
Tributylstannylbromide and unreacted BrOB (13) (Figure 3.7) was first separated from
the mixture, followed by the isolation of debrominated product, OB (11). IH-NMR-data
of the latter was in agreement with data obtained for OB. The H-6 resonates as a singlet
at OH 7.2 for BrOB and as a doublet at 0 8.33 (JH6, HS = 8.00 Hz) for OB (11), H-5
resonates as a doublet at OH 6.82 (JH5, H6 8.0 Hz). ES-MS of odourless viscous oil that was
isolated indicated that it was a tin bearing compound, by isotope profiles at m/z 657
(122Sn), 654 e 19Sn), 653 eiSSn), 652 (ll7Sn) and 651 (116Sn); tributylstannyl OB (14),
C32HtsN06Sn requires 658.43). IH-NMR analysis was not in agreement with a possible
stannylated OB compound showing none of the characteristic tin resonance peaks at high
field. This either indicates that the desired product was identified by ES-MS but in
insignificant quantities, or otherwise the peaks at m/z 657-653 belong to another
compound not containing BU3Sn.
The moderate yields in the tributylstannylation of bromo isopthalic methyl ester (27),
which is a very good electronic model of BrOB (13) where no desired product was
detected under similar reaction conditions, suggested that steric considerations could be
ascribed to this difference in reactivity. We therefore, decided to replace the
hexabutylditin with hexamethylditin in a separate experiment (Figure 3.8).
QtH
0 OH 0
QtH
0 OH 0
N cat. Pd(PPh3)4 N
I Me3SnSnMe3 IH H
CH3 CH3
Br SnMe3
(13) (15)
Figure 3.8 The attempted catalytic stannylation ofBrOB (13).
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Two fractions were isolated by column chromatography following the reaction, and
analysed by IH_NMR. Apart from the dehalogenated product, OB (11), the further
fraction contained unreacted BrOB (13) and an unidentified product. This product shared
the dihydroisocoumarin structure of BrOB (13) (H-7 appeared as two doublets at OH 2.77
(J = 12.0 Hz) and 2.84 (J = 12.2 Hz) but did not contain the phenylalanine side chain, i.e.
the H-15 protons which resonate as a multiplet at OH 3.2, together with phenylalanine
peaks (H-17-H-19) at OH 7.26 were absent. A small amount of the fraction «10%)
contained a trimethylstannyl substituted species. The characteristic tin singlet resonance
at OH 0.5 Hz was observed. The absence of the phenylalanine proton resonance peaks
suggested that the hexamethylditin could have reacted with the labile phenylalanine
benzylic (C-15) protons. The use of BrO~ (the hydrolysis product of BrOB, 13) as
subtrate could circumvent this problem. This approach was not explored any further.
3.3.2 Fluorodestannylation by Xenon difluoride.
This procedure was conducted on the tributylstannylisophthalic ester intermediate (28)
(Figure 3.9). Treatment of this compound with xenon difluoride in carbon tetrachloride, is
a modification of the method used by Duelfer et al., 1991, which described the use of 18F2
gas, trapped at O°C in acetonitrile containing a trimethylstannyl precursor, as the fluorine
source. The limited availability of not only F2 gas but also the highly specialised
equipment, and expertise in its usage, prompted us to apply xenon difluoride as our
source of fluorine. This approach has been implemented with great success by Lothian
and Ramsden, 1993, in the rapid fluorodesilylation of aryltrimethylsilanes in fluorinated
solvents.
~*OCH3~C C
CH30/ ~ I <,OCH3
~ CH3
Sn (CH2CH2CH2CH3h
(28)
~*OCH3~C C
CH30/ ~ I <,OCH3
~ CH3
F
(29)
Figure 3.9 Attempted fluorodestannylation of the tributylstannylisophthalic ester
intermediate by XeF2.
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Treatment of 2-methoxy-4-methyl-5-tributylstannylisophthalic methyl ester (28) with
xenon difluoride to fluoro-substitute the halophilic tributylstannyl group, met with limited
success. The rapid reaction of the fluorine source with the tin substrate afforded
predominantly the protonated analogue, 2-methoxy-4-methylisophthalic methyl ester. It
was characterised by H-6 and H-5 resonance peaks, featuring as doublets at DH 7.86 (JH6,
HS = 8.9 Hz) and 7.05 (IHS, H6 = 9.0 Hz). For successful fluorination at C-5, the 13C_NMR,
should have indicated the characteristic splitting patterns for the C-5 fluorine-bearing
carbon atom (Jc, F;:::::; 240 Hz) as well as the marked downfield shift associated with fluoro
compounds. These features were not observed.
3.3.3 Attempted synthesis of trimethylsilyl aromatic intermediates.
The ability of tin to undergo undesired radical reactions, together with the prevalance of
the benzylic hydrogen atoms that are prone to take part in radical processes during the
replacement of the trialkyltin substituent with a fluorine substituent led to the
investigation of the trialkylsilanes which is less apt to radical procesess. Furthermore, the
fluoro substitution of aryltrimethylsilanes on aromatic species is rapid and can be
achieved under farely mild conditions using xenon difluoride (Lothian and Ramsden,
1993). Our attempts were limited to the reaction of model compounds, 5CISA (18) and
5BrSA (20) with hexamethyldisilane in the presence of tetrakis(triphenylphospine)
palladium (0) as catalyst, as described in the method by Babin et al., 1993.
The chioro substrate showed no reactivity towards catalytic silylation and the unreacted
product was isolated in all the attempts incorporating varying temperatures, prolonged
reaction times, elevated catalyst and hexamethyldisilane concentrations.
Although large amounts (up to 51%) of the unreacted acid was isolated, the 5-bromo
salicylic acid was more reactive but non- selective for trimethylsilyl substitution. The
product isolated was predominantly the debrominated compound (17) product, and small
amounts of a biaryl compound was also obtained (Figure 3.10).
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&tOH
(17)
Figure 3.10 Non-selective side products in the attempted catalytic silylation of BrSA.
HO
A}Y C___OH
Br
(20)
I
(CH3)3SiSi(CH3h
cat. Pd(PPh3)4
OH +
The limited success obtained, prompted the application of the method described by
Kimes et al., 1992; which entails much more harsh conditions. The method entails the
treatment of arylbromides with hexamethyldisilane in the presence of tetrakis
(triphenylphosphine )palladium(O) as catalyst at high temperatures 150-170°C in sealed
reaction vessels for prolonged periods of time (2 days). These reaction conditions did not
prove successful and afforded similar results as previously obtained under milder
conditions. Furthermore, the application of this method on subtrates containing sensitive
functional groups, such as BrOB (13) was not feasible.
An alternative of this method was found in a newly proposed protocol for the catalytic
silylation of aryl bromides as desribed by Goojien and Ferwanah, 2000. This method,
which employs a catalytic system consisting of tris(dibenzylideneacetone )dipalladium(O)
and different phosphines, has been proven to be mild and extremely efficient in affording
arylsilanes from arylbromides.
The method is based on the rationale that arylbromides oxidatively adds to the palladium
phosphine substrates, creating a Pd(II) species that will subsequently react with the
hexamethyldisilane. In the case of a substituted aryl component, the Pd(II) species will be
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activated in varying degrees, owing to the spectrum of substituents on the aromatic ring.
BrOB (13) is a relatively electron rich aromatic ring, thus the use of an electron poor
phosphine, such as diphenyl-2'-pyridylphosphine (PPh2Py), will balance the electronic
nature of the Pd (II) reactive intermediate.
However, the method did not prove successful in the silylation of BrOB (13), the product
spectrum revealed that no biaryl specie had formed by furnishing predominantly the
unreacted BrOB and trace amounts of the debrominated product, OB (11).
3.4 Direct catalytic fluoro substitution of aryl bromides.
The low selectivity which accompanied the subtitution of the aryl bromide substrates for
the trialkylstannyl- and -silyl groups, as well as the difficulty in isolating these
intermediates prompted the investigation into a direct fluoro halogen subtitution method.
The method involves the substitution of an aryl bromine atom for a nucleophilic fluoride
(F-, from tetrabutylammonium fluoride and cesium fluoride) in the presence of
tetrakis(triphenylphosphine )palladium(O). The arylbromide substrates used were
5BrSAPhe (25), 3-bromoanisole (30) and 5-bromo-2-methoxy 4-methylisopthalic methyl
ester (27) (Figure 3.11).
The first reaction entailed treatment of a mixture of 3-bromoanisole (30) in mesitylene
with tetrabutylammonium fluoride in the presence of tetrakis(triphenylphosphine)
palladium (0). After a prolonged reaction time (20 h), the crude product was analysed by
ES-MS. The characteristic isotope peaks (m/z mand m+2) confirmed that no bromo
substitution had taken place.
The reaction was repeated on BrSAPhe (25), using toluene as solvent. ES-MS analysis of
the crude product revealed the base peak at m/z 215/217 which supports the
bromo salicylic acid (20) structure (M-l; C7Hs03Br requires 216). Furthermore the peak
at m/z 155, supports the analogous fluoro compound, fluorosalicylic acid (M-l; C7Hs03F
requires 156). The fluorination could not be confirmed by IH-NMR, which implies that
the fluoroproduct (19) was insignificant or that the peak at m/z 156 does not belong to 19.
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Qr:H~O ::/,OH
I IH ::::-....
Br
cat.Pd(PPh3)4
(Bu)4NF,C6HsCH3
Qr:H~O ::/,OH
I IH ::::-....
F
(25) (24)
CH,)~tOCH;yCH3
Br
(27)
cat.Pd(PPh3)4
CsF,C6H4(CH3)2
~*OCH3~C C
CH30/ -:?' I 'OCH3
::::-.... CH3
F
(29)
cat.Pd(PPh3)4
(Bu)4NF,C6H3(CH3h
(32)
Figure 3.11 The attempted direct catalytic fluorosubstitution of aryl bromides.
In a final attempt, a mixture of 5-bromo-2-methoxy-4-methylisophtalic methyl ester (27)
lil xylene was reacted with cesium fluoride lil the presence of
tetrakis(triphenylphosphine) palladium (0) under reflux in a argon atmosphere for 21 h.
ES-MS analysis of the crude mixture did not support the desired structure. The only
product supported was the unreacted bromoisophtalic methyl ester (27) (m/z 316/318) and
its debrominated analogue (30) (m/z 239).
3.5 Attempted synthesis of 2-fluoroacetoacetaldehyde.
It is clear from the discussion of a proposed method for the synthesis of fluoro-ochratoxin
B, based on the diester approach of Kraus, 1981, that 2-fluoroacetoacetaldehyde is a key
intermediate in this de nova synthesis route. The first step would include the synthesis of
sodium acetoacetaldehyde followed by fluorination using Selectfluor™. Deprotonation
by a mild base should render the corresponding sodium salt of fluoroacetoacetaldehyde.
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The method used, was based on the synthesis of bromoacetoacetaldehyde from sodium
acetoacetaldehyde by Lipinsky et al., 1984.
3.5.1 Synthesis of sodium acetoacetaldehyde.
Sodium acetoacetaldehyde was prepared as described by Lipinsky et al., 1984. The
product was obtained in 64% yield. IH-NMR analysis revealed that a major impurity of
this reaction proved to be sodium formate, the proton resonates as a singlet at SH 8.33
(Figure 3.12). The structure of sodium acetoacetaldehyde, is supported by the resonance
of H-l as a singlet at SH 8.75, H-2 a doublet at 5.13 and H-3 a singlet at 2.12. The mole
fraction of the sodium acetoacetaldehyde to sodium formate was determined by the ratio
of the single proton absorbance at SH 8.33 and 8.75.
o
II
HCOEt +
Na+o IJ
II ',_- ~/ II
HC-CfI-C-CH3
3 2 I
TM 0 0
Selectfluor II II
HCCHFCCH3
1
Figure 3.12 The synthesis of the sodium salt of fluoroacetoacetaldehyde.
3.5.2 Attempted fluorination of sodium acetoacetaldehyde.
Freshly prepared sodium acetoacetaldehyde (containing trace amounts of sodium
formate) in acetonitrile was treated with Selectfluor™ at ambient temperatures for 72 h.
The sodium salt had a poor solubility in acetonitrile, but upon addition of the fluorinating
reagent it afforded a clear solution. However, IH-NMR analysis of the crude product
revealed that no fluorination had taken place and that a large amount of product
decompostion had occurred.
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Product decomposition was ascribed to the presence of sodium formate in the starting
substrate. The presence of excess Selectfluor™ in the reaction mixture could lead to the
formation of hydrogen fluoride due to the oxidation of sodium formate, which could
facilitate side reactions. No further attempts were made in the preparation of fluoro
acetoacetaldehyde due to time constraints.
3.6 Peptide synthesis
Peptide synthesis methodology forms an integral part in our structure activity relationship
study of OA analogues. The areas of application includes (1) the coupling of fluoro
substituted DL-phenylalanine to Oa, (34) (2) the synthesis of dipeptide histidylhistidine,
and the attempted coupling to Oa, (34) (3) the synthesis of phenylalanine analogues,
SAPhe (22), ClSAPhe (23) and BrSAPhe (25) for application in fluorination
methodologies and (4) the coupling of F-013 to L-phenylalanine, as a route to fluoro-
ochtaoxin B (12). Figure 3.13 illustrates the different synthetic routes and intermediates.
3.6.1 Acid hydrolysis of OAe
Oa (34), derived from the facile acid hydrolysis of OA, provides the access route to the
synthesis of OA analogues by the modification to the L-phe side chain. The method by
Xiao et al., 1995, was utilised for the hydrolysis of OA (10) to afford Oa (34) which was
used in the various coupling procedures. It entails treatment of the lactone acid with 6N
HCl over a 72 h period under reflux. The crystals of Oa could be harvested directly from
the reaction mixture and 12 h at ambient temperature was allowed for their formation.
Repeated washing of the crystals with distilled water removed any traces of L-Phe.
Residual Oa from the acid-water fraction was separated from Phe by partitioning into
chloroform. Pure Oa crystals could be obtained by recrystallisation from methanol and
water (1:1).
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o OH 0
Cl Cl
(36) Rt=F R2=H R3=H Rt=H (42) Rt=F R2=H R3=H Rt=H (34) R=OH
(37) Rt=H R2=F R3=H Rt=H (43) Rt=H R2=F R3=H Rt=H (35) R=CI
(38) Rt=H R2=H R3=F Rt=H (44) Rt=H R2=H R3=F Rt=H
(39) Rt=F R2=H R3=H Rt=CH3 (45) Rt=F R2=H R3=H Rt=CH3
(40) Rt=H R2=F R3=H Rt=CH3 (46) Rt=H R2=F R3=H Rt=CH3
(41) Rt=H R2=H R3=F Rt=CH3 (47) Rt=H R2=H R3=F Rt=CH3
o OH 0
(48) (49) (50)R]= acyl R2 = H
(51)R]=R2=TBDMS
Coupling of2F-, 3F- and 4F- DL-Phe to Ou.
(42)---- ....
(43)---- ....
(44)---- ....
(10)---+ (34)---+ (35) + (39)
(35) + (40)
(35) + (41)
(45)
(46)
(47)
-----+ (42)
-----+ (43)
----+ (44)
(45)
----+ (46)
----+ (47)
Coupling of dihistidine to Ou
(48) + (34) (49)
Figure 3. 13Peptide synthesis routes employed in synthesis of OA analogues.
116'
Stellenbosch University http://scholar.sun.ac.za
METHODOLOGY, RESULTS AND DISCUSSION
3.6.2 Coupling of ortho-, meta- and para- substituted DL-fluorophenylalanine methyl
ester to Oa-CI (35).
The method by Steyn and Holzapfel., 1965, for the coupling of L-Phe to Oa was used
extensively for the coupling of 0-, m- and p-substituted DL-tluoro-phenylalanine to On,
The first step in this method entails the derivatisation of the substituted DL-
tluorophenylalanine to its methyl ester hydrochloride, followed by deprotonation to yield
the methyl esters.
The coupling substrate, Oa-C1 (35) was obtained by the treatment of Oo, (34) with
freshly distilled thionyl chloride under retlux for 2 h in an argon atmosphere. In order to
confirm the presence of Oa-CI (35), and thus monitor the reaction by TLC, a drop of
absolute ethanol was added to a fraction of the reaction mixture. The ethyl ester of Oa-CI
(35), the product of the reaction, migrates with the solvent. When hydrolysis was
complete the thionyl chloride was evaporated under a dry stream of argon to afford the
acyl chloride (34). This compound was immediately reacted in separate experiments with
2- (39), 3- (40) and 4- (41) F-DL-phenylalanine methyl esters. The reaction proved to be
rapid and efficient and was complete after 2 hours. The isolated methyl esters were
hydrolysed to produce the respective ortho- (44), meta- (43) and para-substituted (42)
DL-tluorophenylalanine OA. The products were purified by crystalisation from methanol
and diethyl ether. The structural assignments of the modified analogues are based on
comparisons of their spectroscopic data with those of OA (10) and 2- (36), 3- (37) and 4-
(38) F-DL-Phenylalanine (Table 3.5,3.6 and 3.7).
Table 3.5 Infrared data (cm") for ortho-substituted DL-tluorophenylalanine On and OA.
Compound N-H HN-C=O C=O vibration
vibration vibration HOC=O Amide/Lactone
OA 3398 1536 1737 1669
ortho-tluoroPhe Oa 3392 1530 1739 1671
The molecular ion (~) for the three analogues was obtained by EI-MS at m/z 435/437.
The structure C2,H'906CIFN required m1z 435.8. Identical base peaks were observed for
the three analogues at m/z 293.
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Table 3.6 IH_ and I3C-NMR data (CDCh) for ortho-, meta- and para- substituted DL-
fluorophenylalanine Oe,
o OH 0
19 13
Cl
ortho-f1uoroPheOa
(44) F
F o OH 0 o OH 0
19 13 19 13
Cl
para-f1uoroPheOa
(42)
meta-f1uoroPhe
(43)
ortho-tluoroPhe Ou meta-tluoroPhe Oe para-tluoroPhe o«
Carbon oc/ppm oH/ppm JH,HIHz oc/ppm oH/ppm JH.HIHz oclppm oH/ppm JH,HIHz
I 110.05 - - 111.36 - - 111.72 - -
2 169.66 - - 168.00 - - 168.55 - -
3 75.85 4.76 16.8,12.0 75.26 4.74 - 75.55 4.74 -
4 30.90 2.84 17.4,3.8 31.59 2.91 17.4,12.0 31.65 2.94 18.0,12.1
3.28 17.4,3.8 3.11 8.4,4.0 3.10 18.0,7.0
5 140.67 - - 139.95 - - 136.28 - -
6 120.56 - - 120.11 - - 121.61 - -
7 138.73 8.38 141.62 8.31 - 142.13 8.10 -
8 120.73 - 115.85 - - 120.41 - -
9 158.00 - 158.5 - - 158.87 - -
10 20.65 1.59 6.0 19.99 1.47 6.0 20.03 1.47 6.3
II 162.38 - - 162.81 - - 163.31 - -
12 32.22 5.01 "complex" 53.60 4.84 "complex" 54.00 4.88 "complex"
13 31.06 3.43 13.8,4.8 36.09 3.10 8.4 35.68 3.12 8.4
3.21 13.8,6.0
14 128.72 - - 121.00 3.21 3.5, 8.4 10.2 133.52 3..23 3.5,8.4, 10.2
128.67
15 160.27 7.26 - 135.80 7.07 - 115.41 7.23 -
162.57 115.13
16 131.72 7.04 - 162.70 - - 131.33 7.14 -
161.09 131.44
17 124.06 7.20 - 135.80 7.04 - 159.96 - -
163.18
18 131.72 6.98 - 130.02 7.32 - 131.33 7.14 -
131.44
19 124.02 - - 125.28 7.10 - 115.40 7.23 -
115.13
20 172.70 - - 172.06 - - 172.70 - -
N-H 8.56 - - 8.69 - - -
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Table 3.7 UV spectroscopy data for ortho-substituted DL-fluorophenylalanine Oa. and
OA.
Compound Amax/nm E/dm3.mor1.cm-1
OA 216 31500
330 6050
ortho-fluoroPhe o« 217 31450
330 5900
3.6.3 The synthesis of histidylhistidine methyl ester.
Through a common interest in our research area, the methodology for the efficient
synthesis of histidylhistidine was available to us. Furthermore, the aromatic nature of the
constituent amino acid, L-histidines (52,53) resembles that of L-phe. The coupling of a
dipeptide to On, a novel endeavor, could provide further insight into the role that the
amide, if any, has to play in the toxicity ofOA (10)
A general method by Rautenbach, 1999, for the synthesis of dipeptides using
diisopropylcarbodiimide (DIPCDI) (54) as coupling reagent was utilised. The reaction
mechanism is depicted in Figure 3.14.
The method entails the activation of the u-carboxyl group of t-butoxycarbonyl (tBOC)-
histidine (tBOC-His) (52), by DIPCDI (54), to provide the activated carboxylic acid
derivative (56). Treatment of the 56 with a solution of deprotonated (by triethylamine)
histidine methyl ester dihydrochloride (His-OCH3) (53), in freshly distilled DMF,
renders the dipeptide. The addition of hydroxybenzotriazole (HOBt) (55), a "trapping
agent", to the reaction mixture prevents the racemisation of the amino acids during the
coupling reaction (Lloyd-Williams, 1997).
A side product of the reaction, diisopropylurea (57), is highly insoluble in the DMF and
easily removable by filtration. The use of t-BOC-His (52) allows for complete solubility
in DMF and protection of the amino group to reactivity of the dehydrating agent. The t-
BOC group can easily be removed by treatment of the dipeptide (58), with a 10%
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aqueous solution of trifluoroacetic acid. The volatile side products of the reaction,
isobutene and CO2, can be removed by evaporation under reduced pressure.
(52) (54)
"N, r>:
N" N-O( BORV-~
(53)
(59)
(55) (56)
(58)
oR--< +
NH-R'
Where R=
N~
~+o R'=
Figure 3.14 The mechanism of synthesis ofhistidylhistidine methyl ester by activation of
DIPCDI (54) and HOBt (55).
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The resultant white coloured residue was purified from the unreacted histidine amino
acids (52, 53) and trace amounts of diisopropylurea (57) by column chromatoghraphy
(silca! ethyl acetate:ethanol, 3:1).
Upon treatment of the concentrate containing the desired product, with a 10% aqueous
TFA solution the methyl ester of histidylhistidine (48) was isolated in good yield
(79%)(Figure 3.1.5). The white precipitate was recrystalised from a methanol: ether
solution (with an excess diethylether). The histidyl-histidine methyl ester appeared to be
highly hygroscopic, and was stored under argon.
(52) + (53) I) TEA, DMF ..
2) 54, 55
(58) + (57)
95%aq. TFA
Figure 3.13 The synthesis ofhistidylhistidine methyl ester (48) by activation of DIPCDI
(54) and HOBt (55).
Using the IH NMR data and the I3C NMR data of analogous compounds and the
precursors, the following assignments were made in Table 3.8.
The purified histidylhistidine methyl ester provided a dipeptide for the direct coupling to
Oa-Cl.
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Table 3.8 IH_ and 13C_NMR [(CD3)2S0] data for histidylhistidine methyl ester (48).
17
OCH3
N 7
\LN5 ,
H
6
/H
12 N 14
N_J
13
oclppm oH/ppm
2 4.56-4.59 52.10
3 3.03-3.07 26.41
4 - 130.06
5 8.15 134.08
7 7.14 116.08
8 - 167.89
9 9.23 -
10 4.l5 52.19
11 3.12-3.17 27.62
12 - 130.46
13 8.51 134.69
15 7.28 118.07
16 - 170.40
17 3.64 51.68
3.6.4 Efforts to couple histidylhistidine methyl ester (48) to Oa-CI (35).
The method used in the synthesis of Da-Cl (35) and subsequent coupling to the fluoro
substituted phenylalanine methyl esters (section 3.6.2), was utilised in the coupling of
Da-Cl (35) to histidylhistidine methyl ester (48).
The method utilised to couple the dipeptide methyl ester to Da-Cl was unsatisfactory.
This finding was confirmed by the analysis of the isolated product by IH_ and 13C-NMR
and ES-MS, and by comparing these results with the spectroscopic data obtained from the
building blocks, Da (34) and dihystidine methyl ester. No further coupling techniques
were explored in this regard.
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3.6.5 The coupling of halosalicylic acids and salicylic acid to L-Phe.
The method used by Steyn and Holzapfel 1967, was used for the coupling of
phenylalanine to salicylic acid and other halogenated salicylic acid derivatives. Salicylic
acid, 5-chloro- and 5-bromosalicylic acid were respectively refluxed in thionyl chloride
to afford the corresponding acyl chlorides. Treatment of the latter with sodium azide
afforded the acyl azide. In each case the salicyl azide, was isolated and reacted without
purification with the triethylammonium salt of the amino acid. Reactions were monitored
using TLC (toluene:acetic acid, 5:1) and reached completion in 48 hours. Payne, 1999,
modified the method used by Steyn and Holzapfel, 1967, by using ethyl acetate instead of
DMF as solvent for the reaction. Not only can the reaction be monitored more effectively
in this solvent, but ethyl acetate can also be removed more easily by evaporation and is
less toxic than DMF.
Furthermore, CISAPhe (23) and BrSAPhe (25) could easily be purified by crystallisation
from chloroform. SAPhe (22), is a colourless oil, and was purified by column
chromatography (toluene:acetic acid 5: 1). SAPhe could also be obtained by the catalytic
dehalogenation using Pd/C in methanol and ammonium formate. The coupled products
were afforded in fairly low yields, i.e. for CISAPhe (23) (49%), BrSAPhe (25) (38%) and
SAPhe (22) (38% from the acid, quantitatively from CISAPhe). IH-NMR and 13C_NMR
data for the coupled products were consistent with the data obtained by Payne, 1999.
These phenylalanine coupled salicylic acid derivatives provided, in the amino acid side
chain and substituted aromatic substrate, the OA related functional groups for the
application in fluorination techniques.
3.6.6 Peptide coupling by the DCC carboxyl activation.
As discussed previously (section 2.3.1.2.3), the presence of the free hydroxyl group in
OA (10) and halosalicylic acid allows for the intramolecular binding to the derivatised
carbodiimide that leads to the formation of a undesired adduct. In an attempt to avoid the
formation of this by-product, and increase the yield of the desired amide, the reactivity of
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the hydroxyl group of 5CISA (18) was blocked using different derivatives. In order to
apply this method to Oa (34), the protective group employed should i) efficiently
derivatise the hydroxyl group ii) be stable under coupling conditions and iii) easily be
removed after coupling.
As part of this approach we derivatised the phenolic hydroxyl group of 5CISA (18) by
acetylation using acetyl chloride in pyridine, employing the method by Kendall et al.,
1979. Alternatively, protection of both hydroxyl and carboxyl group of5CISA (18) as the
tert-butyldimethylsilyl (TBDMS) ether and ester respectively (51), can be achieved by
treatment with tert-butyldimethylsilyl chloride, utilising the method by Ronald et aI.,
1982.
5-Chlorosalicylic acid (23) was acetylated with acetyl chloride, to afford 2-acetoxy-5-
chlorobenzoic acid in respectable yield (87%). The reaction was monitored with TLC
(toluene:acetic acid, 5:1) where the product appeared as a dark spot under UV absorbance
(Rf = 0.75). The structure of the product was confirmed by IH-NMR, 13C-NMR. The
assignments were made from data of 5-chlorosalicylic acid and other analogous
compounds (Table 3.9).
Tabel3.9 IH_and 13C_NMR data for 2-acetoxy 5-chlorosalicylic acid.
OCOCH38 9
Cl
oclppm oH/ppm JH,H 1Hz
1 130.48 -
2 169.50 -
3 126.24 7.31 8.7
4 133.79 7.76 8.7,2.7
5 149.28 -
6 131.02 7.94 2.7
7 164.89
8 156.12 -
9 20.75 2.27
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tert-Butyldimethylsilyl 2-tert-butyldimethylsilyloxy-5-chlorobenzoate (51), was
synthesised in good yield (84%). The structure of the product was confirmed by IH_
NMR and 13C_NMR. The assignments were made from data of 5-chlorosalicylic acid and
other silylated compounds (Table 3.10).
Table 3.10 IH_ and 13C_ NMR data for DiTBDMS-chlorosalicylate (51).
Cl
oc!ppm oH/ppm JH,HIHz
1 125.36 -
2 164.03 -
3 122.93 6.80 8.4
4 132.63 7.27 9.0,3.0
5 125.50 -
6 131.10 7.65 3.0
7 154.50 -
8,9 -4.70
10-12 25.75 0.98
13, 14 -4.01
15-17 25.75 0.98
18/19 25.71 0.34,0.98
The selective hydrolysis of the silyl ester will allow for the DCC activation and peptide
coupling. Further application of this methodology on Ou could provide the protected
intermediate needed for the coupling to amino acids by the use of DCC as coupling
reagent.
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4.1 General
4.1.1 The purification of organic solvents.
Acetonitrile: The solvent was primarily dried on 4A molecular sieves, followed by
stirring with calcium hydride. The purified solvent was obtained, following fractional
distillation immediately prior to use.
Diethyl ether and petroleum ether (60-80°C): The solvents were dried over sodium
wire followed by fractional distillation immediately prior to use.
Carbon tetrachloride and Chloroform: The solvents were purified by elution through a
column of activated alumina, followed by refluxing with potassium pentoxide and
distilling immediately prior to use.
Ethyl acetate: The solvent was refluxed with a 10% (v/v) acetic anhydride solution in
the presence of a catalytic amount of cone. sulphuric acid for 4 hours. The mixture was
fractionally distilled and the distillate stirred with 2% (w/v) anhydrous potassium
carbonate, filtered and redistilled.
Ethyl and methyl alcohol: The solvents were purified upon distillation from magnesium
-ethoxide and -methoxide, respectively immediately prior to use.
Dimethyl formamide: The solvent was purified by stirring with 10% (w/v) potassium
hydroxide, followed by filtration and fractionated vacuum distillation.
Pyridine: The solvent was purified upon stirring with calcium hydride and fractional
distillation immediately prior to use.
Tetrahydrofuran: The solvent was purified by refluxing with a sodium-potassium
liquid alloy (1 :5) followed by fractional distillation immediately before use.
Toluene and Xylene: The solvents were purified by refluxing with potassium pentoxide
followed by fractional distillation immediately before use.
Thionyl chloride: The reagent was purified by primarily refluxing with 5% (w/w) of
dipentene (p-menta-1 ,8-diene). Following distillation of the mixture, the distillate was
refluxed with 1-2% (w/w) oflinseed oil and fractionally redistilled.
Reagents and chemicals: Reagents were purchased from Merck and Sigma-Aldrich,
were of high purity and were used without further purification.
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4.1.2 Chromatography
4.1.2.1 Thin layer chromatography (TLC): The method was used extensively to
monitor the progress of reactions. The stationary phase used was precoated Kieselgel 60
F254 (Merck) plastic and glass-supported plates. The mobile phase used is specified where
applicable in the experimental procedure. Apart from the visualization under UV light,
the plates were treated with iodine vapour.
4.1.2.2 High performance liquid chromatography (HPLC): The method was used to
monitor the progress of reactions, of which the samples were prepared in the following
manner: Periodic samples (50 ul) were removed from the reaction mixture and the
solvent evaporated under a stream of dry argon. The residue was suspended in
chloroform (1 ml) and acidified with 1M HCI (200 ul), The aqueous phase was extracted
three times with chloroform (3xO.5 ml) and the combined chloroform extracts were
evaporated under a dry stream of argon. The residue was suspended in AR methanol (500
ul) and distilled water (500 ul) and assayed.
4.1.2.3 Preparative chromatography: The method described by Still et al., 1966 for
Flash chromatography was used in the separation and purification of reaction products.
The stationary phase used was Kieselgel 60 (Merck, mesh size 230-400 nm) and the
mobile phases are specified where applicable in the experimental procedure.
4.1.3 Instrumentation
4.3.1 Melting points: The melting points of compounds were determined usmg a
Gallenkamp melting apparatus and are uncorrected.
4.1.3.2 Infrared spectroscopy: The IR spectra were recorded on a Perkin-Elmer 1720
FT-IR spectrometer using KBr pellets.
4.1.3.3 Mass spectrometry: EI mass spectra were recorded on a AMD 604 spectrometer
at 70 eV. Electrospray mass spectra were recorded on a Micromass Quattro, triple
quadropole mass spectrometer coupled to a HPLC system.
4.1.3.4 Ultraviolet-visible spectroscopy: UV spectra were recorded in methanol on GBC
UV/VIS 920 spectrometer
4.1.3.5 Nuclear magnetic resonance spectroscopy: IH and 13C spectra were all recorded
on a Varian VXR 300 MHz spectrometer (at 25°C) unless stated. IH and 13C spectra were
recorded at 300 MHz and 75 MHz, respectivelr Spectra were further recorded on Varian
Inova 600MHz (25°C) spectrometer. IH and I C-spectra were recorded at 600 MHz and
150 MHz respectively. All chemical shifts (ppm) are reported relative to
tetramethylsilane (8=0). The abbreviations used to describe 'Hvmultiplicity are: s =
singlet, d = doublet, t = triplet, q = quintet, m = multiplet, td = triplet of doublets etc. and
for 13C-multiplicity: S= singlet, D = doublet, T = triplet, Q = quintet.
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4.1.3.6 High Performance Liquid Chromatography: Waters 2690 system fitted with a
thermostatic column compartment, auto sampler, and Millennium software was used.
Detection was achieved by fotodiode array (258 nm-330 nm) and fluorescence detectors
(excitation wavelength was set at 331 nm and the emission wavelength at 460 nm).
Separation was achieved on a CI8 reversed phase column (4.6 mm x 150 mm, 5 urn,
Discovery, Supelco, Bellefonte, PA, USA) at 30°C, employing an isoeratic mobile phase
of methanol/water/acetic acid (60:40:2), an injection volume of 50 ul. and a flow rate of
1 ml/min.
4.2Physicochemical data of relevant compounds.
4.2.1 Ochratoxin A (10)
Emperical formula: C20H18CIN06
Structural formula:
20
C02H 0 OH 0
12 N
13 I
H
Cl
Melting point: 90°C (containing 1 mol of benzene)
171°C (from xylene) (Van der Merwe et al., 1965)
Specific rotation: [a]~ (c 1.07, CHCb), -46.8° (Semenuik et al., 1971)
ORD: (c 0.18, MeOH), [~]600-380°, [~]589-403°, [~h42-4600°, [~h19-0°, [~h04+1650°,
[~h69 -62700(Steyn, 1984).
UV: (AmaxMeOH/0.0005 M H2S04) 216, 330 nm (E 31,500 and 6400, respectively);
(AmaxMeoH210and 330 nm (E 37 060 and 6050, respectively)(Steyn, 1984).
IR: (vmax CHCh), 3380, 2988, 2928, 1723, 1674, 1612, 1528, 1425, 1381, 1304, 1260,
1170, 1140, 1107, 827 cm-1 (Steyn, 1984). The distinctive absorption bands are;
carboxylic acid carbonyl stretch 1723 cm-I(strong) and 1500 to 1700 cm-I (broad),
secondary amide 1665, 1535 (strong) and 3430 cm-I(medium), lactone group 1678, 1132
cm-1 (strong) (Van der Merwe et al., 1965).
EI-MS: m/z M+, 403 (13%), 359 (31%), 358 (18%), 357 (14%), 258 (52%), 257 (97%),
256 (100%), 255 (86%), 242 (49%), 241 (94%), 240 (98%), 239 (81%) and 238 (99%).
(Steyn, 1984).
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IHNMR: IH NMR (500 MHz) of ochratoxin A in CDCb.(Stander, 2000)
Proton DH/ppm J/Hz Multiplicity Coupling
OH 12.74 s
NH 8.50 7.07 d JNH,12
3 4.76 11.75, 6.05, 3.49 d,q,d J3,4a, J3, 10, J3, 4b
4a 2.86 17.47, 11.75 d,d J4ao 4b, J4a, 3
4b 3.29 17.47,3.49 d,d J4b, 4a, J4b, 3
7 8.43 s
10(3) 1.60 6.05 d JIQ,3
12 5.06 7,07, 7.07, 5.35 d,d,d J12, l3a, J12, NH, J12, 13b
13a 3.23 14.08, 7.07 d,d J13a, 13b, J13a, 12
13b 3.36 14.08,5.35 d,d J13b, 13a, J13b, 12
15-19 7.27 ill
13eNMR: l3C chemical shifts and directly bonded
[IJ(C,H)] coupling constants ofOA (de Jesus et al., 1980).
Carbon Dc/ppm" IJ(C,H) Multiplicity
1 110.1 S
2 169.6 S
3 75.9 149.7 D
4 32.2 131.9 T
5 141.0 S
6 123.2 S
7 138.9 168.9 D
8 120.3 S
9 159.1 S
10 20.6 128.3 Q
11 163.0 S
12 54.3 144.5 D
13 37.5 130.3 T
14 135.9 S
15,19 129.4 158.9 D
16,18 128.6 159.5 D
17 127.2 160.8 D
20 174.9 S
129
Stellenbosch University http://scholar.sun.ac.za
EXPERIMENT AL
4.2.2 Ochratoxin B (11)
Emperical formula: C20H19N06
Structural formula:
18 20
C02H 0
12 N 1113 I
H
OH o
Melting point: 220-221°C (from MeOH) (Van der Merwe et al., 1965).
Specific rotation: [a]~ (c 0.29, MeOH), -56 (Steyn, 1967).
ORD: (c 0.18, MeOH), [$]600-203°, [$]589-206°, [$]325-5200°, [$boo-O°, [$]295-1456°,
[$]284_0°, [$]266-2860° (Steyn, 1967).
UV: (AmaxEtOH 218 and 318 nm (E 34300 and 6750, respectively)(Steyn, 1967)
IR: (vmax Nujol), 3460 (N-H), 1728 (C=O acid), 1666 (C=O lactone), 1658 (C=O amide),
1532 (CO-N amide), and 1130 cm-1 (CO-O lactone)(Steyn, 1967)
EI-MS: m/z M+, 369 (2%), 221 (57%), and 205 (100%) (Steyn, 1967)
IH-NMR: (500 MHz) ofOB in CDCb (Bredenkamp, 1989; this thesis).
Proton 8H/ppm JlHz Multiplicity Coupling
NH 8.48 7.4 d JNH,12
3 4.83 11.3, 6.3, 3.4 d,q,d J3,4a, J3, 10, J3, 4b
4a 2.97 16.8,11.3 d, d J4a, 4b, J4a, 3
4b 3.08 17.2,3.8 d,d J4b, 4a, J4b, 3
6 6.95 8.0 d J6,7
7 8.07 7.9 d Ji,e
10(3) 1.42 6.3 d JIO,3
12 4.72 4.9, 7.5, 7.5 td J12, l3a, J12, NH, J12, 13b
13a 3.08 13.5, 7.5 d,d Jl3a, 13b, Jl3a, 12
13b 3.20 13.9,5.0 dd J13b, 13a, Jl3b, 12
15-19 7.18-7.28 - m -
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l3C NMR: '3C (126 MHz) chemical shifts ofOB in CDCb
(Bredenkamp et al., 1989; this thesis).
Carbon oclppm
1 109.3
2 169.1
3 76.1
4 33.6
5 144.7
6 118.5
7 136.9
8 118.3
9 159.4
10 20.1
11 163.6
12 53.8
13 36.7
14 137.0
15,19 129.2
16,18 128.2
17 126.6
4.2.3 Bromo-Ochratoxin B (13)
Emperical formula: C2oH'8BrN06
Structural formula:
OH 0
'5
Br
Melting point: 140.6°C (from chloroform) Steyn and Payne, 1999.
UV: A.max (MeOH)/nm 217.3 (E/dm3mor'cm-'30500) and 332 (s/dnr'mollcm' 5150)
(Steyn and Payne, 1999).
IR: Vlllax (KBr), 3368 (N-H),1730 (C=O acid), 1671 (C=O lactone and amide) and 1526
(CO-N amide) cm-'.(Steyn and Payne, 1999; this thesis)
ES-MS: m/z; 450 [M\8'Br), 100%], 448 [M\79Br), 100%], 404 (33%), 402 (32%) and
322 (14%)(Steyn and Payne; this thesis)
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IH-NMR: (300 MHz) ofBr-OB in CDCh (Steyn and Payne, 1989; this thesis).
Proton oH/ppm JlHz Multiplicity Coupling
OH 12.7 - - -
NH 8.5 7.1 d JNH,14
6 7.2 - S -
7a 2.8 17.4,11.5 d,d J7a, 7b, J7., 8
7b 3.3 - m "complex multiplet"
8 4.7 - m "complex multiplet"
9 (3) 1.6 6.3 d J9,8
14 5.1 5.4, 7.1, 7.6 td J14, 15, J14, NH, J14, 15
15 3.2 - m "complex multiplet"
17-19 7.2 m
l3C NMR: l3C chemical shifts of Br-OB in CDCh
(Steyn and Payne, 1989; this thesis).
Carbon oc/ppm
1 120.7
2 159.8
3 110.5
4 142.9
5 112.4
6 142.2
7 34.9
8 75.8
9 20.5
10 169.9
11 163.9
13 177.2
14 54.2
15 37.3
16 135.8
17 129.4
18 128.8
19 127.4
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4.2.4 Ochratoxin a (34)
Empericalformula: C"H9C10s
Structural formula:
o OH 0
HO
Cl
Melting point: 245-246°C (from methanol) (Xiao et al., 1995).
UV: Amax (EtOH)/nm 218 (s/drrr' mor'cm-'23 000) and 335 (e/drrr' mor'cm-' 6200)(Xiao
et al., 1995).
Fluorescence: 335 nm (excitation), 433 nm (emission)(Xiao et al., 1995).
IR: Vmax (KBr), 3368 (N-H), 1730 (COOH), 1671 (lactone and amide CO absorption) and
1526 (amide II) cm-' (Xiao et al., 1995).
EI-MS: m/z 258 [M+e7Cl), 45%] 256 [M+esCl), 15%], 214 (35%), 212 (100%), 194
(70%)(Xiao et al., 1995; this thesis).
IH-NMR: (300 MHz) ofOa in CDCh (Xiao et al. 1995; this thesis).
Proton oH/ppm J/Hz Multiplicity Coupling
OH 13.30 - s -
COOH 10.45 s -
3 4.82 - m "complex"
4a 2.91 17.6,11.6 d,d J4a, 4b, J4a, 3
4b 3.30 17.6,3.5 d,d J4b, 4a, J4b, 3
6 8.41 - s -
11(3) 1.63 6.3 d JII,3
J3e NMR: l3C chemical shifts ofOa in (CD3)2S0
(Kraus, 1981; this thesis)
Carbon oe/ppm
1 167,03
3 74.23
4 32.08
5 120.44
6 135.88
7 117.73
8 160.31
9 112.31
10 143.08
11 20.00
12 165.24
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4.2.5 N-(2-hydroxyphenylcarbonyl)-L-phenylalanine, SA Phe (22).
Emperical formula: C16H15N04
Structural formula:
14 16
13 C02H 0 OH
8N~) 39 I I I
H 6~ 4
5
UV: Amax (MeOH)/nm 208 (s/dm'rnollcm' 35600), 235 (s/drrr'mollcm' 10050) 302
(s/dm ' morlcm-I 4500)(Payne, 1999).
IR: Ymax (Nujol) cm-I; 3428 (N-H), 1722 (C=O acid), 1645 (C=O amide) 1534 cm' (CO-
N amide )(Payne, 1999).
EI-MS: m/z; M+, 285 (12%), 148 (13%), 137 (42%) 121 (53%) and 91 (16%) (Payne,
1999; this thesis).
'ttNMR: (300 MHz) of SAPhe in CDCb (Payne, 1999; this thesis).
Proton bH/ppm J/Hz Multiplicity Coupling
3 7.18 7.6,2.1 d,d J3,4, J3• 5
4 6.97 8.9,2.6 d,d J4,3, J4, 5
5 6.80 8.9, 8.9, 2.6 td J5, 4, J5, 6, J5, 7
6 7.18 7.6,2.1 d,d J6, 5, J6,4
8 5.00 4.9,7.1,5.1 td Jg, 9a, Jg, NH, Jg, 9b
9b 3.28 14.0,5.1 d,d J9b, a, J9b, s
9a 3.10 14,0,5.0 d,d J9a, l» J 9a, s
11/15 7.29 m -
12/14 7.29 m -
13 7.38 m -
NH 9.20 7.0 d IN s
13C NMR: l3C chemical shifts of SAPhe in CDCb (Payne, 1999; this thesis).
Carbon be/ppm
1 118.7
2 161.6
3 113.8
4 134.8
5 119.0
6 125.7
7 169.8
8 53.0
9 37.3
10 135.2
11/15 129.4
12/14 128.9
13 127.6
16 175.7
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4.2.6 N-(5-chloro-2-hydroxyphenylcarbonyl)-L-phenylalanine, CISAPhe (23).
Emperical formula:C 16HI4CIN04
Structural formula:
14 16
13 C02H 0 OH
8 N 39 I
H
Cl
Melting point: 182°-183°C (Payne, 1999; this thesis)
IR: Vmax (KBr) cm-I, 3368 (N-H), 1722 (C=O acid), 1632 (C=O amide) 1534 cm-I (CO-N
amide )(Payne, 1999; this thesis).
EI-MS: m/z; 321 [M+e7CI), 13%], 319 [M\35CI), 39%], 184 (13%),182 (37%), 173
(23%), 171 (69%), 157 (32%), 155 (100%)(Payne, 1999; this thesis).
JH NMR: (300 MHz) ofCISAPhe in CDCh (Payne, 1999; this thesis).
Proton bA/ppm J/Hz Multiplicity Coupling
3 6.98 8.7 d,d J3,4
4 7.48 8.7,2.8 d,d J4, 3, J4, 6
6 7.96 3.0 d J6,4
8 4.72 7.0, 7.0, 5.2 td Jg, 9a, Jg, NH, Jg, 9b
9b 3.29 14.0,5.4 d,d J9b, a, J9b, s
9a 3.10 14.0, 5.4 d,d J9a, br J 9a, s
11/15 7.28 ill
12/14 7.28 ill
13 7.35 ill
NH 9.05 6.0 d IN s
J3C NMR: 13Cchemical shifts ofClSAPhe in CDCl} (Payne, 1999; this thesis).
Carbon be/ppm
1 120.3
2 160.3
3 114.7
4 134.7
5 123.7
6 125.2
7 168.7
8 52.9
9 37.3
10 135.1
11/15 129.4
12/14 129.1
13 127.8
16 168.7
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4.2.7 N-(5-bromo-7-hydroxyphenylcarbonyl)-L-phenylalanine, BrSAPhe (25).
Emperical formula:C 16H14BrN04
Structural formula:
14 16
13 C02H 0 OH
8N~) 39 I I I
H 6~ 4
5
Melting point: 178°C (Payne, 1999; this thesis)
UV: Amax (MeOH)/nm 210 (e/drrr' morlcm-I 68744) and 312 (s/dm ' morlcm-I 5616)
IR: Vmax (KBr) cm-I; 3360 (N-H), 1747 (C=O acid), 1636 (C=O amide) 1526 cm-I (CO-N
amide )(Payne, 1999).
EI-MS: m/z; 365 [M+(8IBr), 39%], 363 [M+C9Br), 39%], 226/228 (33%),215/217 (73%)
and 199/201 (100% )(Payne, 1999; this thesis).
JH NMR:(300 MHz) ofBrSAPhe in CDCh (Payne, 1999; this thesis).
Proton oH/ppm J/Hz Multiplicity Coupling
3 6.87 8.7 d,d J3,4
4 7.20 ill
6 7.20 ill
8 4.76 7.1, 7.2, 5.3 td J8, 9a, J8, NH, J8, 9b
9b 3.24 12.5, 6.4 d,d J9b, a, J9b, 8
9a 3.10 12.6,6.4 d,d J9., b, J 9a. 8
11/15 3.10
12/14 7.30 ill
13 7.35 ill
NH 9.03 6.0 d JN 8
J3C NMR: l3C chemical shifts of BrSAPhe in CDCb (Payne, 1999; this thesis).
Carbon oe/ppm
1 120.5
2 160.6
3 116.9
4 137.2
5 110.4
6 130.2
7 169.1
8 54.3
9 37.2
10 137.9
11/15 128.7
12/14 128.9
13 127.2
16 172.2
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4.2.8 5-Bromo-2-methoxy-4-methylisophthalic methyl ester (27)
Emperical formula: C12H13BrOs
Structural formula:
21
OCH30
II
C 20
10'OCH3
Br
EI-MS: m/z; 318 [M+(8IBr), 59%], 316 [M+C9Br), 54%], 288 (100%), 286 (100%).
'nNMR:(300 MHz) of27 in CDCb.
Proton bR/ppm Multiplicity
6 8.05 s
7 2.35 s
19 3.95 s
20 3.93 s
21 3.92 s
J3e NMR: l3C chemical shifts of27 in CDCh.
Carbon be/ppm
1 133.9
2 156.2
3 119.7
4 141.8
5 124.8
6 136.2
7 20.3
10 165.1
Il 167.5
19 51.9
20 51.9
21 63.5
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4.2.9 2-Methoxy-4-methyl-5-tributylisophthalic methyl ester (28) (Payne, 1999)
Emperical formula: C24H4005Sn
Structural formula:
21
OCH30
II
2 C 20
s-: 3 10"OCH3
14
7
CH3
Sn (CH2CH2CH2CH3)3
22 23 24 25
TH NMR: 13C chemical shifts (300 MHz) of28 in CDCi).
Proton 8H/ppm Multiplicity
6 8.95 S
7 2.20 S
19 3.95 S
20 3.95 S
21 3.87 S
22 l.l0 M
23 1.30 M
24 1.51 M
25 0.90 M
4.2.10 Sodium acetoacetaldehyde
Emperical formula:C4H502Na
Structural formula:
JH NMR:(60 MHz) of sodium acetoacetaldehyde in CDCi)
Proton 8H/ppma Multiplicity
1 8.75 S
2 5.13 D
3 2.12 S
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4.2.11 DL-2-Fluorophenylalanine methyl ester hydrochloride (39)
Emperical formula:ClOH13ClFN02
Structural formula:
EI-MS: m/z; M+ 198 (4%), 177 (5%), 138 (92%) and 88 (100 %)
IHNMR: (300 MHz) of39 in CDCh.
Proton eSH/ppma JIHz Multiplicity Coupling
3 7.12 12.0, 7.0, 3.0 td J3.4, J3,5 J3, F
4 7.28 - m "complex"
5 7.04 12.0, 11.7, 5.0 td J5,4, J5,6 J5, 3
6 7.44 11.5,7.5, d,d J6, 5, J6, 4
7a 3.36 12.0,6.0 d, d J7., 7b, J7., 8
7b 3.48 9.0, 15.0 d,d J7b,7., J7b, 8
8 4.24 6.0,9.0,9.0 td J8, 7. , J8, NH, ls,7b
10 3.70 - s -
NH 9.05 - broaden -
13C NMR: 13C chemical shifts of 39 in CDCh.
Carbon eSc/ppm" J/Hz Multiplicity
1 121.24 15.4 D
121.04
2 162.74 250.2 D
159.50
3 115.05 27.0 D
114.70
4 132.00 4.7 D
131.94
5 124.17 3.9 D
124.12
6 129.28 8.5 D
129.17
7 29.62 - S
8 30.26 - S
9 169.04 - S
10 52.28 - S
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4.2.12 DL-3-Fluorophenylalanine methyl ester hydrochloride (40)
Empericalformula: C1oHI3ClFN02
Structural formula:
F
7
EI-MS: m/z; M+ 198 (2%), 38 (84%) and 88 (100%)
IHNMR: (300 MHz) of 40 in CDCb.
Proton DH/ppma I/Hz Multiplicity Coupling
2 7.09 m "complex"
4 6.79 12.2, 7.0, 3.5 td J4, 5, '/'4,6, J6, F
5 7.29 m "complex"
6 7.09 m "complex"
7a 3.36 12.0,6.0 d,d J7a, 7b, J7a, 8
7b 3.48 9.0, 15.0 d,d J7b, 7a, J7b, 8
8 4.24 m
10 3.75
NH 9.04 broaden
13C NMR: Chemical shifts of 40 in CDCb,
Carbon Dc/ppm" I(C-F)/Hz Multiplicity
1 137.07 7.7 D
136.97
2 114.59 2l.6 D
114.31
3 164.41 251,7 D
16l.l5
4 116.81 22.4 D
116.52
5 130.43 9.3 D
130.31
6 125.47 3.1 D
125.43
7 30.89 S
8 35.80 S
9 169.20 S
10 52.81 S
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4.2.13 DL-4-Fluorophenylalanine methyl ester hydrochloride (41)
Empericalformula: CIOH1302NClF
Structural formula: FnJ3 9 IQ
4 -:/ 112 C02CH3
5 ~ 8
6 7 NH2·HCl
EI-MS: m/z; M+, 197 (3%), 138 (86%) and 88 (l00 %)
JH NMR: (300 MHz) of 41 in CDCb.
Proton oH/ppma J/Hz Multiplicity Coupling
2,6 7.05 m "Complex"
3,5 7.33 m "Complex"
7a 3.29 12.1,6.0 d,d Jt« 7b, -li« 8
7b 3.41 8.7,15.0 d,d J7b, 70' )7b, 8
8 4.18 m
10 3.76 s
NH 9.27 broaden
J3C NMR: Chemical shifts of 41 in CDCb,
Carbon odPl!_m" J(C-F)/Hz Multiplicity
1 130.40 3.l D
130.36
2, 6 131.43 8.5 D
131.32
3,5 115.63 22.4 D
115.34
4 163.69 251.7 D
160.43
7 35.25 S
8 53.931 S
9 169.26 S
lO 52.678 S
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4.2.14 ortho-fluorophenylalanine Oa (44)
Emperical formula:C20H 17CIFN06
Structural formula:
20
C02H 0 OH 0
2
12 N "19 13 I
H 3 CH310
Cl
EI-MS: m/z ,437 [M+e7CI), 2%], 435 [M+esCI), 6%],378 (5%), 376 (16%), 241 (35%)
239 (100%).
IR: Ymax (Nujol) cm-I; 3392 (N-H), 1739 (C=O acid), 1671 (C=O amide) 1530 cm-I (CO-
N amide).
'ttNMR: (300 MHz) of44 in CDCi}.
Proton 8H/ppma JIHz Multiplicity Coupling
3 4.76 m "complex"
4a 2.84 17.4,3.8 d,d 14a,4b, 14a,3
4b 3.28 17.4, 3.8 d,d 14b, 4., 14b,3
7 8.38 s
10 l.59 6.0 d 110,3
12 5.01 m "complex"
13a 3.43, 13.8,4.8 d,d 113a,13b,113a,12
13b 3.21 13.8,6.8 d,d 113b,13" 113b, 12
16 7.04 m
17 7.20 m
18 6.98 m
19 7.26 m
N-H 8.56 broaden
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J3C NMR: I3C chemical shifts of 44 in CDCh.
Carbon bc/ppm" J(C-F)fHz
1 110.05
2 169.99
3 75.85
4 30.90
5 140.67
6 120.56
7 138.73
8 120.73
9 158.00
10 20.65
Il 162.38
12 32.22
13 31.06
14 128.72, 128.67 3.9
15 160.20,162.57 184.0
16 131.72
17 124.06
18 131.72
19 124.02
20 172.70
4.2.15 meta-fluorophenylalanine Oa (43)
Emperical formula: C20H17CIFN06
Structural formula:
F
20
C02H 0
12
19 13
OH 0
N
I
H
Cl
EI-MS: m/z; 437 [M+e7CI), 2%], 435 [M+esCI), 6%],378 (5%), 376 (16%), 241 (35%)
239 (100%).
143
Stellenbosch University http://scholar.sun.ac.za
EXPERIMENT AL
IHNMR: (300 MHz) of 43 in CDCh.
Proton bH/Ppma I/Hz Multiplicity Coupling
3 4.74 - m "complex"
4a 2.91 17.4, 12.0 d,d 14a,4b,14.,3
4b 3.11 8.4,4.0 d,d 14b,4a, 14b,3
7 8.31 s
10 1.47 6.0 d 110,3
12 4.84 m "complex"
Ba 3.10 13.8,4.8 d,d 113a,13b,113a,12
Bb 3.21 13.5,8.4,10.2 d,d Jl3b,13a, Jl3b, 12
15 7.07 m
17 7.04 m
18 7.32 m
19 7.10 m
N-H 8.56 broaden
J3e NMR: 13C chemical shifts of 43 in CDCh
Carbon be/ppm' l(C-F)/Hz
1 111.36
2 168.00
3 75.26
4 31.56
5 139.95
6 120.11
7 141.62
8 115.85
9 158.50
10 19.99
11 162.81
12 53.60
13 36.09
14 121.00
15 135.80
16 162.70,161.09 124.1
17 135.80
18 130.02
19 125.28
20 172.06
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4.2.16 para-fluorophenylalanine Ou (42)
Emperical formula: C20H17ClFN06
Structural formula:
F 20
C02H 0 OH 0
14
12 N II19 13 I
H
Cl
EI-MS: m/z; 437 [M+e7Cl), 2%], 435 [M+esCl), 6%], 378 (5%), 376 (16%), 241 (35%)
239 (100%).
IH NMR: (300 MHz) of42 in CDCb.
Proton Dn/ppma JIHz Multiplicity Coupling
3 4.74 - m "complex"
4a 2.94 17.4,12.0 d, d l4a,4b, l4a,3
4b 3.10 8.4,4.0 d,d l4b, 4a, l4b,3
7 8.10 s
10 1.47 6.0 d llO,3
12 4.88 m "complex"
13a 3.12 13.8,4.8 d,d l13a,13b, l13a,12
13b 3.23 13.5,8.4, 10.2 d,d l13b,13a, ll3b, 12
15,19 7.23 m
16,18 7.14 m
/3CNMR: l3C chemical shifts of 43 in CDCl]
Carbon Dc/ppma J(C-F)1Hz
1 111.72
2 168.55
3 75.55
4 31.65
5 136.28
6 121.61
7 142.13
8 120.41
9 158.87
10 20.03
Il 163.31
12 54.00
13 35.68
14 133.52
15 115.41,115.13 21.6
16 131.33,131.44 8.5
17 159.96,163.18 248.6
18 131.33,131.44 8.5
19 115.40,115.13 20.9
20 172.70
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4.2.17 Histidylhistidine methyl ester (48).
Emperical formula: C l3H 13N603
Structural formula:
2
9
8 NH
N ~7 0
)LN,
H
6
ES-MS: m/z; M+, 306 (72%), 291 (20%), 135 (100%).
IH NMR: (300 MHz) of 48 in CDCb
Proton bH/ppma Multiplicity
2 4.56-4.59 ill
3 3.03-3.07 ill
5 8.15 s
7 7.14 s
9 9.23 s
10 4.15 ill
11 3.12-3.17 ill
13 8.51 s
15 7.28 s
17(3H) 3.64 s
/3CNMR: 13Cchemical shifts of 43 in CDCb
Carbon be/ppm"
2 52.10
3 26.41
4 130.06
5 134.08
7 116.08
8 167.89
10 52.19
11 27.62
12 130.46
13 134.69
15 118.07
16 170.40
17 51.68
/H
12 N 14
N-J
13
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4.2.18 2-acetoxy-S-chlorobenzoic acid
Emperical formula:C9H7CI04
Structural formula:
8 9ococn,
4
el
Melting point: 130°C (Steyn, 1967)
UV: Amax(MeOH)/nm 222 (s/dm ' morlcm-I 9400) and 288 (e/dm ' mor'cm-I 1350)
(Steyn, 1967).
IR: CO (1767, 1741 and 1704 cm-I) (Steyn, 1967).
EI-MS: m/z; 216 [M+C7CI), 2%], 214 [M+C5CI), 6%], 174 (80%), 172 (26%), 154
(100%) and 156 (36%).
JH NMR: (300 MHz) of48 in CDCb
Proton OH/ppm" JlHz Multiplicity Coupling
3 7.31 8.7 d H3-4'
4 7.76 8.7,2.7 d,d H4-3, H4-6
6 7.94 2.7 d H6-4
9 2.27 - - -
J3C NMR: J3C chemical shifts of 43 in CDCb
Carbon oc/ppm"
1 130.48
2 169.50
3 126.24
4 133.79
5 149.28
6 13l.02
7 164.89
8 156.12
9 20.75
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4.2.19 tert-ButyldimethylsilyI2-tert-butyldimethylsilyloxy-5-chlorobenzoate (51)
Emperical formula.C 19H3303NCISi2
Structural formula:
Cl
EI-MS: m/z; 345 [M+e7CI), 1%],343 [M+esCI), 3%],231 (39%) and 229 (100%).
TH NMR: (300 MHz) of 51 in CDCl)
Proton bH/ppma J/Hz Multiplicity Coupling
3 6.80 8.4 d J3,4
4 7.27 9.0,3.0 d,d J4, 3, J4, 6
6 7.65 3.0 d J6,4
8-9 0.34
10-12 0.98
13/14 0.18
15-17 0.98
T3C NMR: Chemical shifts of 43 in CDCl)
Carbon be/ppma
1 125.36
2 164.03
3 122.93
4 132.63
5 125.50
6 l31.10
7 154.50
8-9 -4.70
10-12 25.75
13/14 -4.01
15-17 25.75
18/19 25.71
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4.3 Experimental Procedures
4.3.1 Selective electrophilic aromatic fluorination:
4.3.1.1 Using 1-(Chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane
bis(tetrafluoroborate), Selectfluor™ (6).
4.3.1.1.1 Fluorination of methoxybenzene.
A magnetically stirred degassed solution of Selectfluor™ (6) (556 mg, 1.57 mmol) and
methoxybenzene (115 mg, 1.06 mmol) in dry acetonitrile (lO ml) was heated at 90°C for
15 h under an argon atmosphere. The reaction was monitored by TLC (hexane:ethyl
acetate 10:1) and after the completion of the reaction the mixture was cooled to room
temperature. The clear solution was diluted with dry diethyl ether (30 ml) and a white
precipitate was isolated by filtration to yield a white solid, 1-(chloromethyl)-1 ,4-
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate), 458 mg (1.36 mmoi). The solvent of
the filtrate was removed under reduced pressure, which afforded an unidentified dark
coloured oil, 98 mg. The oil was not identified, but lH_,13C_NMR and ES-MS results
suggest that no fluorination had taken place and revealed the presence of predominantly
an o-substituted dimer.
4.3.1.1.2 Attempts to fluorinate other compounds using Selectjluor™ (6).
This method was further employed on salicylic acid (17) (223 mg, 1.61 mmoi), SAPhe ()
(65 mg, 0.240 mmoi), OB (11)(2 mg, 5.4 umol) and OB methyl ester (l8 mg, 47 urnol).
The reactions was conducted at elevated temperatures (70-90°C) and the reaction period
prolonged (20 d) during which the reaction was monitored by HPLC (see section 4.1.)
using a UV detector (328 nm). In the case of salicylic acid (6) as substrate small amounts
of fluorosalicylic acid was identified by HPLC and UV-detection (332 nm). The
predominant product of the reaction was unreacted salicylic acid (17). Similarly in the
cases of SAPhe (22), OB (11) and OB methyl ester as substrates the unreacted products
were quantitatively recovered and identified by lH-NMR and ES-MS (in the case of OB
methyl ester).
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4.3.1.2 Using N-Fluorobenzenesulfonimide (8)
4.3.1.2.1 Fluorination of salicylic acid (17)
Salicylic acid (17) (148 mg, 1.07 mmol) was dissolved in dry THF (10 ml), cooled in an
ice bath to O°C and treated with N-fluorobenzenesulfonimide (8) (111 mg, 0.352 mmol),
The reaction was stirred under an argon atmosphere and the reaction temperature was
kept between 0 and 8°C. The reaction was monitored by TLC (toluene:acetic acid 5:1).
After 12 h a further aliquote of sulfonimide (111 mg, 0.352 mmol) was added and the
temperature was gradually increased to 70°C and stirred for another 12 h. Monitoring
indicated that no reaction had occurred. The reaction mixture was allowed to cool, the
solvent removed in vacuo and the residue suspended in chloroform (5 ml). The solution
was acidified with 1M HCI (1 ml) and the aqueous phase extracted three times with
chloroform (3x 5 ml) after separation. The combined extracts were dried over anhydrous
Na2S04, filtered and concentrated in vacuo to yield a white residue, 115 mg, identified as
unreacted salicylic acid by 'H- and '3C-NMR.
4.2.1.2.2 Attempts to fluorinate other compounds using N-Fluorobenzenesulfonimide
(8).
This method was further employed on SAPhe (22) (67 mg, 0.247 mmol) and OB (11) (2
mg, 5.4 umol). The reactions were followed by HPLC using a UV-detector (258-332 nm)
over an extended period (20 d) (see section 4.1.). In both cases the unreacted product
were recovered quantitatively and identified by 'H-NMR.
4.3.1.3 Using Xenon difluoride.
4.3.1.3.1 Fluorination of salicylic acid (17).
To a degassed solution of salicylic acid (17) (82 mg, 0.594 mmol) in dry dichloromethane
(3 ml) was added xenon difluoride (101 mg, 0.597 mmol) in a glass vessel. The reaction
mixture was stirred under an argon atmosphere and the reaction temperature maintained
between -60 and O°e. The reaction was monitored by TLC (toluene:acetic acid 5:1) and
after 18 h indicated that no reaction was occurring.
The mixture was subsequently diluted with dichloromethane (10 ml) and washed with a
1M NaHC03 solution. The aqueous phase was acidified with 1M HCI (2 ml) and the
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extracted with chloroform (3x10 ml). The combined organic extracts were dried over
anhydrous Na2S04, filtered and the solvent evaporated under reduced pressure to yield an
unidentified black coloured oil. IH_ and 13C_NMR analysis of the recovered product
indicated a large proportion of substrate decomposition and small amounts of the
unreacted product, salicylic acid (17).
4.3.1.3.2 Attempts to fluorinate other compounds using xenon difluoride.
This method was further employed on SAPhe (22) (59 mg, 0.218 mmol) and OB (11)
(2mg, 5.4 umol). In the case of OB (11) (20 mg, 54 umol) the reaction were conducted in
a,a,a- trifluorotoluene (5 ml) as solvent. The reactions were monitored by HPLC using
a UV detector (332 nm) over an extended period of time (21 d) (see section 4.1.). The
recovered products were identified by IH_, 13C_NMR and ES-MS analysis as the
unreacted substrates SAPhe (22) and OB (11) in each case.
4.3.2 Fluorodehalogenation of aryl halides, via a palladium catalysed
metal substitution, followed by xenon difluoride fluorosubstitution.
4.3.2.1 Dehalogenation of OA (10) (Bredenkamp et al., 1989)
Ochratoxin A (250 mg, 0.619 mmol) was added to a suspension of 10% Pd/C (158 mg)
and ammonium formate (230 mg, 3.75 mmol) in AR methanol (10 ml). The reaction
mixture was stirred at room temperature in a closed vessel. The reaction was monitored
by TLC (toluene:acetic acid, 5: 1). Upon completion of the reaction (overnight) the
mixture was filtered, and the solvent evaporated under reduced pressure.
The residue was dissolved in ethyl acetate (10 ml) and treated with 1M HCI (10 ml). The
aqueous phase was extracted three times with ethyl acetate (3x10 ml) and the combined
organic extracts evaporated under reduced pressure. The residue was recrystallised from
methanol to yield OB (11) in quantitative yield, 228 mg (0.618mmol) (Characterised by
IH_, 13C_NMR and EI-MS see section 4.2.2).
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4.3.2.2 Dehalogenation of CSAPhe (23)
CSAPhe (23) (200 mg, 0.625 mmol) was added to a suspension of 10% Pd/C (189 mg)
and ammonium formate (270 mg, 3.98 mmol) in AR methanol (10 ml). The reaction
mixture was stirred at room temperature in a closed vessel. The reaction was monitored
by TLC (toluene:acetic acid, 5:1). Upon completion of the reaction (overnight) the
mixture was filtered, and the solvent evaporated under reduced pressure.
The residue was dissolved in ethyl acetate (10 ml) and treated with 1M HCI (10 ml). The
aqueous phase was extracted three times with ethyl acetate (3x 10 ml) and the combined
organic extracts evaporated under reduced pressure. The resultant oil was purified by
column chromatography (silica! toluene:acetic acid - 7:1) to yield a colourless oil,
SAPhe (17), 149 mg (0.525 mmol, 84%)(Characterised by IH_, 13C_NMR and EI-MS see
section 4.2.5).
4.3.2.3 Synthesis ofBrOB
4.3.2.3.1 Preparation of Pyridinium hydrobromide perbromide.
The experimental procedures reported by Fieser and Fieser, 1967, were employed. A
mixture of pyridine (15 ml, 0.18 mol) and 48% hydrobromic acid (30 ml, 170.0 mmol)
was cooled on ice and treated with bromine (27.00 g, 0.169 mmol) whilst the reaction
mixture was stirred. Upon completion of the addition of bromine the reaction mixture
was filtered and the crystalline material washed with acetic acid:water (1: 1). The product
was recrystallised from the fresh acetic acid:water (1: 1) solution to yield an orange
coloured crystalline product, pyridinium hydro bromide perbromide, 31.00 g (94.20
mmol,55%).
4.3.2.3.2 Bromination ofOB (11) (Steyn and Payne, 1999)
A mixture of ochratoxin B (Il) (200 mg, 0.544 mmol) in glacial acetic acid (20 ml) was
treated with pyridinium hydrobromide perbromide (261 mg, 0.816 mmol) and stirred at
50°C. The reaction was monitored by TLC (toluene:acetic acid, 5:1) and the reaction was
complete in 6 h. The reaction mixture was poured into water (20 ml) and extracted three
times with chloroform (3x20 ml). The combined organic extracts were washed twice with
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water to remove the excess acetic acid, dried over anhydrous Na2S04, filtered and the
filtrate concentrated under reduced pressure to yield, Br-OB (13), 220 mg (0.49 mmol,
88%). Rf values for OB and BrOB were 0.48 and 0.85, respectively.(Characterised by
IH_, 13C_NMR and ES-MS see section 4.2.3).
4.3.2.4 Attempted catalytic stannylation of aryl halides, followed by XeF 2
fluorosubstitution.
4.3.2.4.1 Catalytic Stannylation of 5-bromo-2-methoxy- 4-methylisophthalic methyl
ester (27) using hexabutylditin in the presence of tetrakisïtriphenylphosphine)
palladium (0).
AIO ml round bottom flask equipped with a reflux condenser and a magnetic stirring bar
was charged with 5-bromo-2-methoxy-4-methylisopthtalic methyl ester (27) (100 mg,
289 umol), tetrakis(triphenylphosphine)palladium(O) (43 mg, 37.0 umol) and xylene (3
ml). Hexabutylditin (830 mg, 1.44 mmol) was introduced. The reaction was protected
from light and heated under argon at 115°C. The reaction was monitored by TLC
(petroleum ether (60-80°C): ethyl acetate - 10:1) and the reaction was complete after 19
h. The reaction mixture was cooled to room temperature and filtered. The filter cake was
washed with xylene (9 ml in three portions) and benzene (2 ml). The solvent of the
filtrate was evaporated under reduced pressure and purified by column chromatography
(silica gel, petroleum ether (60-80°C): ethyl acetate, 10:1) to yield a colourless oil, 2-
methoxy-4-methyl 5-tributylstannylisophthalic methyl ester (28),82 mg (155 umol, 53%)
(Characterised by IH-NMR see section 4.2.8).
4.3.2.4.2 Attempts to catalytically metallate other aryl halides.
The reaction was further employed on BrSAPhe (20) (100 mg, 0.275 mmol), CSAPhe
(18) (100 mg, 0.313 mmol) and BrOB (13) (78 mg, 0.174 mmol). In the case of the latter,
both hexabutyl- and hexamethyl distannane was used as nucleophilic agent. IH_, 13C_
NMR and ES-MS data of the recovered products, in the case of CSAPhe (18) as
substrate, revealed that no reaction occurred. Multiple products were observed by
analysis of the 'n., 13C_NMR and ES-MS data of the recovered products in the case of
BrSAPhe as substrate. This included predominantly unreacted BrSAPhe (25), SAPhe (22)
and small amounts of an unidentified biaryl compound. The tributylstannylation of OB
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was unsuccessful and the recovered products were identified by IH_, 13C-NMR and ES-
MS as predominantly Br-OB (13), OB (11) and trace amounts of an unidentified
stannylated product. Where hexamethylditin was used as nucleophilic agent, unreacted
Br-OB (13), OB (11) and trace amounts of an unidentified stannylated compound were
identified by IH_, 13C_NMR and ES-MS.
4.3.2.4.3 Attempted fluorodestannylation of 2-methoxy-4-methyl-5-tributylstannyl-
isopthalic methyl ester (28) by XeF2
To a degassed solution of the diester (28) (52 mg, 99 umol) in dry carbon tetrachloride (5
ml) was added xenon difluoride (31 mg, 183 umol) in a glass vessel. The reaction
mixture was stirred at room temperature under an argon atmosphere and monitored by
TLC (petroleum ether (60-80°C):ethyl acetate, 10:1). After the completion of the reaction,
the yellow solution was diluted with carbon tetrachloride (lO ml) and washed with a 1M
NaHC03 solution. The aqueous phase was acidified and extracted with chloroform (3xl0
ml). The combined organic extracts were dried over Na2S04, filtered and the solvent
evaporated under reduced pressure. The residue was purified by column chromatography
(silica gel, petroleum ether: ethyl acetate, 10: 1) to yield predominantly the reduced
product (30),23 mg (63%iH-, 13C_NMR discussed in section 3.3.2).
4.3.2.5 Attempted catalytic silylation of aryl halides
4.3.2.5.1 Catalytic silylation of 5-bromosalicylic acid (20) catalysed by tetrakis
(triphenylphosphineïpalladiumïtl)
A 50 ml round bottom flask equipped with a reflux condenser and a magnetic stirring bar
was charged with 5-bromosalicylic acid (20) (300 mg, 1.38 mmol) and
tetrakis(triphenylphosphine)palladium(O) (19 mg, 16.8 umol). The reaction flask was
purged with argon and degassed xylene (7 ml) and hexamethyldisilane (853 mg, 5.83
mmol) was added via an airtight syringe. The resulting yellow mixture was stirred at
140°C for 48 h in which time the reaction was monitored by TLC (toluene:acetic acid
5: 1). After 24 h a black precipitate, decomplexed palladium catalyst, had formed and
another aliquot of the catalyst was added (12 mg, 10.4!lmol) and the reaction stirred for a
further 24 h at 140°C. The reaction mixture was cooled, petroleum ether (30-60°C) (30
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ml) was added, and the suspension filtered. The filtrate was evaporated under reduced
pressure to yield a dark red oil which was purified by column chromatography (silica gel/
toluene:acetic acid, 7:1). The major products isolated were a) 5-bromosalicylic acid (20),
175 mg (58% unreacted) and b) salicylic acid (17) (45 mg, 23% reduced) as characterized
by IH_, 13C_NMR and ES-MS.
4.3.2.5.2. Catalytic silylation of bromo-ochratoxin Busing hexamethyldisilane in the
presence of tris-t,dibenzylideneacetone)dipalladium (0).
A 50 ml round bottom flask equipped with a reflux condenser and a magnetic stirring bar
was charged with tris( dibenzylideneacetone )dipalladium(O) (2 mg, 2.20 umol), diphenyl-
2'-pyridylphospine (25.09 mg, 9.53 umol), bromo-OB (13) (47 mg, 105 umol) and
K2C03 (70 mg, 509 umol), The reaction vessel was purged with argon and degassed
DMPU (5 ml) was added via syringe. The resulting orange slurry was stirred for 10 min
at room temperature. Subsequently, water (4 mg, 214 umol) and hexamethyldisilane (18
mg, 118 umol) were added via syringe and the reaction mixture was stirred at 100°C for
22 h. After this time a palladium mirror had formed indicating completion of the reaction.
To the reaction mixture was added NH40H (to pH of 11) and extracted three times with
diethyl ether (10 ml). The alkaline aqueous phase was acidified with 1M HCI (to pH 3)
and extracted three times with chloroform (3x lOmI). The organic layer was dried over
Na2S04, filtered and evaporated under reduced pressure. The residue was purified by
column chromatography, (silica gel/ toluene:acetic acid, 12:1) to yield, unreacted bromo-
OB (13) 12 mg (26.7 umol, 25%) and OB 9 mg (24.4, 23%)(Characterised by IH_, 13C_
NMR and EI-, ES-MS see section 4.2.3 and 4.2.2, respectively).
4.3.3 Direct catalytic fluorosubstitution of aryl bromides.
4.3.3.1. Attempts to fluorinate N-(S-bromo-2-hydroxyphenylcarbonyl)-L-
phenylalanine (2S)(S-BrSAPhe) using tetrabutylammonium fluoride in the presence
of tetrakis(triphenylphosphine)palladium(O).
A 50 ml round bottom flask equipped with a reflux condenser and a magnetic stirring bar
was charged with 5-BrSAPhe (100 mg, 275 umol), 1M tetrabutylammonium fluoride
(TBAF) in THF (0.7 ml) and toluene (10 ml). The reaction vessel was purged with argon
155
Stellenbosch University http://scholar.sun.ac.za
EXPERIMENTAL
and the THF removed in vacuo. Tetrakis(triphenylphospine)palladium(O) (4 mg, 3.6
umol) was added to the degassed solution and the mixture heated under reflux in an
argon atmosphere. The reaction was monitored with TLC (toluene: acetic acid - 5: 1) and
after 21 h the reaction mixture was allowed to cool to room temperature, filtered and the
solvent of the filtrate evaporated under reduced pressure. The residue was suspended in
chloroform (10 ml) and shaken up with 1M HCI (10 ml). The aqueous phase was
extracted three times with chloroform (3x5 ml). The combined chloroform extracts were
evaporated under reduced pressure to afford predominantly unreacted BrSAPhe (25)
(Characterised by IH_, 13C_NMR and ES-MS see section 4.2.7).
4.3.3.2 Attempts to fluorinate other compounds.
The reaction was further employed to 3-bromoanisole (31) (1.00 g, 5.34 mmol) using
TBAF (1M in THF) (0.4 ml, 0.4 mmol) as well as 5-bromo-2-methoxy-4-
methylisophthalic methyl ester (27) (100 mg, 0.315 mmol) using cesium fluoride (205
mg, 0.350 mmol). In the case of 31 as substrate, ES-MS analysis of the crude reaction
mixture indicated that no reaction had taken place. In the case of 27, ES-MS analysis of
the crude reaction product indicated predominantly unreacted substrate, 27 and small
amounts of the debrominated product, 30.
4.3.4 Attempted synthesis of 2-fluoroacetoacetaldehyde.
4.3.4.1 Synthesis of sodium acetoacetaldehyde
To a slurry of freshly prepared sodium ethoxide (27.00 g, 500 mmol) in dry diethyl ether
(226.8 g) under nitrogen was added drop-wise a solution of acetone (29.05 g, 500 mmol)
and ethyl formate (37.05 g, 500 mmol). The reaction was stirred during the 30-minute
addition period under nitrogen, and the internal reaction temperature was maintained at
25-30°C in an ice bath. After the addition was complete, the stirring was continued for 15
minutes, and the resulting tan solid was collected by filtration, washed with ether, and
then dried under an argon to prevent water absorption. After further drying under reduced
pressure a pale tan powder, sodium acetoacetaldehyde was isolated, 38.0 g (0.33 mol,
64%). The purity (from sodium formate) was established by rapid IH-NMR (60 MHz)
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analysis of the product. The mole fraction of the sodium acetoacetaldehyde to sodium
formate was determined by the ratio of the single proton absorbance at bH 8.33 and 8.75
(Characterised by IH-NMR see section 4.2.10).
4.3.4.2 Fluorination of sodium acetoacetaldehyde
Selectfluor™ (324 mg, 926 umol) was added to a solution of sodium acetoacetaldehyde
(100 mg, 926 umol) in dry acetonitrile (10 ml) and stirred for 72 h at ambient
temperature. The solvent was removed under reduced pressure, the residue acidified with
a 1M HCI solution (10 ml) and extracted with dichloromethane (15 ml). The organic
extracts were dried over anhydrous Na2S04, filtered and the solvent removed under
reduced pressure to yield a white coloured solid. IH-NMR of the product suggested that
decomposition had occurred.
4.3.5 Peptide synthesis
4.3.5.1 Synthesis of ortho-, meta- and para-substituted DL-fluorophenylalanine Oa
(44,43 and 42, respectively).
4.3.5.1.1 Acid hydrolysis ofOA (lO)
OA (250 mg, 0.62 mmol) was heated with 6M HCI (100 ml) and refluxed for 72 h. The
hydrolysed Oa (34) crystallized from the acidic solution at room temperature over 12 h
without purification. The crystals of Oa were isolated by filtration and were washed
repeatedly with distilled water to remove L-Phe. Pure Ou crystals were obtained
following recrystalisation from a mixture of methanol and water (1:1). Residual Oa from
the acid-water fraction was separated from L-Phe by partitioning into chloroform (250
ml). The chloroform extract was concentrated under reduced pressure. The residue (50
mg) was reconstituted from a mixture of methanol and diethyl ether (3: 1). The total yield
ofOa (34) from OA (10) was 95 mg, (0.37 mmol, 60%) (Characterised by IH_, 13C_NMR
and EI-MS see section 4.2.4).
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4.3.5.1.2 Synthesis of the acyl chloride ofOa(Oa-Cl)(35)
A 50 ml round bottom flask equipped with a reflux condenser and a magnetic stirring bar
were charged with O« (50 mg, 0.195 mmol) and freshly distilled thionyl chloride (10 ml,
137 mmol ) and heated under reflux in an argon atmosphere for 3 hours. The solution was
allowed to cool to room temperature, and the excess thionyl chloride evaporated under a
dry stream of argon. The acyl chloride (35) was further dried under vacuum pressure at
room temperature for 12 h to remove any residual S02 or HCl. The product (35) was
protected from any moisture and stored under argon. The presence of the product was
established by treatment with ethyl alcohol and monitoring the ethyl ester of Oe, the
product of the reaction, by TLC (neutral CHCh).
4.3.5.1.3 Preparation ofDL-2-fluorophenylalanine methyl ester (39).
DL-2-fluorophenylalanine (36) (250 mg, 1.36 mmol) was added to a cold solution (-10°C)
of AR methanol (3 ml) and thionyl chloride (400 ul, 5.52 mmol) and heated under reflux
for 2 h. The reaction mixture was allowed to cool and the solvent evaporated under
reduced pressure. The white precipitate was filtered off and recrystallised from a mixture
of methanol and ether (1:1) and afforded, DL-2-fluoro-phenylalanine methyl ester
hydrochloride 302 mg (1.29 mmol, 95%). (Characterised by IH_, 13C_NMR and EI-MS
see section 4.2.11).
The methyl ester hydrochloride salt (200 mg, 0.855 mmol) was dissolved in ether (5 ml)
and cooled on ice. 0.5M Potassium carbonate (2.5 ml) was added to the solution and
stirred for 1 h. The organic layer was separated and dried over anhydrous Na2S04,
filtered and the solvent removed from the filtrate under reduced pressure to yield 157 mg
of a colourless oil, DL-2-fluoro-phenylalanine methyl ester (39) (0.79 mmol, 92%).
4.3.5.1.4 Preparation of DL-3- and -d-phenylalanine methyl esters (40,41 respectively).
The isomeric fluorophenylalanine methyl esters were prepared using the identical
procedures used in section 4.6.1.3 yielding 280 mg (1.20 mmol, 88%) of 3-fluoro- and
300 mg (1.28 mmol, 94%) of 4-fluoro-phenylalanine methyl ester hydrochloride
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Both hydrochloride salts were converted, as described in section 4.6.1.3, to the respective
methyl esters (both colourless oils) to yield 141 mg ofDL-3-fluoro-phenylalanine methyl
ester (40) (0.71 mmol, 83%) and 148 mg of 4-fluoro-phenylalanine methyl ester (41)
(0.74 mmol, 87 %) (Characterised by IH_, 13C_NMRand EI-MS see section 4.2.12 and
4.2.13).
4.3.5.1.5 Coupling ofOa (34) to DL-2-fluorophenylalanine methyl ester (39).
The Oa-CI (35) (50 mg, 18 umol) was dissolved in dry pyridine (3.5 ml) and cooled on
ice. A solution of DL-2-flurophenylalanine methyl ester (39) (46 mg, 230 umol) and
triethylamine (23 mg, 230 umol) in ethyl acetate (3.5 ml) was added drop-wise to the
cold acyl chloride solution. The reaction was stirred for 7 h at room temperature, and
thereafter washed with O.lM HCI, O.lM Na2C03 and water, respectively. The organic
layer was dried over anhydrous Na2S04, filtered and the solvent of the filtrate evaporated
under reduced pressure. The dried residue was treated with 0.5M NaOH at room
temperature for 12 h. The mixture was then acidified with 6M HCI to pH < 1.0 and
allowed to stand for 12 h at room temperature followed by extraction with chloroform
(3x5 ml). The combined extracts were dried over anhydrous Na2S04, filtered and the
solvent of the filtrate removed under reduced pressure to yield, 68 mg (0.16 mmol, 88%)
ortho-fluorophenylalanine Oe (44) (Characterised by IH_, 13C-NMR and EI-MS see
section 4.2.14).
4.3.5.1.6 Coupling of Oa (34) to DL-3- and -4- fluorophenylalanine methyl ester (40,
41 respectively).
The coupling of these isomeric fluorophenylalanine methyl esters was done using an
identical procedure as in 4.6.1.5 yielding 45 mg meta-(O.ll mmol, 61%) and 62 mgpara-
(0.15 mmol, 83%) fluorophenylalanine Oe (43, 42 respectively) (Characterised by IH_,
13C_NMRand EI-MS see section 4.2.15 and 4.2.16) ..
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4.3.5.2 Attempted synthesis of histidylhistidine Oa (49)
4.3.5.2.1 Synthesis of histidylhistidine methyl ester (48)
L-Histidine methyl ester dihydrochloride (0.284 mg, 1.175 mmol) and triethylamine
(237 mg, 2.35 mmo!) was dissolved in freshly distilled N,N-dimethylformamide (15 ml),
and treated with a solution of Na-(tert-butoxycarbonyl)-L-histidine (300 mg, 1.175
mmol) in dimethylformamide (15 ml). Diisopropylcarbodiimide (177 mg, 1.41 mmol)
and 1-hydroxybenzotriazole hydrate (190 mg, 1.41 mmol) was added to the above
solution and stirred at room temperature in a closed vessel for 15 h.
After the completion of the reaction the solvent was concentrated in vacuo and the white
precipitate, diisopropylurea (57), separated by filtration. The rest of the solvent was
removed from the filtrate under reduced pressure and the residue purified by column
chromatography (silica gel! ethylacetate:ethanol - 3:1). The fractions containing the
product were combined and the solvent evaporated under reduced pressure. The residue
was treated with 95% trifluoroacetic acid for 1 h and concentrated under high vacuum.
The residue was recrystalised from methanol:ether (excess ether) to yield a white solid,
histidylhistidine methyl ester (48), 284 mg (930 umol, 79%)(Characterised by IH_, I3C_
NMR and ES-MS see section 4.2.17).
4.3.5.2.2 Attempted coupling ofOa-CI (35) to histidylhistidine methyl ester (48)
The procedure as described in 4.6.1.5 was employed for the attempted coupling of the
Oe-Cl (35) to the histidylhistidine methyl ester (48). The reaction was monitored by TLC
(toluene:acetic acid, 5:1) and after 7 h indicated that a reaction had occurred. IH_, I3C_
NMR and EI-MS data from the resultant product indicated that no coupling took place.
4.3.5.3 Synthesis of model peptides.
4.3.5.3.1 Peptide coupling of I-Phe to salicylic acid (17)
A round bottom flask (100 ml) equipped with a reflux condenser and a magnetic stirring
bar was charged with salicylic acid (17) (1 g, 7.25 mmol) and freshly distilled thionyl
chloride (10 ml, 137 mmol) and heated under reflux in an argon atmosphere for 3 hours.
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The solution was allowed to cool to room temperature, and the thionyl chloride
evaporated under a stream of dry argon.
The colourless oil residue, salicyl chloride, was dissolved in ethyl acetate (10ml) and
cooled on ice. A cold solution of sodium azide (1.4 g, 23.1 mmol) in water (10ml) was
added drop-wise to the salicyl chloride solution and stirred for 25 min on ice. The ethyl
acetate was separated from the aqueous phase and extracted three times with ethyl acetate
(3x lOmi). The combined extracts were dried over anhydrous Na2S04, filtered and
evaporated under reduced pressure, which yielded a white solid, salicyl azide 745 mg
(4.572 mmol, 63%). The presence of the azide was established by the increased in Rf
value when separated by TLC (toluene:acetic acid - 5:1). The azide appears as a dark
spot compared to the blue absorbance of salicylic acid when viewed under UV -light.
The salicyl azide (745 mg, 4.572 mmol) was redissolved in ethyl acetate (10ml) and
treated with a solution of L-Phenylalanine (1.131 g, 6.858 mmol) and triethylamine
(0.692 g, 6.858 mmol) in water (10 ml). The reaction was stirred at room temperature for
56 h, inwhich time the reaction was monitored by TLC (toluene: acetic acid - 5:1). After
completion of the reaction, the organic layer was separated, 1M Na2C03 (10 ml) was
added to the aqueous phase which in tum was extracted three times (3 x10 ml) with ethyl
acetate.
The aqueous phase was acidified with 1M HCI to pH 2 and extracted three times (3 xl 0
ml) with chloroform. The combined organic extracts were dried over anhydrous Na2S04,
filtered and the filtrate evaporated under reduced pressure. The residue was purified by
column chromatography (silica gel, toluene:acetic acid, 5:1) to yield a colourless oil,
SAPhe, 791mg (2.785 mmol, 38%) (Characterised by IH_, 13C_NMR and ES-MS see
section 4.2.5).
161
Stellenbosch University http://scholar.sun.ac.za
EXPERIMENTAL
4.3.5.3.2 Peptide coupling of L-Phe to 5-chlorosalicylic acid (18) and 5-bromosalicylic
acid (20)
The method used in 4.6.3.1 was further applied in the preparation of CISAPhe (23) and
BrSAPhe (25). These products were purified by crystallization from chloroform in a total
yield of 49% and 38%, respectively (Characterised by IH_, 13C_NMR and ES-MS see
section 4.2.6 and 4.2.7).
4.3.5.4 Phenolic hydroxyl derivatisation of 5-chlorosalicylic acid (18).
4.3.5.4.1 By acetylation, as 2-acetoxy-5-chlorobenzoic acid (50).
A solution 5-chlorosalicylic acid (18) (500 mg, 2.90 mmol) and pyridine (0.52 g, 6.12
mmol) in dichloromethane (20 ml) was cooled on ice and treated with acetyl chloride
(424 mg, 5.4 mmoi). The reaction was stirred at room temperature for 10 h in a closed
vessel. The reaction mixture was poured onto ice and acidified with 1M HCI (5 ml) and
extracted with chloroform (3 x lOml). The combined chloroform extracts were dried over
anhydrous sodium sulfate, filtered and the solvent evaporated under reduced pressure.
The residue was recrystalised from chloroform to yield a white solid 50, 540 mg (2.53
mmol, 87% )(Characterised by IH_, 13C-NMRand EI-MS see section 4.2.18).
4.3.5.4.2 By iett-butyldimethylsilylation, as tert-butyldimethylsilyl 2-tert-butyldimethyl
silyloxy-5-chlorobenzoate (51).
A solution of 5-chlorosalicylic acid (18) (500 mg, 2.897 mmoi), tert-butyldimethylsilyl
chloride (1.091g, 7.238 mmol) and imidazole (0.789 mg, 11.59 mmol) in DMF (15 ml)
was stirred at 50°C under an argon atmosphere for 15 h. The reaction mixture was poured
into water and extracted three times (3x 10 ml) with petroleum ether (60-80°C). The
combined extracts were washed with a brine solution, dried over anhydrous Na2S04,
filtered and the solvent evaporated under reduced pressure. The residue was purified by
column chromatography (silica, petroleum ether (60-80°C):ether, 10:1) to yield a
colourless oil 51, 980 mg (2.44 mmol, 84%)(Characterised by IH_, 13C_NMR and EI-MS
see section 4.2.19).
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CONCLUSION
The synthesis of fluoro-Ochratoxin B.
From our investigation into the synthesis of fluoro-OB, have emerged a number of
possible synthetic routes. These include:
a) The use of ortho-directed metallation methodology described by Sibi et al.,
1985, on fluorinated starting materials, such as 5-fluorosalicylic acid or the
corresponding benzamide analogue. This synthetic sequence will circumvent
the problems encountered in the selective aromatic fluorination of the
multifunctional aromatic ring.
b) The successful fluorination of sodium acetoacetaldehyde will allow for the
incorporation of this key intermediate into the synthetic procedure employed
by Kraus, 1981 for the preparation of OA.
c) The palladium catalysed trimethylstannylation of BrOB revealed that
metallation was successful at the halogen position and could possibly be
enhanced in the absence of labile phenylalanine benzylic protons. The use of
BrOp, the hydrolysis product of BrOB, as subtrate could avoid this problem.
The coupling of other amino acids and dipeptides to Ou
d) The coupling of L-Histidine, which shares a commonality with L-Phe in the
aromatic nature of their side chains, to Oa will not only probe the amino acid
moiety but also allow for further coupling of histidylhistidine. The effect that
the presence of a dipeptide coupled to Oa will have on the toxicity of OA
could further be explored in the coupling of glycylphenylalanine to Oa.
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